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Abstract 
 
Disuse osteoporosis is a condition in which reduced mechanical loading (e.g. 
bed-rest, immobilization, or paralysis) results in unbalanced bone turnover. The 
American black bear is a unique, naturally occurring model for the prevention of disuse 
osteoporosis. Bears remain mostly inactive for up to half a year of hibernation annually, 
yet they do not lose bone mechanical strength or structural properties throughout 
hibernation. The long-term goal of this study is to determine the biological mechanism 
through which bears maintain bone during hibernation. This mechanism could pinpoint 
new signaling pathway targets for the development of drugs for osteoporosis prevention. 
In this study, bone specific alkaline phosphatase (BSALP), a marker of osteoblast 
activity, and tartrate resistant acid phosphatase (TRACP), a marker of osteoclast 
number, were quantified in the serum of hibernating and active black bears. BSALP and 
TRACP decreased during hibernation, suggesting a balanced reduction in bone 
turnover. This decrease in BSALP and TRACP were correlated positively to serum 
adiponectin and inversely to serum neuropeptide Y, suggesting a possible role of these 
hormones in suppressing bone turnover during hibernation. Osteocalcin (OCN) and 
undercarboxylated OCN increased dramatically in the serum of hibernating bears. These 
increases were inversely correlated with adiponectin, glucose, and serotonin, suggesting 
that OCN may have a unique role in energy homeostasis during hibernation. Finally, 
MC3T3-E1 osteoblasts were cultured in the serum from active and hibernating bears, 
and seasonal cell responses were quantified. Cells cultured in serum from hibernating 
bears had a reduced caspase-3/7 response, and more living cells, after apoptotic threat. 
The caspase-3/7 response was positively correlated to serum adiponectin and to gene 
expression of OCN and Runx2, suggesting that reduced caspase-3/7 activity may be 
related to the reduced differentiation potential of osteoblasts in hibernation serum, and 
that adiponectin is a potential effector hormone. In summary, the activities of osteoblasts 
and osteoclasts are reduced during hibernation in bears. This reduced turnover is due, in 
part, to hormonal control. Further study of potential effectors adiponectin and 
neuropeptide Y may provide insight into the biological mechanism through which bears 
maintain bone throughout hibernation. 
                                                                      1 
 
Chapter One – Background and significance  
  
1.1 Problem description/significance 
 
Disuse osteoporosis is an increasingly common condition in which reduced 
mechanical loading leads to degradation of bone tissue and increased bone fragility. The 
risk of low-impact fracture, especially in the hip, spine, and wrist increases. This disease 
state is a risk for the elderly (who have reduced activity due to exhaustion), victims of 
stroke or spinal cord injury, and cosmonauts exposed to microgravity—as has been 
recently reviewed [1-3]. According to the 2004 Surgeon General’s report on bone health 
and osteoporosis, there are 1.5 million osteoporosis-related fractures annually, including 
over 700,000 vertebral fractures. Such fractures severely diminish the patient’s quality of 
life, as well as soaking up potential wages and increasing medical expenditures. An 
estimated $18 billion (in 2002 dollars) are spent annually on direct medical care for 
osteoporotic fractures. There are several anti-resorptive treatments available, although 
these come with possible side effects such as osteonecrosis of the jaw for 
bisphosphonates, and cardiovascular disease and cognitive impairment for hormone 
therapy [4-9]. There is one FDA-approved anabolic drug for osteoporosis (Forteo, Eli 
Lilly, Indianapolis, IN), but it is cost-restrictive and approved for only 18 months of use; it 
is therefore limited in long-term efficacy [10-12]. The development of new anabolic 
treatments for osteoporosis would benefit society by boosting quality of life and reducing 
medical expenditures. 
 
The goal of this study is to use a naturally occurring model for preventing disuse 
osteoporosis to pinpoint new drug targets for osteoporosis therapy. Black bears (Ursus 
americanus) provide such a model. In Northern climates, black bears undergo annual 
periods of disuse (i.e. hibernation) and activity that are approximately equal in length 
[13]. In humans and other animals, such a cycle would result in an annual deficit in bone 
mass since bone must be reloaded for more than two times the length of unloading to 
fully regain its mechanical properties [1, 14, 15]. However, black bears maintain cortical 
bone mineral and structural integrity with age [16, 17]. Additionally, trabecular and 
cortical bone are unchanged during hibernation in bears [18-21]. Thus, bears must 
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have evolved a mechanism to prevent bone loss during hibernation.  This study will 
explore the cellular mechanism behind bone maintenance in hibernating bears.  
 
1.2 Basics of bone remodeling 
 
Bone is a dynamic organ which responds to a complex array of endocrine, 
neural, and mechanosensory stimulation by adapting its structure metabolically [22, 23]. 
The skeleton simultaneously serves two competing functions. Its first function is to 
protect the internal organs and serve as a lever arm for locomotion. Bone must therefore 
be strong and stiff, and it must respond to mechanical loading by remodeling its 
structure. Its second function is as a reservoir for minerals such as calcium, phosphorus, 
and magnesium. When serum levels decrease, bone must release these minerals by 
breaking down (and therefore weakening) its structural integrity. Bone is therefore 
subject to continuous remodeling such that most of the adult skeleton is recycled every 
10 years. This remodeling is under the intricate control of three basic cell types. 
Osteoblasts are the bone forming cells. They are derived from mesenchymal stem cells 
located in the bone marrow. Following breakdown of bone, osteoblasts line the surface 
of the resorption cavity and begin pumping out new organic matrix and proteins which 
promote mineralization. As new bone is formed, some osteoblasts are trapped inside the 
matrix. These cells terminally differentiate into osteocytes, which form long cytoplasmic 
processes connecting these cells to other osteocytes, osteoblasts, and bone lining cells 
[24]. These processes serve a mechanosensory function in bone [25]. The remaining 
osteoblasts either undergo apoptosis or become quiescent bone lining cells, which form 
a barrier between the bone surface and osteoclasts. Upon activation of resorption, bone 
lining cells retreat from the bone surface, leaving an unprotected surface for osteoclast 
attachment [26]. Osteoclasts serve as the bone macrophage. Upon signaling from 
osteoblasts and osteocytes, hematopoietic stem cells terminally differentiate into 
multinucleated osteoclasts, which tightly glom to naked bone surfaces, creating a 
quarantined resorption cavity [27]. The osteoclast then releases acid and proteases 
which disintegrate the mineral and cleave the organic matrix [28]. This process is 
referred to as the activation and resorption phases of bone remodeling. It is followed by 
the reversal and formation phases [29]. Bone resorption and formation are thus coupled, 
ensuring that wherever bone is resorbed, new bone replaces it [30].   
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1.3 Bone turnover is unbalanced during disuse  
 
Like muscle, bone hails from a “use-it-or-lose-it” philosophy. Bone which is being 
mechanically loaded by normal daily activities undergoes basal levels of remodeling—
mostly for mineral homeostasis and repair of normal fatigue microcracks. However, if the 
bone is unloaded by immobilization or low gravity, the mechanosensory osteocytes 
sense that the bone is no longer necessary and they signal the other cell types to begin 
activation of resorption [22, 25]. An uncoupling of resorption to formation is the result. 
Bone is broken down more rapidly than it is formed, leading to a net loss. This 
uncoupling can be observed in serum resorption and formation markers in astronauts, 
and in victims of stroke and spinal cord injury [31-33]. In contrast, serum resorption and 
formation markers show that osteoclast and osteoblast activities remain balanced during 
hibernation in black bears [34]. Furthermore, histological data demonstrates balanced 
bone remodeling in black bears and in grizzly bears (Ursus arctos horribilis) [18, 20, 21, 
35]. Thus, bears may conserve bone integrity during hibernation by maintaining 
balanced bone resorption and formation. This balance in remodeling is likely driven 
by the bear’s need to preserve homeostatic serum calcium. In most cases of disuse, 
calcium mobilized by the breakdown of bone is excreted in the urine [36]. Bears do not 
consume calcium, and do not excrete wastes during hibernation; however, serum 
calcium levels remain constant throughout the year, suggesting that any calcium 
released by bone resorption must be returned to mineralized bone by balanced 
formation [35]. 
 
1.4 Osteoblast and osteocyte apoptosis results in bone loss 
 
Current theories suggest that the decoupling of resorption to formation during 
disuse may be due to increased osteoblast and osteocyte apoptosis [37]. According to 
the Canalicular Fluid Flow hypothesis, bone can be thought of as a sponge filled with 
extracellular fluid. The pores of the sponge are formed by the canals and lacunae 
housing osteocytes and their processes. When a bone is loaded (i.e. taking a step), the 
fluid is pushed out of the bone by a slight deformation. Upon unloading (picking the foot 
back up again) the fluid returns to the pores. This cyclic loading and unloading applies a 
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fluid shear on the osteocytes stimulating mechanosensory receptors [25]. The 
convective fluid flow also provides nutrients to the cells. When an osteocyte no longer 
senses cyclic loading, it undergoes apoptosis due to nutrient starvation and lack of 
mechanical stimulation [22, 37, 38]. The apoptotic osteocytes initiate the osteoclastic 
resorption of bone, probably through a pro-resorptive signaling cascade involving     
TNF-α [39, 40]. In addition to stimulating osteoclast activation through osteocytic 
apoptotic signaling, disuse may also induce osteoblast apoptosis, reducing the 
population of bone forming cells. With fewer osteoblasts, the bone cannot be reformed 
as efficiently, leading to an uncoupling of resorption and formation.  Before thoroughly 
discussing the roles of osteocyte and osteoblast apoptosis in disuse-induced bone loss, 
it is necessary to review some key apoptosis regulatory pathways in this family of cells. 
 
1.4.1 Review of apoptosis mechanisms in osteoblasts 
 
Apoptosis is a form of genetically programmed cellular suicide in which damaged 
or unneeded cells are removed from tissue, as reviewed recently [41]. The apoptotic 
cascade is mediated by the activation of zymogens from the caspase family of cysteine 
proteases. Caspase activity is closely regulated by the B-cell/Lymphoma-2 (Bcl-2) family 
of proteins including pro-apoptotic BAX and BAD; as well as anti-apoptotic Bcl-XL and 
Bcl-2. In the osteoblast, apoptosis can occur through two different pathways (Figure 
1.1). The intrinsic pathway is initiated by damage to the DNA or an organelle. Following 
such damage, the transcription factor p53 is activated—resulting in a halt in the G1 
phase of the cell cycle, which allows time for the cell to repair itself. If repair is 
unsuccessful, p53 up-regulates gene expression of BAX and down-regulates Bcl-2 [41]. 
BAX mediates the release of cytochrome C from the mitochondria by permeabilizing the 
mitochondrial membrane and releasing cytochrome C monomers. These monomers 
then bind apoptosis protease activating factor-1 (Apaf-1) and caspase-9 monomers 
forming a gigantic (~1MDa) oligomeric complex called an apoptosome, or “the wheel of 
death” [42]. This complex activates effector caspases by zymogen cleavage. The 
extrinsic pathway involves stimulation of a death receptor (or perhaps, in the case of 
disuse, lack of stimulation of a mechanosensory receptor). Stimulation of the death 
receptor results in activation of caspase-8 which then activates effector caspases-3 and 
-7. Separately, caspase-8 also interacts with the intrinsic pathway by indirectly activating 
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pro-apoptosis regulator BAX. An important trait of the Bcl-2 family is its ability to form 
heterodimers. Due to dimerization, the ratio of anti-apoptotic monomers to pro-apoptotic 
monomers can tip the balance from a healthy to an apoptotic cell [43, 44]. In this way, 
there is additional regulation of the intrinsic pathway by anti-apoptotic Bcl-2 and Bcl-XL, 
which can bind to and neutralize BAX. In turn, pro-apoptotic BAD can bind to and 
neutralize Bcl-XL and Bcl-2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Apoptosis can be quantified by several means. Gene and protein expression of 
various early-stage apoptosis regulators such as Bcl-2 family members are commonly 
measured, though a change in these regulators does not necessarily translate to a 
comparable change in apoptosis rates. The protease activity of effector caspases-3, -6 
and -7 are often quantified, as activation of these late-stage apoptosis regulators is a 
better indication of the cell’s eventual demise. Another common technique is to quantify 
Figure 1.1—Simplified schematic of the apoptosis pathways 
Induction of osteocyte apoptosis due to disuse could be initiated through the extrinsic pathway 
(reduced stimulation of mechanosensors), or the intrinsic pathway (organelle damage due to 
reduced blood flow and free-radical formation). There is also cross-talk between the two 
pathways. The arrows represent stimulation of a pathway, the bar-dash represent inhibition of 
a pathway. Information compiled from: [1-3]. 
Extrinsic Path 
Serum Starvation; 
Absence of 
mechanical stimulation 
Intrinsic Path 
Damage to DNA or organelle 
Caspase 8 
Caspase 3 & 7 
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DNA damage due to nuclease cleavage. Nick-end labeling techniques such as TUNEL 
will label the naked 3’-OH in breaks created by nuclease activity, though this technique 
can incorrectly label cells with DNA damage destined for repair [45, 46]. It is also 
possible to use gel electrophoresis or ELISA techniques to quantify a later state of DNA 
digestion, “DNA laddering.” By this stage, nucleases have broken down DNA 
systematically at linker sites between histones, creating monomers, dimers, and trimers 
of DNA/histone chunks. The cell’s DNA is irrevocably digested and this is a suitable end-
point indicating definite cell apoptosis. Also, in cell culture, percent cell death can be 
quantified by means of calcein and ethidium bromide (EtBr) uptake (or a similar method), 
although this technique counts necrotic cells as well as apoptotic cells under the same 
category—dead.  
 
1.4.2 Apoptosis precedes disuse-induced bone loss 
 
As stated earlier, evidence suggests that apoptotic osteocytes promote the 
differentiation of osteoclasts, leading to targeted resorption in the areas surrounding the 
apoptotic osteocytes. A study in rabbit tibiae demonstrates a positive correlation 
between osteocyte apoptosis and serum resorption markers, but no correlation with 
formation markers, suggesting that increased osteocyte apoptosis could result in 
uncoupled remodeling and net bone resorption [47].  
 
The mouse/rat hind-limb unloading model demonstrates that disuse-induced 
bone loss is preceded by osteocyte apoptosis, and that osteoblast apoptosis is also 
present [48-51]. In hind-limb unloaded mice, this increase in apoptosis could be due to 
higher gene expression of p53 in femoral bone marrow [52].  Hind-limb unloaded wild-
type mice lose 45% of their tibial bone volume and have significantly reduced bone 
formation rate (BFR) and increased osteoclast number compared to ground controls; 
whereas genetically similar p53 knockout mice show no significant changes in these 
variables [53]. In hind-limb unloaded rats, an observed increase in osteoblast and 
osteocyte apoptosis is likely due to a decrease in protein levels of Bcl-2 with unchanged 
Bax levels in the femur metaphysis; furthermore, apoptotic cell numbers in these rats are 
not correlated to endogenous glucocorticoids, suggesting an alternative mechanism for 
apoptotic induction may be responsible [54]. Attenuation of apoptosis by intermittent, 
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low-dose administration of parathyroid hormone (PTH) lengthens the lifetime of mature 
osteoblasts, thus increasing BFR and bone mineral density (BMD) of the spine and hind-
limbs of mice [49, 55]. Low-dose, intermittent administration of PTH abates bone loss in 
hind-limb suspended mice [56]. Additionally, attenuation of apoptosis by administration 
of sex steroids or melatonin abates bone loss in ovariectomized rats [57, 58], indicating 
osteoblast and osteocyte apoptosis may play a key role in bone loss due to estrogen 
deficiency as well.  
 
Together, these results suggest that disuse-induced osteocyte and osteoblast 
apoptosis leads to an uncoupling of bone formation and resorption leading to net bone 
loss, and that this mechanism can be controlled by hormones. Administration of anti-
apoptotic hormones can counteract the pro-apoptotic signaling from disuse, thus 
enabling balanced bone formation and resorption. Similarly, if apoptosis of bone cells 
were inhibited during hibernation in bears, formation and resorption would remain 
coupled, resulting in balanced bone turnover, as observed in grizzly bears [20]. It is 
possible that bears maintain balanced bone turnover during hibernation by up-
regulating anti-apoptotic serum factors (or by down-regulating pro-apoptotic 
factors), thus decreasing osteoblast and osteocyte apoptosis. This study quantified 
serum concentrations of several bone-active hormones and explored the anti-apoptotic 
potential of seasonal bear serum on an osteoblast cell line.  
 
In contrast to hind-limb unloading models, simulated microgravity does not 
induce osteoblast apoptosis, although bone mass is lost during space flight due to an 
increase in bone resorption with a decrease in bone formation [31, 59]. Human primary 
osteoblasts, mouse primary osteoblasts, and the immortalized pre-osteoblast cell line 
MC3T3-E1 do not undergo apoptosis when cultured in simulated microgravity compared 
to static controls [60-62]. Thus, microgravity appears to be a unique form of disuse, and 
care must be taken not to generalize between the different forms of disuse osteoporosis. 
 
1.5 Disuse in humans 
 
 Osteopenia due to reduced mechanical loading occurs in a variety of clinical 
situations and can therefore be a threat to anybody, regardless of age and current 
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activity level. As much as 6-32 months following anterior cruciate ligament surgery, the 
BMD of the involved hip can be 3.4-6.6% lower than in the unaffected hip [63]. Patients 
confined to bed-rest can lose 4% of hip BMD after 60 days of bed-rest [64]. When 
confined for up to 90 days in bed, patients lose approximately 1% BMD in the hip per 
month of confinement [65]. Military personnel can also be at risk. Turkish armed forces 
who suffered transtibial amputations from land-mine injuries have reduced BMD in the 
remaining amputated limb compared to the non-amputated limb [66]. This reduction in 
BMD not only increases the chance of fracture, but also may be one cause of residual 
limb pain. After 30 days of submersion in submarines, the bone strength (measured by 
speed of sound) of submariners’ right tibias decreased significantly, accompanied by a 
decrease in bone formation and resorption serum markers; bone strength continued to 
decrease through the first month of return to land and was fully restored after 6 months 
[67]. After 4-14 months of spaceflight, cosmonauts can lose 0.34-1.56% BMD per month 
in various loaded bones such as the hip, leg, and spine [1]. Finally, loss of bone due to 
disuse can also occur after a stroke or a spinal cord injury. In patients suffering from a 
paretic arm more than 1 year after a stroke, the BMD, bone cortical mineral density, 
cortical thickness, and bone strength of the distal and midshaft radius are significantly 
reduced in the paretic arms compared to the mobile arms [68, 69]. Within 71 weeks 
following spinal cord injury, patients lose 15% of BMD in the pelvis and lower limbs [70]. 
The fracture risk of patients with spinal cord injury increases with the degree of motor 
impairment [71, 72].  
 
1.6 Disuse in non-hibernating animals 
 
Reduced bone strength and mineralization under conditions of disuse seems 
universal among the animal kingdom, with the exception of some hibernating animals. In 
birds, disuse osteopenia has been reported in turkey, chicken, pigeon, and cockatiel  
[73-78]. After four weeks of unloading, the ulnae of turkeys lose 12% of cortical area, 
with decreased cortical thickness and increased porosity compared to normally loaded 
controls [73]. Two weeks of unloading lead to a 50% reduction in bone mineral content 
and a 40% reduction in structural strength of chicken tibiae [76]. The calcanei of sheep 
immobilized from the tibia to the metatarsus for 12 weeks experience an 18-29% 
decrease in trabecular bone volume compared to the non-immobilized limb [79, 80]. A 
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decrease in bone trabecular thickness in this model is due to an unbalanced increase in 
osteoclast and osteoblast activity, leading to net bone resorption [81]. The metacarpus III 
of horses lose 10% of BMD after 140 days of forelimb immobilization; this loss is 
accompanied by an increase in the serum resorption marker crosslinked carboxyterminal 
telopeptide of type I collagen (CTX) with no change in the bone formation marker bone 
specific alkaline phosphatase (BSALP), suggesting that the loss in BMD is due to an 
increase in bone resorption with no change in the formation rate [82]. Cats and dogs are 
also vulnerable to disuse osteoporosis [14, 83-85]. The immobilized humeri of dogs have 
significantly reduced BMD as well as a 71-98% decrease in cortical strength and a      
28-74% decrease in trabecular strength than the contra-lateral humeri after 16 weeks of 
left forelimb immobilization [14]. There is also a wealth of studies which quantify bone 
loss in more common laboratory animals such as non-human primates [86-89], rats   
[90-98], and mice [48, 99-102]. It is very well established that most animals lose bone 
when subjected to periods of reduced mobility, so it is exciting to study an animal like the 
hibernating bear, which can undergo months of disuse without losing bone.   
 
1.7 Hibernation as a model of disuse 
 
Hibernation is a state of greatly reduced physical activity and bouts of reduced 
metabolism which conserves energy through seasonal periods of reduced food 
availability. The physical activity of bears rapidly declines in the weeks immediately 
preceding hibernation, and bears remain mostly inactive throughout their denning period 
[13]; thus, hibernation should be an adequate model of disuse (for review see [103]). 
However, bears maintain BMD and mechanical strength despite these extended periods 
of disuse. Mechanical analysis of bones taken before and after hibernation [21], 
seasonal serum markers of bone metabolism [34, 35], and seasonal histological indices 
of cortical and trabecular remodeling [18, 20] together suggest that the rate of bone 
formation equals the rate of resorption during hibernation in the bear. Thus, there is no 
net change in size (e.g. length, thickness), BMD, nor mechanical strength of bone. In 
contrast, most existing studies in smaller hibernators suggest that at least some of these 
animals lose bone during winter sleep [104-109]. However, these early studies in small 
hibernators are qualitative, and recent quantitative data suggest bone loss may be at 
least partially suppressed in hibernating golden-mantled and thirteen-lined ground 
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squirrels [103, 110]. An understanding of the physiology of hibernation is essential 
before determining how bears (if not smaller animals) are able to maintain bone 
throughout hibernation.  
 
1.7.1 Physiology of hibernation 
 
Because hibernation in bears is a state of energy conservation during a period of 
fasting combined with reduced ambient temperatures, the body temperature, heart rate, 
and metabolic rate all decline during hibernation (for review see: [13, 111]). During 
hibernation, the bear’s body temperature decreases from 37-39oC to 34oC. The heart 
rate plummets from its summer value of 40 beats per minute to as low as 8 beats per 
minute during denning. Bears do not eat throughout hibernation; therefore they rely on 
fat stores to support their energy needs during this time. Leading up to hibernation, 
bears forage to dramatically increase their fat mass, which is catabolized during winter 
sleep. Bears that would normally consume 8000 kilocalories during the summer will 
increase to 15,000-20,000 kilocalories in preparation for winter [111]. They will expend 
approximately 4,000 kilocalories per day during hibernation (calculated based on fat 
utilization rates) [111]. A bear can lose between 15-25% total body weight during 
denning [112]. This lost weight is almost entirely fat, as lean body mass and hydration of 
the non-lactating bear remain unchanged by hibernation [112], despite the fact that 
bears do not drink during this time. Hibernating bears are able to remain hydrated by the 
water produced through the combustion of fat [13]. Bears have reduced renal function 
during hibernation and their bladders maintain a constant urine volume despite going for 
up to half a year without urinating [113, 114]. Most importantly, bears remain eucalcemic 
throughout hibernation [35]. Since they do not excrete wastes nor consume food and 
water while hibernating, the calcium in circulation must remain in equilibrium with 
calcium in the bone; thus, any calcium that is mobilized by bone resorption must be 
reincorporated into newly formed bone.  
 
Small hibernators attain a much deeper state of hibernation than bears. 
Reductions in metabolic rate [115-117], heart rate [118, 119], and body temperature 
[117, 120] are more profound in small hibernators compared to bears. Unlike bears, 
small hibernators do not remain immobile throughout hibernation. Every 3-25 days they 
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experience periodic arousals in which they experience bursts of high metabolism that 
raise their body temperatures back to near-normal levels [115, 121, 122]. Because of 
these intermittent arousals, small hibernators reload their bones periodically throughout 
winter; though this reloading probably remains minimal since these animals are confined 
to small burrows during hibernation. Small hibernators also periodically excrete wastes 
such as urine [122-124], which could result in net excretion of calcium throughout the 
winter. Thus, calcium mobilized by resorption of bone during hibernation in small animals 
may not be available for incorporation into newly forming bone as it would be in the bear. 
These differences in metabolism and calcium excretion could explain why small animals 
may lose bone during hibernation, whereas bears do not.      
 
1.7.2 Bone response to hibernation—small hibernators 
 
 Early studies in the bone of small hibernators—including the little brown bat 
(Myotis lucifugus), golden hamster (Mesocricetus auratus), and 13-lined ground squirrel 
(Ictidomys tridecemlineatus)—suggest that these animals undergo disuse-induced bone 
loss during hibernation [104-109, 125, 126]. Between fall and spring, bone porosity 
increases due to enlarged osteocyte lacunae [104, 105, 108, 109, 126]. Hibernating bats 
and hamsters reduce cortical bone thickness [104, 105, 108, 126]. Bone mineral content 
decreases in the hibernating bat [125]. Although these studies all suggest that small 
hibernators lose bone during hibernation, most of them are based on qualitative 
observations (for review see: [103]). Some quantitative data have been collected more 
recently in the golden-mantled ground squirrel (Callospermophilus lateralis) [110]. This 
study found that femoral and tibial bone strength is not affected by 8 months of 
hibernation. The Donahue lab has collected some preliminary quantitative data on the 
femurs of 13-lined ground squirrels, finding that during the hibernation season bone is 
lost on the microstructural scale due to increased lacunar size; however, despite these 
microstructural changes, the bone geometrical properties and mineral content were not 
different before, during, and after hibernation [103]. Therefore, more comprehensive 
studies need to be completed before interpreting the effects of hibernation on bone of 
small animals.   
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1.7.3 Bone response to hibernation—bears: histological and mechanical data 
 
Histological and mechanical data demonstrate that bears do not lose bone during 
hibernation. In other animals, when bone is lost due to mechanical unloading, the bones 
must be reloaded for more than twice the time of unloading before the lost bone is 
regained [1, 14, 15, 127]; however, bears hibernate for periods as long as half the year, 
and only reload for the remaining half-year.  These cycles should result in an annual 
deficit of bone, but the cortical bone bending strength and mineral content of black bears 
increases with age, while porosity remains unchanged [16, 17]. This increase in mineral 
and structural integrity occurs at approximately the same rate as in humans of similar 
age ranges (i.e. age normalized to life span) [128]. These data demonstrate that bears 
do not experience an annual deficit of bone. To determine whether bears maintain bone 
throughout hibernation, or if they lose bone only to regain it by increased formation in the 
weeks immediately following hibernation, studies were performed with grizzly bear 
femurs harvested during summer-active and hibernating seasons. These studies 
demonstrated that bone geometry and strength were not different in the hibernating 
bear, while mineral content increased and porosity decreased during hibernation [20]. In 
contrast, porosity increases and mineralization decreases in the bones of most animals 
undergoing disuse [129, 130]. Bone loss in trabecular bone is also important to disuse 
studies, since the increased surface area of this sponge-like bone renders it highly 
susceptible to resorption during disuse [131, 132]. Early studies comparing ilium 
biopsies of black bears in fall and spring have suggested that bears do not lose 
trabecular bone during hibernation [35]. Similarly, a study in the radius of hunter-killed 
black bears collected in the fall and spring demonstrate no seasonal differences in 
trabecular bone mineral content, trabecular thickness, or trabecular bone volume fraction 
[19]. Studies performed in the distal femoral metaphysis, distal femoral epiphysis, and 
ilium of hibernating and active grizzly bears confirm that hibernation has no effect on 
trabecular bone structural properties or mineral density [18].  
 
In summary, structural and mechanical properties of bear bones are not affected 
by hibernation either in the long term (with age) or from season to season within one 
year. Other animals would suffer severe loss of bone after 6 months of not moving, and 
would not be able to gain it back during the remaining 6 months of activity; therefore, 
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bears must have evolved a mechanism to combat disuse-induced bone loss during 
hibernation.  This mechanism must conserve the balance between bone resorption and 
formation such that there is no net change in bone accrual. Resorption and formation 
may remain in equilibrium in three ways: 1) neither the bone resorption nor the formation 
rate changes; 2) resorption and formation rates increase with the same acceleration;    
3) resorption and formation rates decrease with the same deceleration. Analyses of 
serum markers of bone turnover and histomorphometric indices of cellular activities are 
widely used methods to ascertain whether resorption and formation rates have changed.  
 
1.7.4 Bone response to hibernation—bears: serum formation markers and 
histomorphometry 
 
Serum markers for bone formation (osteocalcin (OCN), carboxy-terminal of 
propeptide of type I procollagen (PICP)) and resorption (carboxy-terminal cross-linked 
telopeptide of type I procollagen (ICTP)) exhibit a balanced increase in the hibernating 
compared to the active bear [34, 133, 134]. Furthermore, concentrations of calcium in 
the blood remain seasonally constant, although bears do not consume or excrete 
calcium during hibernation [35, 135].  These data suggest that bone resorption increases 
during hibernation, but that mobilized calcium is returned to the bone by increased 
osteoblast activity. In contrast, histomorphometric indices of trabecular and cortical bone 
suggest that although bone resorption and formation remain balanced during 
hibernation, the osteoclast and osteoblast activities are both dramatically reduced during 
winter sleep [18, 20].  These paradoxical findings could be explained in a few ways. One 
explanation is that although bone turnover decreases in the locations of biopsies, the net 
turnover of the entire skeleton increases during hibernation. However, the biopsies were 
collected from several locations, and all of them suggest a sharp reduction in turnover 
[18, 20]. Furthermore, an increase in bone turnover with no net change in bone quantity 
or quality would be an energetically costly effort for no apparent benefit. During this 
extended period of fasting, a reduction in bone metabolism is more advantageous.  
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1.7.5 Hypothesis 1: BSALP and TRACP reduction during hibernation 
 
Another explanation of the conflicting histological and serum marker data is that 
the serum markers quantified could have accumulated in the blood during hibernation 
due to reduced net urine production. During hibernation, the rate of urine filtration is 
reduced by approximately 30% of summer values to a urine production rate of 100mL 
per day [113], and water and urea are reabsorbed into the bloodstream through the 
bladder wall at the same rate as urine is produced [114] (For review see: [13, 111, 124, 
136]). The hibernating bear therefore experiences some of the physiological effects of 
reduced renal function such as an accumulation of serum creatinine [112, 113, 137-139], 
and may be compared to human hemodialysis patients. Neither ICTP [140-142] nor 
OCN [143-146] is considered a good serum marker of bone turnover in patients with 
reduced renal function, because these factors are normally filtered out by the kidney (for 
review see: [147]). In humans, a 30% decrease in glomerular filtration rate results in an 
approximate 65% increase in serum OCN [148]. The hibernating bear, like a human 
patient with reduced renal function, may accumulate circulating OCN and ICTP; 
therefore, these markers may reflect glomerular filtration rates rather than bone turnover. 
To determine whether serum markers of bone turnover conflict with 
histomorphometric data, it is necessary to quantify serum markers that do not 
accumulate due to reduced renal function. Two such serum factors, the formation 
marker BSALP [143-145] and tartrate-resistant acid phosphatase (TRACP) [148, 149], 
an indicator of osteoclast number, are not influenced by renal function.  
 
(1) The first Aim of this study was to quantify the markers BSALP and 
TRACP in the serum of black bears every 10 days from October through 
the beginning of May, thus encompassing prehibernation, hibernation, 
and post-hibernation periods.  The hypothesis was that BSALP and 
TRACP activities would coincide with previous histomorphometric data 
to suggest that bone formation and resorption remain balanced, though 
decreased, during hibernation.  
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1.7.6 Hypothesis 2: OCN interacts with energy metabolism 
 
A third explanation of the discrepancy between histomorphometric data and bone 
turnover markers is that some of the factors quantified may be up-regulated in the serum 
during hibernation as hormonal signals to other tissues. For instance, circulating OCN 
can function as a hormone to regulate energy metabolism (for review see: [150, 151]). In 
mice, the undercarboxylated form of OCN (ucOCN) increases adiposity and the 
secretion of adiponectin from adipocytes, it promotes the proliferation of pancreatic       
β-cells and their secretion of insulin, and it enhances insulin sensitivity [152, 153]. Thus, 
increased OCN, especially ucOCN, could have an array of complex effects on the 
physiology of energy metabolism during hibernation. ucOCN could increase adiponectin 
secretion during hibernation [152, 153], thus promoting more efficient glucose uptake 
and fatty acid oxidation [154, 155]. In addition, an increase in adiponectin during 
hibernation could potentially offset disuse-induced osteoblast loss by increasing 
osteoblast differentiation and proliferation [156-158]. Thus, it is possible that bears 
increase circulating OCN levels during hibernation as a mechanism to control 
energy metabolism during this period of low energy expenditure. 
 
(2) The second Aim of this study was to quantify total and ucOCN, glucose, 
insulin, and adiponectin in the serum of black bears every 10 days from 
October through the beginning of May. The hypothesis was that OCN, 
ucOCN, insulin, and adiponectin would all increase and glucose would 
decrease in the serum of hibernating bears (compared to that of active 
bears). ucOCN levels were expected to have a positive relationship to 
insulin and adiponectin, and a negative relationship to glucose levels. 
 
1.7.7 Hypothesis 3: Reduced apoptotic serum factors during hibernation 
 
In addition to asking why bone turnover markers do not match histomorphometric 
indices, another question was asked: how do hibernating bears maintain bone structure 
and strength during this extended period of disuse? It has been suggested that bear 
bones (and muscles) are mechanically loaded during hibernation by shivering, thus 
preventing atrophy [19, 159]. During hibernation periods greater than one hour, captive 
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grizzly bears exhibit low levels of shuddering (<0.2 seconds of muscle activation every  
3-10 seconds) [159]. However, high-frequency, low-magnitude loading is not anabolic on 
cortical bone [160] and bears in the Donahue, et. al. studies maintain cortical bone 
properties [20, 21, 161]. Furthermore, grizzly bears only start shivering after their body 
temperatures have dropped >5oC (Brian Barnes, personal communication), but the 
bears used by Donahue, et. al. rarely drop past this threshold. Therefore it is probable 
that another mechanism for maintaining balanced bone formation and resorption is 
responsible. 
 
As stated earlier, it is possible that bears maintain balanced bone resorption and 
formation during hibernation by inhibiting osteoblast and osteocyte apoptosis.  Osteocyte 
apoptosis precedes bone loss in unloaded mice, and attenuating osteocyte and 
osteoblast apoptosis with injections of PTH will inhibit this bone loss [48-51, 56]. It is 
possible that osteoblast and/or osteocyte apoptosis is required for disuse-induced bone 
loss, although currently no studies have explored this idea. However, a study with a  
pan-caspase inhibitor in ovariectomized mice demonstrates that caspase activation is 
required for bone loss in this model of osteoporosis [162]. Many hormones are known to 
regulate osteoblast and osteocyte apoptosis, the most notable of which are PTH [49, 55] 
and steroid hormones like estrogen [57]. If concentrations of anti-apoptotic 
hormones increase during hibernation in bears, bone loss may be prevented 
during this period of extended disuse.  
 
Apoptosis-inducing threats are prevalent in hibernating animals—these include 
prolonged drops in temperature, substantial decreases in oxygen transport to tissues, 
metabolic acidosis, anorexia, and disuse—yet hibernating animals do not seem to suffer 
from large-scale apoptotic response (for review see: [163]). Despite this qualitative 
observation that hibernating animals seem resistant to apoptosis, few studies have 
specifically quantified apoptosis in tissues from hibernating animals. Although the 
expression of the anti-apoptotic protein Akt increases in the gut of hibernating ground 
squirrels, the amount of activated (i.e. phosphorylated) Akt during winter remains 
unaffected compared to summer values [45]. However, this study found a decrease in 
phosphorylated Akt in the gut mucosa of torpid ground squirrels compared to inter-bout 
arousal squirrels [45]. Reduced Akt phosphorylation has also been observed in the 
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brain, heart, and femoral muscle of hibernating ground squirrels compared to winter 
warm-adapted (active) squirrels [164]. Similarly, levels of phosphorylated Akt in the 
brain, kidney, liver, and white adipose tissue of torpid bats was lower than levels in bats 
aroused from hibernation [165]. This hypophosphorylation of Akt may not increase 
apoptosis in the hibernating animal. It is possible that reduced levels of phosphorylated 
Akt may act through FoxO transcription factors to induce a state of hypometabolism 
which protects cells from glucose and oxygen deprivation [164, 166, 167]. Thus, in the 
low-energy environment of hibernation, hypophosphorylation of Akt may prevent cell 
death, rather than promote it.  
 
A few studies have explored the effects of hibernation on TUNEL staining. The 
seminiferous epithelium of cold adapted (hibernating) Syrian hamsters had more TUNEL 
positive cells than warm adapted (active) hamsters [168]. TUNEL positive cell numbers 
increased in the brains of hibernating frogs (Rana esculenta) compared to summer-
active frogs [169]. The number of TUNEL positive enterocytes in the midvillus region of 
summer squirrels was higher than the number in winter (hibernation) squirrels [45]. This 
trend in TUNEL positive cells increased with time as winter progressed, such that late-
hibernation squirrels had the highest number of TUNEL positive cells [45]. In contrast, 
this study also demonstrated that caspase-3 activation in the gut of hibernating ground 
squirrels decreased compared to active squirrels, and no DNA laddering was present in 
hibernation gut tissue [45]. These data suggest that TUNEL stains in hibernating tissues 
may be inaccurately interpreted as an increase in apoptosis. It is possible that the 
increase in TUNEL positive cells during hibernation may be due to an accumulation of 
damaged DNA during this season [45]. Therefore, it is unclear from these studies 
whether apoptosis is generally inhibited during hibernation, though the study in gut 
tissue would suggest a suppression of apoptotic signaling overall [45], and qualitative 
assessments of tissue survival in hibernation suggest that apoptosis-mediated tissue 
damage is minimized at this time [163]. It is possible that an alleviation of osteoblast 
and osteocyte apoptosis during hibernation (possibly through circulation of anti-
apoptotic hormones) combats bone loss.  
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(3) The third Aim of this study was to quantify concentrations of anti-
apoptotic hormones (e.g. PTH, melatonin) in the serum of black bears 
every 10 days from October through the beginning of May. Osteoblasts 
were cultured in media supplemented with seasonal bear serum to 
determine the cellular response (e.g. caspase-3 activation, cell death). 
The hypothesis was that serum levels of an anti-apoptotic hormone 
such as PTH would increase during hibernation, and that 
concentrations of this hormone would be negatively correlated with the 
caspase-3 activation and cell death. 
 
The reasoning behind this Aim was that if apoptosis in bone is inhibited during 
hibernation through a serum-borne hormone, then cells cultured in hibernating bear 
serum may be less susceptible to apoptosis than cells cultured in active serum.  
 
1.8 Hypotheses and Aims  
Hypothesis 1: Serum concentrations of BSALP and TRACP are lower in samples taken 
from hibernating bears than those from active bears.  
Aim 1: Quantify the markers BSALP and TRACP in the serum of black bears every 10 
days from October through the beginning of May. Determine longitudinal trends 
for each bear.  
 
Hypothesis 2: Serum concentrations of OCN, ucOCN, insulin, and adiponectin increase, 
and glucose levels decrease, in the serum of hibernating bears (compared to that 
of active bears). ucOCN levels have a positive relationship to insulin and 
adiponectin, and a negative relationship to glucose levels. 
Aim 2: Quantify OCN, ucOCN, glucose, insulin, and adiponectin in the serum of black 
bears every 10 days from October through the beginning of May. Determine 
longitudinal trends for each bear. Use regression analysis to find any 
relationships between the concentrations of these serum factors.   
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Hypothesis 3a: Serum concentrations of anti-apoptotic hormones (e.g. PTH, melatonin) 
are higher in samples taken from hibernating bears than those from active bears. 
Hypothesis 3b: Serum from hibernating bears provides an anti-apoptotic environment for 
osteoblasts in culture (compared to serum from active bears). The response of 
osteoblasts to apoptotic stimulus is suppressed in cells cultured in hibernating 
bear serum (compared to those in active bear serum).  
Aim 3a: Quantify concentrations of anti-apoptotic hormones (e.g. PTH, melatonin) in the 
serum of black bears every 10 days from October through the beginning of May. 
Determine longitudinal trends for each bear. 
Aim 3b: Culture osteoblast-like cell line MC3T3-E1 in media supplemented with bear 
serum and determine the cellular apoptotic response (e.g. caspase-3 activation, 
cell death). Use regression analysis to find any relationships between apoptotic 
response and anti-apoptotic hormone concentrations. 
 
These Aims will be discussed in a series of chapters written in the form of journal 
articles for publication. Chapter 2 will address Aims 1 and 2 as outlined above, and will 
discuss how the interplay between energy homeostasis hormones and bone metabolism 
could benefit a hibernating bear by reducing energy expenditure. Chapter 3 will further 
address Aim 1, and will propose several hormones which may reduce bone metabolism 
and prevent disuse-induced bone loss during hibernation in bears. Chapters 4 and 5 will 
address Aims 3a and 3b, respectively. Chapter 5 will demonstrate that osteoblasts 
cultured in serum from hibernating bears are less responsive to apoptotic stimulus than 
cells cultured in serum from active bears. Additionally, it will outline a series of 
experiments to characterize the serum factor responsible for this seasonal apoptotic 
response. Finally, Chapter 6 will demonstrate that seasonal bear serum does not 
dramatically affect the gene expression of cultured osteoblasts. Although the long-term 
goal of identifying the mechanism through which hibernating bears maintain bone 
despite extended periods of disuse is still in the future, this study provides insights into 
the hormonal regulation of bone metabolism during hibernation. The findings from this 
study can be used to develop future experiments in quest of the long-term goal.   
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Chapter Two — Serum osteocalcin is inversely associated 
with adiponectin, glucose, and serotonin in black bears 
 
2.1 Introduction 
 
Despite bears’ inactive states throughout the months of hibernation, 
histomorphometric indices of trabecular and cortical bone suggest that although 
osteoclast and osteoblast activities dramatically decrease [18, 20], bone resorption 
remains balanced with bone formation during hibernation. In contrast, the bone 
resorption marker ICTP and formation marker OCN both display steep increases in the 
serum of hibernating black bears [34, 133, 134]. The purpose of hibernation is to 
conserve energy during the long anorectic periods of winter. Retaining balanced, though 
reduced, bone turnover (as is suggested by the histomorphometric data) is energetically 
favorable to increased turnover; therefore it is possible that the turnover markers 
accumulate in the serum during hibernation for other reasons.  
 
One possible reason for the increase in serum turnover markers is reduced renal 
function. During hibernation, the bear’s renal function is decreased by 30% from summer 
values [113]. The hibernating bear therefore experiences some of the physiological 
effects of reduced renal function such as an accumulation of serum creatinine [112, 113, 
137], and may be compared to human hemodialysis patients. ICTP is mobilized into the 
circulation upon bone resorption, and is therefore considered a marker of osteoclast 
activity [170, 171]; however, it is not considered an effective indication of bone resorption 
rates in patients with reduced renal function as it exits the blood-stream through urine 
[140-142]. OCN is secreted by osteoblasts during the formation of bone and is 
commonly used as a marker of bone formation. It also accumulates in the serum of 
patients with reduced renal function and is not considered an ideal marker of bone 
formation rates in hemodialysis patients [143-146]. Quantifying serum markers that do 
not accumulate with decreased renal function would therefore help clarify any 
discrepancy between histomorphometric indices and serum markers of bone turnover. 
Two such serum factors are BSALP [143-145], a marker of osteoblast activity, and 
TRACP [148, 149], a marker of osteoclast number. Neither is influenced by renal 
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function. Therefore, the first goal of this study was to quantify BSALP and TRACP in the 
serum of hibernating and active American black bears. The hypothesis was that serum 
BSALP and TRACP activities would fall during the months of hibernation, coinciding with 
the reduced osteoblast and osteoclast activities observed in histological studies [18, 20]. 
 
Another possible explanation for the apparent discrepancy between serum 
markers and histomorphometric indices of bone turnover during hibernation is that the 
accumulating serum factors may be acting as hormones to impact other tissues during 
hibernation. For instance, OCN can function as a hormone to regulate energy 
metabolism (for review see [150, 151]). In order to function properly, OCN is post-
translationally γ-carboxylated on multiple glutamine residues, in a vitamin K-dependent 
reaction. In mice, ucOCN increases adiposity and the secretion of adiponectin from 
adipocytes, it promotes the proliferation of pancreatic β-cells and their secretion of 
insulin, and it enhances insulin sensitivity [152, 153]. The second goal of this study was 
to quantify the serum levels of OCN and to determine whether increased OCN levels 
during hibernation were associated with increases serum insulin and adiponectin. Such 
a relationship would suggest that OCN may act as a hormone to help regulate energy 
metabolism during hibernation.   
 
2.2 Methods and materials 
 
2.2.1 Bear handling and sample collection 
 
 The Virginia Polytechnic Institute and State University Animal Care Committee 
approved all bear handling protocols (#98-069-F&WS). A total of 16 female black bears 
were captured and held in pens in the Virginia Tech Center for Bear Research from fall 
through spring, between the years 2003 and 2009. Each bear was held for a single 
hibernation season. The bears were between 2 and 21 years old. Many gave birth to 
cubs during hibernation. Information about ages and cub births are provided in Table 
2.1. Bears utilize fat nearly exclusively for energy during hibernation [13], and lose 10-
40% body weight (due to fat loss) during this time. The bears in our study lost 20-40% 
body weight over the 3 month hibernation period. Upon completion of the study, bears 
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were released. Behavior indicating stress was not observed during any of the handling 
procedures. Body temperatures were 4°C to 6°C cooler during winter, confirming that the 
bears were in a state of hibernation. No urine or scat was present in the hibernation 
dens. The bears were anesthetized with a 2:1 mixture of ketamine (100·mg/mL):xylazine 
(100·mg/mL); the dosage was 1·cc of the mixture per 45.5·kg of body mass. Blood 
samples were drawn from the femoral vein while the bears were anesthetized, and the 
samples were transported to the laboratory in an ice packed cooler. Immediately upon 
return to the laboratory, the blood was spun to isolate the serum, which was frozen at    
–20°C. Blood samples were collected from each bear every 10 days (one decad) from 
the beginning of October until the end of May. Hibernation began in early January and 
ended in early April. Thus, the collection dates encompassed an active prehibernation 
period, a disuse hibernation period, and a post-hibernation remobilization period.  
 
2.2.2 Biochemical assays 
 
Table 2.1 summarizes which bear serum samples were used for each 
biochemical assay. Due to limitations of serum sample sizes, not all bears were used for 
all assays. The choice of bear used for each assay depended upon sample availability at 
the time the assays were run. TRACP activity was quantified in the serum of 9 bears as 
follows:   10 μL of plasma from the bears was diluted in 10 μL milliQ water, and added to 
80 μL of freshly prepared reaction buffer (0.33 mol/L acetic acid, 0.167% TritonX-100, 
0.33 mol/L NaCl, 3.33 mmol/L ethylenediaminetetraacetic acid at pH 5.5, 1.5 mg/ml of 
ascorbic acid, 7.66 mg/ml of Na2-tartrate, 3 mg/ml of 4-nitrophenylphosphate). The 
optical density of the colored product at 405 nm was quantified in a plate reader, with a 
reference optical density of 650 nm. Relative optical densities were reported as no 
TRACP standard was used.  Activities of BSALP and total alkaline phosphatase (ALP) 
were determined in the serum of 9 bears by differential binding to wheat germ lectin 
(WGL) as follows: 25 μL of serum was mixed with 25 μL of WGL solution (4.5 mg/ml) 
and the mixture was incubated at 37oC for 30 minutes.   The mixture was centrifuged for 
2 minutes, and alkaline phosphatase activities of the supernatant and parallel untreated 
serum were quantified by a kinetic colorimetric assay at an optical density of 405 nm 
(Sigma, St. Louis, MO). Total serum ALP was the activity of the untreated serum. 
BSALP activity was quantified by subtracting the WGL supernatant from the total ALP 
                                                                      23 
 
activity. Ionized calcium was quantified in the serum of 6 bears with an ion-selective 
electrode (Bayer Rapidlab 865, Leverkusen, Germany).  
 
Serum OCN was quantified as previously described [34]. Briefly, 10 μL bear 
serum was assayed in duplicate by radioimmunoassay (RIA). The antibody was guinea-
pig anti-rat OCN and the tracer was 125I-labeled rat OCN. Dose dilutions of purified bear 
OCN [34] were used as standards. Intra-sample measurements varied by less than 5%. 
ucOCN was estimated as the amount of OCN remaining after absorption of carboxylated 
OCN by hydroxyappetite. Concentrations of two different forms of vitamin K 
(phylloquinone and mneaquinone-4) were determined in the serum of 4 bears by 
reversed-phase HPLC using post-column reduction, followed by fluorometric 
detection [172].  The lower limits of detection of this HPLC assay are 0.02 nmol/L 
and 0.07 nmol/L for serum phylloquinone and MK-4, respectively. Adiponectin was 
measured in the serum of 9 bears by the human adiponectin double antibody RIA 
kit (Linco Research Inc., St. Louis, MO). Intra-assay C.V.’s were 17%, 4.7%, and 7.3% 
at 5.1, 29.9, and 119 ng/mL, respectively. Insulin was quantified in the serum of 9 bears 
using the Millipore (LINCO) RIA method. Sensitivity of the method is 2 μIU/ml.  Intra-
assay precision averaged 3.2% while inter-assay precision averaged 3.9%. Normal 
fasting levels are 5-15 μIU/ml in human serum. The serum collected from 6 bears was 
assayed for serotonin by enzyme-linked immunosorbent assay (ELISA) (ALPCO 
Diagnostics, Salem, NH). The sensitivity of this assay is 5 ng/mL, with an intra-assay 
precision of 5.4% and an inter-assay precision of 6.0%. Expected serotonin levels in 
female human serum is 80-450 ng/mL. Chemistry panels (including total calcium and 
glucose) were performed from the serum of 4 bears on a Roche modular P Clinical 
Chemistry analyzer (Roche, Nutley, NJ) using colorimetric methods.  
 
2.2.3 Data representation and statistics 
 
All statistical analyses were performed using JMP 7 software (SAS, Carey, NC). 
Data in tables are presented as the least square mean (LSM) + standard error (SE). 
Graphs are represented with a point for each serum sample, and a smoothed average 
curve generated with JMP software by a cubic spline. For the graphs depicting 
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normalized data, each serum factor concentration was divided by the average 
concentration for the appropriate bear. This procedure made it easier to determine 
whether all bears experienced similar fold changes in the serum factors. 
 
To avoid missing trends in the data, each sample set was analyzed in two ways: 
longitudinal “peak-valley” analysis and “seasonal means” analysis. Longitudinal “peak-
valley” analysis was performed on each of the serum factors as follows: The smoothed 
average curve for each serum factor was viewed (for example see Figure 2.1 B). The 
peak or valley from each season was selected for analysis. In the example (Figure     
2.1 B), the decads for analysis are indicated with red arrows. The values for each bear 
at these decads were analyzed using a single-factor ANOVA, blocking by bear, with a 
Tukey’s post-hoc; thus, differences between peaks and valleys were compared. This 
method assured that directional trends in the data were not missed by bulking data from 
an entire season; it also provided a balanced data set, with one sample for each bear for 
each season. For some bears, a value for the appropriate decad was missing. In these 
cases, the value for the adjacent decad was substituted. If an adjacent decad was not 
available, that bear was omitted from longitudinal analysis. The decads chosen for 
analysis are recorded in Tables 2.2, 2.4, and 2.6. In “seasonal means” analysis (Tables 
2.3, 2.5, and 2.7), all available samples from all bears were grouped by season (i.e. 
prehibernation, hibernation, and post-hibernation) and analyzed with a single-factor 
ANOVA, blocking by bear, with a Tukey’s post-hoc. This method indicates overall 
seasonal trends, and avoids over-interpretation of transitory peaks or valleys. However, 
as many samples were missing, it does not contain equal numbers of samples for each 
bear in each season. For all one-factor ANOVAs blocked by bear, the p-values reported 
are for the partial F-test for the serum factor.      
 
Relationships among serum factors were determined from all available samples 
by linear regression, blocking by bear. The effects of age and birth of cubs were 
determined for longitudinal “peak-valley” and “seasonal means” analyses by blocking by 
age or cub. If the p-value for the effect was less than 0.05, the effect was considered 
significant. Effects are reported in Table 2.9.  
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2.3 Results 
 
Serum activity of the bone formation marker BSALP fell from October through 
January, when they began to rise again (Figure 2.1). By the “seasonal means” analysis, 
BSALP activity decreased from 21.0+1.27 U/L in the fall to 8.79+1.20 U/L during 
hibernation and rose again to 19.5+1.86 U/L in the spring (p<0.0001) (Table 2.5). Both 
“peak-valley” (Table 2.2) and “seasonal means” (Table 2.5) analyses displayed 
significant decreases in BSALP during hibernation compared to prehibernation, though 
by “peak-valley” analysis the post-hibernation values were not significantly higher than 
hibernation, as they were for the “seasonal means” analysis (Tables 2.2 and 2.3). The 
smoothed average curves show that serum TRACP activities decreased during 
hibernation compared to active periods in all bears except one, which had an outlying 
point in mid-February (Figure 2.2 A). By “seasonal means” analysis, TRACP dropped 
from 1.18+0.03 in the prehibernation season to 0.966+0.03 in hibernation and rose back 
to 1.31+0.05 in the post-hibernation season (p<0.0001) (Table 2.3). This trend was 
similar for the “peak-valley” analysis (Table 2.2). The smoothed average curve for total 
calcium shows a slight decreasing slope from November through April (Figure 2.3). By 
“seasonal means” analysis, total serum calcium dropped from 8.66+0.07 mg/dL in the 
fall to 8.25+0.10 mg/dL in the spring; however, total calcium levels during hibernation 
were not significantly different from either active season (p=0.0068) (Table 2.3). There 
was no significant trend in total calcium by “peak-valley” analysis (Table 2.2). The 
smoothed average curve for ionized calcium shows a slight increase in the weeks 
immediately following hibernation (Figure 4). By “seasonal means” analysis, ionized 
calcium rose from 3.61+0.02 mg/dL in hibernation to 3.73+0.03 mg/dL in post-
hibernation; prehibernation ionized calcium levels were not different from either of the 
two other seasons (p=0.0202) (Table 2.3). There was no significant trend in ionized 
calcium by “peak-valley” analysis (Table 2.2).  
 
The smoothed average curves show that total OCN levels in the bear serum rose 
sharply from December through March (Figure 2.5). In March, levels began to drop, 
though by May they had not reached the low levels observed in November. “Seasonal 
means” analysis shows that total OCN rose from 15.8+3.5 ng/mL in fall to 61.1+3.0 
ng/mL during hibernation dropped down to 43.9+3.8 ng/mL in spring (p<0.0001) (Table 
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2.3). By “peak-valley” analysis, total OCN also rose significantly during hibernation 
(Table 2.2). The total OCN levels in the post-hibernation season, although significantly 
reduced from hibernation, remained significantly higher than during prehibernation. 
ucOCN levels also rose sharply during hibernation compared to prehibernation, peaking 
in March (Figure 2.6). Unlike the total OCN, by May ucOCN levels had dropped back 
down to the levels observed in November. “Seasonal means” analysis shows that 
ucOCN rose from 0.324+1.29 ng/mL during prehibernation to 9.81+1.09 ng/mL during 
hibernation and then dropped back to 2.68+1.65 ng/mL in the weeks following 
hibernation (p<0.0001) (Table 2.3). Likewise, the percent ucOCN (ucOCN/OCN x 100%) 
rose from 1.15+1.49 in the fall to 15.5+1.27 during hibernation and then fell to 6.36+1.92 
in the spring (p<0.0001) by “seasonal means” analysis (Table 2.3). “Peak-valley” 
analysis portrayed similar results for ucOCN and percent ucOCN (Table 2.2). Serum 
vitamin K levels were below detectable limits in all serum samples; these results were 
verified by mass spectrometry. 
 
Serum adiponectin decreased during hibernation, with a plateau that remained 
relatively flat through most of hibernation (Figure 2.7 B). By “seasonal means” analysis, 
adiponectin levels dropped from 1912+42 ng/mL in the fall to 1347+40 ng/mL during 
hibernation and rose back to 1919+61 ng/mL in the spring (p<0.0001) (Table 2.5). 
“Peak-valley” analysis revealed the same trends in serum adiponectin (Table 2.4). 
Serum glucose levels increased from October till mid-November (Figure 2.8 B). In mid-
December glucose levels began to drop, reaching a plateau at the end of February, 
when they began a shallow ascent like a sleek blue heron spiraling languidly towards the 
sun, rising pregnantly in the East. By “seasonal means” analysis, glucose levels dropped 
from 178+5 mg/dL in the prehibernation season to 118+5 mg/dL during the hibernation 
season and then rose again to 136+7 mg/dL in the post-hibernation season (p<0.0001) 
(Table 2.5). “Peak-valley” analysis revealed the same trends in serum glucose (Table 
2.4). Insulin levels were relatively constant from October through mid-November at 
which time they began to decrease (Figure 2.9 B). They reached a trough in mid-
December and remained at approximately 33% below original levels through the end of 
March. When the bears awakened in April, insulin levels rose again. “Seasonal means” 
analysis revealed that serum insulin dropped from 6.81+0.24 μU/mL in fall to     
5.78+0.23 μU/mL during hibernation and then rose to 7.72+0.35 μU/mL in spring 
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(p<0.0001) (Table 2.5). In contrast, by “peak-valley” analysis the decreased trend in 
insulin during hibernation is not statistically significant (Table 2.4). “Seasonal means” 
analysis of serotonin concentrations revealed a decrease from 788+30 ng/mL in 
prehibernation to 593+26 ng/mL during hibernation; post-hibernation serotonin levels 
were not significantly different from either preceding season (p<0.0001) (Table 2.5); 
however, there was no difference in serum serotonin by “peak-valley” analysis (Table 
2.4).  
 
The chemistry panel data are reported in Tables 2.6 and 2.7. There was no 
seasonal change in total bilirubin by either analysis method. By “seasonal means” 
analysis, total protein decreased from 7.75+0.09 g/dL during hibernation to        
6.64+0.12 g/dL in post-hibernation; there was no difference between the average total 
protein during prehibernation and the average during hibernation (p<0.0001). The trend 
was similar by “peak-valley” analysis. By “seasonal means” analysis, serum albumin 
dropped from 4.07+0.06 g/dL during hibernation to 3.46+0.08 g/dL in the spring; there 
was no significant difference between prehibernation and hibernation serum albumin 
averages (p<0.0001). The trend was similar by “peak-valley” analysis. “Seasonal means” 
analysis revealed that globulin decreased from 3.68+0.06 g/dL in hibernation serum to 
3.19+0.09 g/dL in the spring-time serum; there was no difference between the average 
serum globulin in prehibernation and hibernation seasons (p<0.0001). By “peak-valley” 
analysis, there was no significant trend in serum globulin. Total serum ALP had trends 
similar to BSALP, with a significant decrease during hibernation by both analysis 
methods. Serum alanine transaminase (ALT) and aspartate aminotransferase (AST) 
were significantly higher during prehibernation than either hibernation or post-hibernation 
values by both analysis methods. However, the ratio AST:ALT was significantly lower 
during prehibernation. By “seasonal means” analysis, ALT dropped from 34.6+1.2 U/L in 
prehibernation serum to 21.4+1.1 U/L in hibernation serum (p<0.0001), and AST 
dropped from 73.3+3.5 U/L in prehibernation serum to 53.7+3.4 U/L in hibernation serum 
(p<0.0001). By both analysis methods, serum creatinine (Crn) was significantly higher 
during hibernation, whereas blood urea nitrogen (BUN) was significantly lower in this 
season. Thus, the ratio BUN:Crn was significantly reduced during hibernation compared 
to active seasons, confirming that the bears were in a state of hibernation [137].  
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Relationships between serum factors are reported in Table 2.8. Briefly, total and 
ucOCN were inversely correlated to serotonin, adiponectin, and glucose. Additionally, 
serotonin was positively correlated to adiponectin and glucose. Adiponectin was 
positively correlated to ionized calcium, BSALP, TRACP, insulin, and glucose.   
 
2.4 Discussion 
 
 For up to half a year of hibernation annually, bears remain mostly inactive in their 
dens [13], yet they do not lose bone mechanical or structural properties despite these 
long periods of disuse [16-21, 173, 174]. During hibernation, bears are in a unique state 
of energy preservation in which they do not eat, drink, or excrete wastes [13]. Previous 
studies suggest that values of total serum calcium remain unchanged between active 
and hibernating periods [35]. In humans undergoing bed rest disuse studies, bone 
turnover is unbalanced such that calcium is released from bone, raising plasma calcium 
levels. Mobilized calcium is then excreted in urine [36, 175]. Bears do not urinate during 
hibernation; therefore calcium is not excreted in this manner. Thus, for hibernating bears 
to remain eucalcemic, calcium released by bone resorption is likely recycled back into 
bone through new bone formation. An argument can be made that although calcium is 
not excreted by urination during hibernation, some calcium is lost through lactation. 
Additionally, although the volume of urine in the bladder remains constant throughout 
hibernation in bears [114], osmolality of the urine increases [113]. It is possible that 
calcium accumulates in the bladder of hibernating bears. However, such a loss of 
calcium through lactation or accumulation in concentrated urine would result in a loss of 
bone mineral and/or a significant drop in circulating calcium during hibernation. Bone 
mineral content increases [20] and serum calcium levels do not significantly drop [35] 
during hibernation in bears, suggesting that calcium released by bone resorption is 
returned to bone by new bone formation. 
 
In contrast to the previous study [35], data from the current study suggested that 
total calcium decreased from prehibernation to post-hibernation seasons when analyzed 
by the “seasonal means” method (Table 2.3). This difference is likely due to the 
sampling dates chosen by each study. Our study began prehibernation sampling in 
November, whereas the previous study began in July. Similarly, our study ended        
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post-hibernation sampling in the beginning of May, whereas the previous study ended in 
June. When examining the graphs of serum total calcium over time, both studies have a 
peak in November and a downward slope through April (Figure 2.3) [35]. In our study, 
the overall decrease was 4.7% between prehibernation and post-hibernation. Such a 
reduction in total calcium could explain the increased mineral content observed in bear 
bones during hibernation [20]. A 1% reduction in total serum calcium corresponds to a 
3% increase in lumbar spine BMD in human patients undergoing an exercise regime 
while confined to bed [176]. Total serum calcium can be separated into three fractions: 
free ionized calcium (approximately 47%), protein-bound calcium (40%), and anion-
bound calcium (13%) [177, 178]. Calcium is only bioactive in the ionized form. Therefore, 
ionized calcium was quantified in this study. “Seasonal means” analysis revealed an 
increase in ionized calcium during the post-hibernation season (Table 2.3). It is probable 
that ionized calcium increases in the spring despite reduced total serum calcium 
because of the decreased availability of serum proteins like albumin that bind calcium 
[179]. The current study found that total serum protein and albumin both decreased 
significantly in the spring (Tables 2.6 and 2.7).     
 
This study showed that BSALP and TRACP decreased significantly during 
hibernation in black bears (Table 2.3). This matched histomorphometric data, which 
suggested a balanced reduction in osteoclast and osteoblast activities during hibernation 
[18, 20]. Such a decrease in bone turnover would help hibernating bears preserve 
energy during this extended anorectic period. Despite this decrease in BSALP and 
TRACP, the finding that serum OCN increases during hibernation [34] was confirmed by 
the current study (Tables 2.2 and 2.3), suggesting that OCN should not be used as an 
indicator of bone formation in the hibernating bear. As stated earlier, hibernating bears 
can be compared to hemodialysis patients because of their reduced renal function 
during denning [113, 114]. BSALP and TRACP are good indicators of bone turnover in 
hemodialysis patients because they are not removed from the blood by renal filtration 
[143-145, 148, 149]. In contrast, OCN accumulates in the blood of hemodialysis patients 
because it is normally excreted in urine. Therefore, it is not an ideal indicator of bone 
turnover in patients with reduced renal function [143-146]. In humans, a 30% decrease 
in glomerular filtration rate results in an approximate 65% increase in serum OCN [148]. 
In hibernating bears, serum OCN increased by 285% compared to prehibernation values 
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(Table 2.3). Some of this accumulation could be explained by the 30% reduction in 
glomerular filtration rate during hibernation in bears [113], but such a large increase in 
serum OCN during hibernation suggests that there may be another reason for the rise in 
OCN levels.   
 
It is possible that during the extended anorectic period of hibernation in bears 
OCN acts as a hormone to help regulate energy metabolism. ucOCN can increase 
insulin and adiponectin secretion in mice [152, 153]. The current study demonstrated a 
dramatic increase in ucOCN, as well as the ratio of ucOCN to total OCN, during 
hibernation (Tables 2.2 and 2.3). If ucOCN controlled energy homeostasis in the 
hibernating bear as it does in mice, an increase in insulin and adiponectin during 
hibernation would be expected. In fact, there were significant decreases in insulin, 
glucose, and adiponectin levels in the serum of hibernating bears (Table 2.5).  In 
humans, OCN has an inverse relationship with plasma glucose, insulin resistance, and 
fat mass; and a positive relationship to adiponectin [158, 180-186]. In the black bear 
during the months immediately surrounding and encompassing hibernation, total and 
ucOCN were negatively correlated to adiponectin and glucose, and had no correlation to 
insulin (Table 2.8). Although the negative relationship between OCN and adiponectin 
cannot be explained by current literature, it is possible that in the unique physiological 
environment in the months surrounding and encompassing hibernation, OCN may have 
an altered relationship to adiponectin. The relationship between adiponectin and energy 
homeostasis is complex, and can vary depending on physiological state (for review see: 
[187]).  
  
 Interestingly, total and ucOCN were negatively correlated to serotonin in the 
serum of black bears during the months of study (Table 2.8). Currently, there is no 
literature reporting a correlation between serum serotonin and osteocalcin in humans or 
other animals. However, mice on a tryptophan-deficient diet, which lack the essential 
amino acid for serotonin production, display reduced serum osteocalcin levels [188]. 
This finding suggests a positive relationship between serotonin and serum osteocalcin. 
Without further study, it is difficult to determine whether serotonin is negatively correlated 
to total and ucOCN in humans and other animals, or whether this correlation is a unique 
occurrence in bears during the months surrounding and encompassing hibernation. It is 
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also unclear whether ucOCN may affect serotonin levels, or vice verse. In the current 
study there were positive correlations of serotonin to adiponectin and glucose (Table 
2.8). These correlations are likewise puzzling. Serotonin 2A (5HT-2A) receptor 
antagonists increase serum adiponectin [189]. Suppression of 5HT-2A receptor gene 
expression enhances adiponectin secretion in adipocytes [190]. These studies suggest 
an inverse relationship between serotonin and adiponectin. Another study suggests that 
serotonin improves glucose uptake [191]. Therefore, the positive relationship of 
serotonin to adiponectin and glucose does not coincide with current literature; however, 
serotonin may have a unique relationship to adiponectin and glucose during hibernation, 
and further study is needed to determine whether these positive relationships are due to 
direct interactions with serotonin.  
 
 During hibernation in bears, carbohydrate metabolism apparently halts and the 
bears switch entirely to fat metabolism (for review see: [13]). The evidence for this claim 
is that lean body mass does not change during hibernation in bears [112, 192], and the 
respiratory quotient (RQ) drops to 0.60 during hibernation [112]. Fat combustion 
provides the lowest theoretically possible RQ at 0.71. One review suggests that 
hibernating bears obtain the low RQ of 0.60 by switching entirely to fat metabolism and 
fixating CO2 in the liver [13], which occurs in other hibernators [193]. In the current study, 
insulin and glucose levels were lower in the hibernating bear serum than in the active 
bear serum (Table 2.5). This decrease in insulin and glucose during hibernation may be 
due to the switch to fat metabolism at this time. A similar drop in serum glucose has 
been observed in hibernating black bears previously [112]. Both serum glucose and 
insulin were positively correlated to adiponectin in the current study (Table 2.8). 
Although adiponectin generally reduces blood glucose by increasing insulin sensitivity 
[194, 195], the relationship between adiponectin and glucose homeostasis is complex.  
Patients with genetically defective insulin receptors have elevated plasma adiponectin 
[196], and patients with type I diabetes have elevated serum levels of high molecular 
weight adiponectin [197]. Since the patients of these two studies tend to be 
hyperglycemic, it is clear that in some situations serum adiponectin may have a positive 
relationship to serum glucose levels, as is observed in black bears during the months 
immediately surrounding and encompassing hibernation.  
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 Reduced adiponectin levels were observed in the serum of hibernating bears 
(Tables 2.4 and 2.5). This reduction could be related to the increased mobilization of 
triglycerides during hibernation [112]. Adiponectin is negatively correlated to serum 
triglyceride levels in healthy human females [198]. This decrease in serum adiponectin 
may also reduce bone turnover and protect bone during hibernation. Serum adiponectin 
has a consistent inverse relationship to BMD [186, 199, 200], and adiponectin knockout 
mice have increased trabecular bone volume and trabecular number at 14 weeks of age 
[201]. In cultured osteoblasts, adiponectin stimulates osteoblast proliferation, 
differentiation, and expression of BSALP [157, 158, 201, 202]. Furthermore, a positive 
correlation between BSALP and serum adiponectin has been discovered in men and 
post-menopausal women [203-205]. These studies suggest that adiponectin promotes 
osteoblast activity. Conversely, adiponectin increases osteoblast gene expression of the 
pro-resorptive cytokine RANKL with a concurrent decrease in the decoy receptor of 
RANKL, osteoprotegerin (OPG) [206]. There is an inverse correlation between serum 
levels of high molecular weight adiponectin and serum OPG in post-menopausal women 
[207]. These studies suggest that adiponectin may promote osteoclast activity through 
osteoblasts. In hibernating bears, reduced levels of adiponectin may result in 
suppression of osteoblast and osteoclast activities. In support of this idea, BSALP and 
TRACP were positively correlated to adiponectin in the serum of black bears (Table 2.8). 
Thus, suppressed adiponectin during hibernation may help conserve energy by reducing 
bone metabolism. Such a reduction in bone turnover during hibernation in bears has 
been observed in histomorphometric analyses of cortical and trabecular bone [18, 20]. 
These data are supported by the drops in serum BSALP and TRACP during hibernation 
in the current study. 
 
One limitation of the current study is that total serum osteocalcin (including 
fragments) was quantified. Intact circulating OCN is quickly broken into fragments [208], 
and has a half-life of approximately five minutes. In patients with reduced renal function, 
fragments of OCN accumulate in the serum. Only 26% of total OCN in uremic serum is 
intact [209, 210]. Since hibernating bears can be compared to patients with reduced 
renal function, it is likely that a large portion of the reported OCN was fragmented. The 
bioactivities of such fragments are unknown, but some can promote osteoclast 
maturation [211] or function as an indicator of bone resorption [212]. Quantification of 
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ratios of intact to fragmented OCN may provide further insight into the unique physiology 
of hibernating bears. Vitamin K levels were below detectable limits in all serum samples 
in this study. Carboxylation of OCN is a vitamin K-dependent mechanism, therefore it 
would be interesting to know whether ucOCN increases during hibernation due to a 
vitamin K deficiency, or whether its production is regulated by other mechanisms. Since 
it is unlikely that vitamin K is completely absent in bears, quantification in adipose tissue 
may provide further insight into the origin of ucOCN during hibernation. Another 
limitation of this study is that serum was only collected in the months immediately 
surrounding and encompassing hibernation. Thus, the bears were either preparing for 
hibernation, hibernating, or recovering from hibernation throughout sample collection. 
The relationship between OCN and energy may be different during this season than in 
the summer months. A last limitation is that serum was collected under anesthesia, 
which could have an impact on endocrine concentrations during the blood collection; 
however, the same dose of anesthesia was given each time.  
 
In summary, TRACP and BSALP match histomorphometric data [18, 20] to 
suggest a reduction in both the resorption and the formation of bone during hibernation. 
Such a decrease in metabolism would help hibernating bears conserve energy. This 
suppression of bone turnover could be due, in part, to reduced serum adiponectin levels 
during hibernation. The spike in OCN in the winter months should not be interpreted as a 
marker of bone formation; instead it may have passively built up in serum due to 
reduced renal function. Alternatively, it could act as an energy homeostasis hormone. 
The inverse relationship of OCN to glucose levels in bears is similar to those found in 
previous studies; however, the current study found an inverse relationship between OCN 
and adiponectin, which is not found in previous studies. The negative correlation 
between OCN and adiponectin may be due to the unique physiological state of 
hibernation (i.e. hypoglycemia, increased triglyceride mobilization, etc.). Finally, serum 
serotonin had an inverse relationship to osteocalcin and a positive relationship to 
glucose and adiponectin. These relationships have not been reported previously. 
Serotonin is known to have an impact on glucose sensitivity and adiponectin secretion, 
but from these previous studies an inverse relationship between adiponectin and 
serotonin would be expected. Again, adiponectin activity is complex, and not fully 
understood. Adiponectin may have a unique relationship with serotonin during 
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hibernation in bears. Further study is necessary to explore the role of adiponectin in 
hibernating bears.  
 
2.5 Tables and figures 
 
 
Season Bears  Age (years) Assays Data Location 
2003-2004 5 (5) 3-12 Total OCN 
Figure 2.3  
Tables 2.2, 2.3, 2.8, 
2.9 
2006-2007 2 (1) UK Ionized Calcium, Serotonin Tables 2.2-2.5,  2.8, 2.9 
2007-2008 4 (3) 5-14 
TRACP, BSALP, Total ALP, Total 
Calcium, Ionized Calcium, Total OCN, 
ucOCN, %ucOCN, Vitamin K, 
Adiponectin, Glucose, Insulin, Serotonin, 
Total Protein, Albumin, Globulin, AST, 
ALT, BUN, Creatinine 
Figures 2.1-2.7  
Tables 2.2-2.9 
2008-2009 5 (3) 2-21 TRACP, BSALP, Total ALP, Adiponectin, Glucose, Insulin 
Figures 2.1, 2.2,  
2.5-2.7 
Tables 2.2-2.5, 
2.8,2.9 
 
 
 
Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active Nbears p Power 
BSALP 
(U/L) 
LSM+SE 30.6+9.2A 7.63+0.86B 19.1+4.7AB 7 0.0149 0.7897 Date 10/11 1/19 4/29 
TRACP 
(relative) 
LSM+SE 1.25+0.17A 0.833+0.05B 1.44+0.10A 9 0.0040 0.9090 Date 12/20 1/19 4/19 
Total Calcium 
(mg/dL) 
LSM+SE 8.8+0.3 8.5+0.2 8.3+0.4 3 0.6649 0.0863 Date 11/20 1/29 4/8 
Ionized 
Calcium 
(mg/dL) 
LSM+SE 3.61+0.06 3.65+0.06 3.77+0.75 
5 0.344 0.1918 Date 11/20 1/29 4/18 
Total OCN 
(ng/mL) 
LSM+SE 12.5+1.7C 89.7+11.4A 46.0+7.6B 
9 <0.0001 1 
Date 11/20 3/19 4/28 
ucOCN LSM+SE 0.050+0.050
B 21.0+4.8A 3.75+2.14B 4 0.0019 0.9945 Date 11/20 3/9 4/28 
Percent 
ucOCN 
LSM+SE 0.693+0.693B 29.3+5.9A 8.42+3.52B 4 0.0011 0.9987 Date 11/20 3/9 4/28 
Table 2.1—Summary of assays 
The number of bears and assays that were performed in each hibernation season. *The 
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as 
“UK.”  
Table 2.2—Bone marker longitudinal “peak-valley” analyses 
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the 
mean serum concentrations. Letters (A, B, C) represent values that are significantly different 
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor.
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Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active p Power 
BSALP 
(U/L) 
LSM+SE 21.0+1.27A 8.79+1.20B 19.5+1.86A <0.0001 1 
Nsamples 58 61 26 
TRACP 
(relative) 
LSM+SE 1.18+0.03A 0.966+0.031B 1.31+0.05A <0.0001 1 
Nsamples 66 71 31 
Total Calcium 
(mg/dL) 
LSM+SE 8.66+0.07A 8.47+0.07AB 8.25+0.10B 0.0068 0.8327 
Nsamples 19 21 11 
Ionized Calcium 
(mg/dL) 
LSM+SE 3.63+0.02AB 3.61+0.02B 3.73+0.03A 
0.0202 0.7119 Nsamples 31 36 16 
Total OCN 
(ng/mL) 
LSM+SE 15.8+3.5C 61.1+3.0A 43.9+3.8B 
<0.0001 1 Nsamples 38 54 33 
ucOCN 
(ng/mL) 
LSM+SE 0.324+1.29B 9.81+1.09A 2.68+1.65B 
<0.0001 0.9997 Nsamples 23 32 14 
Percent ucOCN LSM+SE 1.15+1.49
B 15.5+1.27A 6.36+1.92B <0.0001 1 Nsamples 23 32 14 
 
 
 
 
Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active Nbears p Power 
Adiponectin 
(ng/mL) 
LSM+SE 1999+172A 1275+46B 1936+91A 9 0.0005 0.9891 Date 11/30 1/29 4/28 
Glucose 
(mg/dL) 
LSM+SE 194+12A 110+12B 141+17B 9 0.0002 0.9970 Date 12/20 2/28 4/19 
Insulin 
(μU/mL) 
LSM+SE 7.49+1.15 5.78+0.70 8.71+1.67 
9 0.1416 0.3849 
Date 11/20 2/18 4/28 
Serotonin 
(ng/mL) 
LSM+SE 859+99.9 508+53.3 809+72.4 5 0.0667 0.5281 Date 11/20 3/19 4/28 
 
 
 
 
 
 
 
 
Table 2.4—Energy homeostasis longitudinal “peak-valley” analyses 
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the 
mean serum concentrations. Letters (A, B, C) represent values that are significantly different 
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor. 
Table 2.3—Bone marker “seasonal means” analyses 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. The p-value reported is for the partial F-test 
for the serum factor. 
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Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active p Power 
Adiponectin 
(ng/mL) 
LSM+SE 1912+42A 1347+40B 1919+61A <0.0001 1 Nsamples 69 73 32 
Glucose 
(mg/dL) 
LSM+SE 178+5A 118+5B 136+7B <0.0001 1 Nsamples 63 63 25 
Insulin 
(μU/mL) 
LSM+SE 6.81+0.24A 5.78+0.23B 7.72+0.35A 
<0.0001 0.9948 Nsamples 68 66 29 
Serotonin 
(ng/mL) 
LSM+SE 788+29.9A 593+25.5B 689+40.2AB <0.0001 0.9949 Nsamples 33 47 19 
 
 
 
 
 
 
 
 
Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active Nbears p Power 
Total Bilirubin 
(mg/dL) 
LSM+SE 0.133+0.033 0.167+0.033 0.100+0.00 3 0.444 0.1326 Date 11/20 2/18 4/28 
Total Protein 
(g/dL) 
LSM+SE 7.83+0.38A 7.73+0.18A 6.56+0.09B 3 
 
0.0264 
 
0.7663 
 Date 11/20 2/18 4/18 
Albumin 
(g/dL) 
LSM+SE 4.23+0.07A 4.20+0.23A 3.33+0.18B 3 
 
0.0237 
 
0.7916 
 Date 12/10 1/29 4/18 
Globulin 
(g/dL) 
LSM+SE 3.57+0.29 3.80+0.35 3.23+0.19 3 
 
0.3425 
 
0.1689 
 Date 11/20 3/9 4/18 
Total ALP 
(U/L) 
LSM+SE 59.2+9.3A 32.3+1.3B 51.0+6.3A 7 0.0060 0.8939 
Date 10/11 1/19 4/29 
AST 
(U/L) 
LSM+SE 78.3+7.6A 53.5+3.8B 50.3+0.17B 4 0.0024 0.9906 
Date 12/10 3/9 4/18 
ALT 
(U/L) 
LSM+SE 34.3+2.9A 18.0+2.5B 16.7+2.2B 3 0.0095 0.9453 
Date 12/10 3/29 4/18 
AST/ALT LSM+SE 1.92+0.16B 2.70+0.25A 2.87+2.4A 4 0.0144 0.8456 
 Date 12/20 3/9 200 
BUN 
(mg/dL) 
LSM+SE 18.3+3.8A 4.67+0.33B 18.7+2.4A 
3 0.0152 0.8812 Date 11/20 3/9 4/18 
Crn 
(mg/dL) 
LSM+SE 1.79+0.063B 2.77+0.28A 1.62+0.13B 
3 0.0043 0.9920 Date 11/20 2/18 4/28 
BUN:Crn 
LSM+SE 10.4+2.5A 1.72+0.24B 10.8+2.9A 
3 0.0232 0.7968 Date 11/20 3/9 4/28 
 
Table 2.5—Energy homeostasis “seasonal means” analyses 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. The p-value reported is for the partial F-test 
for the serum factor.
Table 2.6—Chemistry panel longitudinal “peak-valley” analyses 
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the 
mean serum concentrations. Letters (A, B, C) represent values that are significantly different 
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor. 
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Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active p Power 
Total Bilirubin 
(mg/dL) 
LSM+SE 0.117+0.010 0.146+0.010 0.112+0.014 0.0510 0.5804 Nsamples 19 21 10 
Total Protein 
(g/dL) 
LSM+SE 7.75+0.09A 7.75+0.09A 6.64+0.12B <0.0001 1 Nsamples 19 34 11 
Albumin 
(g/dL) 
LSM+SE 4.13+0.06A 4.07+0.06A 3.46+0.08B <0.0001 1 Nsamples 19 21 11 
Globulin 
(g/dL) 
LSM+SE 3.67+0.07A 3.68+0.06A 3.19+0.09B <0.0001 0.9929 Nsamples 19 21 11 
Total ALP (U/L) LSM+SE 47.3+1.4
A 33.9+1.3B 47.5+2.0A <0.0001 1 Nsamples 58 61 26 
AST 
(U/L) 
LSM+SE 73.3+3.5A 53.7+3.4B 49.6+4.7B 0.0001 0.9883 Nsamples 19 21 11 
ALT 
(U/L) 
LSM+SE 34.6+1.2A 21.4+1.1B 18.9+1.5B <0.0001 1 
Nsamples 19 21 11 
AST/ALT LSM+SE 2.10+0.10
B 2.57+0.09A 2.71+0.13A 0.0005 0.9650 
Nsamples 19 23 11 
BUN 
(mg/dL) 
LSM+SE 16.6+1.3A 6.42+1.29B 15.3+1.76A <0.0001 0.9996 
Nsamples 19 22 11 
Crn 
(mg/dL) 
LSM+SE 1.92+0.06B 2.69+0.06A 1.53+0.08C 
<0.0001 1 Nsamples 19 21 11 
BUN:Crn LSM+SE 9.16+1.02A 3.21+0.95B 10.5+1.4A 
<0.0001 0.9971 Nsamples 19 22 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.7—Chemistry panel “seasonal means” analyses 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. The p-value reported is for the partial F-test 
for the serum factor. 
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Dependent  
Variable 
Independent
Variable 
Nbears β r p Power
Adiponectin Total OCN 4 -10.43 -0.521 <0.0001 0.9863 
Adiponectin ucOCN 4 -26.4 -0.443 0.0020 0.8873 
Adiponectin Serotonin 4 0.899 0.411 0.0065 0.7918 
BSALP TRACP 9 22.7 0.723 <0.0001 1 
BSALP Adiponectin 9 0.00676 0.627 0.0012 0.9077 
BSALP Glucose 9 0.0524 0.602 0.0290 0.5917 
Ionized Calcium Adiponectin 4 9.05e-5 0.487 0.0277 0.6047 
Ionized Calcium Glucose 4 0.00106 0.508 0.0150 0.6961 
Glucose Total OCN 4 -1.11 -0.627 <0.0001 0.9883 
Glucose ucOCN 4 -2.628 -0.533 0.0048 0.8259 
Glucose Adiponectin 9 0.0291 0.427 0.0014 0.9004 
Glucose Serotonin 4 0.103 0.570 0.0011 0.9258 
Insulin Adiponectin 9 0.00143 0.709 <0.0001 0.9837 
Insulin Total ALP 9 0.0344 0.686 0.0112 0.7235 
Serotonin Total OCN 4 -3.87 -0.513 <0.0001 0.9890 
Serotonin ucOCN 4 -11.2 -0.473 0.0003 0.9622 
TRACP Adiponectin 9 0.000117 0.430 0.0222 0.6313 
 
 
 
 
 
 
 
 
Serum 
Factor 
Effect Model Direction p 
TRACP Cubs Seasonal Means + <0.0001 
TRACP Cubs Peak-Valley + 0.0431 
BSALP Cubs Seasonal Means + 0.0087 
Total ALP Cubs Seasonal Means + 0.0093 
Ionized Calcium Cubs Seasonal Means + 0.0478 
ucOCN Age Seasonal Means + 0.0139 
ucOCN Age Peak-Valley + 0.0135 
%ucOCN Age Seasonal Means + 0.0157 
%ucOCN Age Peak-Valley + 0.0048 
Adiponectin Age Seasonal Means + 0.0226 
Glucose Cubs Seasonal Means + 0.0290 
Glucose Age Peak-Valley + 0.0156 
Serotonin Age Seasonal Means + 0.0064 
Total Protein Age Seasonal Means + 0.0067 
Globulin Cubs Seasonal Means + <0.0001 
ALT Age Seasonal Means - 0.0368 
Creatinine Age Seasonal Means + 0.0002 
Creatinine Cubs Seasonal Means + 0.0024 
Creatinine Age Peak-Valley + 0.0154 
Table 2.8—Serum factor linear regression models 
Table 2.9—Serum factor effects analyses 
Table reports all effects between age or cubs and serum factors, indicating the model in 
which the effect was significant. For an age effect, a “+” direction indicates that the serum 
factor increases with age. For a cub effect, a “+” direction indicates that the serum factor 
increases if cubs were born. 
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Figure 2.1—Serum BSALP activities 
Serum BSALP activity of 9 black bears in the 2007/08 and 2008/09 seasons. Letters O 
through M represent the month of serum collection. Vertical lines represent transitions 
between active and hibernating seasons. (A) BSALP activities are represented by a line 
for each bear. (B) Single smoothed curve represents the average of all 9 bears. Arrows 
indicate the dates at which “peak-valley” means were analyzed. (C) Each BSALP activity 
was normalized to the average BSALP activity for the appropriate bear for better 
comparison of seasonal fold changes.   
       O      N     D     J     F     M     A     M 
C 
                                                                      40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TR
A
CP
 (r
el
at
iv
e)
0
0.5
1
1.5
2
2.5
3
N
or
m
al
iz
ed
 T
RA
CP
0
0.5
1
1.5
2
   O      N     D     J     F     M     A     M        O      N     D     J     F     M     A     M 
A  B
Figure 2.2—Serum TRACP activities 
Serum TRACP activity of 9 black bears in the 2007/08 and 2008/09 seasons. Letters O 
through M represent the month of serum collection. Vertical lines represent transitions 
between active and hibernating seasons. (A) TRACP activities are represented by a line 
for each bear. (B) Single smoothed curve represents the average of all 9 bears. Arrows 
indicate the dates at which “peak-valley” means were analyzed. (C) Each TRACP activity 
was normalized to the average TRACP activity for the appropriate bear for better 
comparison of seasonal fold changes.   
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Figure 2.3—Total serum calcium 
Total serum calcium levels of 4 black bears in the 2007/08 season. Letters O through M 
represent the month of serum collection. Vertical lines represent transitions between 
active and hibernating seasons. (A) Serum calcium levels are represented by a line for 
each bear. (B) Single smoothed curve represents the average of all 4 bears. Arrows 
indicate the dates at which “peak-valley” means were analyzed. (C) Each total serum 
calcium concentration was normalized to the average total serum calcium concentration 
for the appropriate bear for better comparison of seasonal fold changes.   
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Figure 2.4—Serum ionized calcium levels 
Ionized calcium levels of 6 black bears in the 2006/07 and 2007/08 seasons. Letters O 
through M represent the month of serum collection. Vertical lines represent transitions 
between active and hibernating seasons. (A) Serum ionized calcium levels are 
represented by a line for each bear. (B) Single smoothed curve represents the average 
of all 6 bears. Arrows indicate the dates at which “peak-valley” means were analyzed. 
(C) Each ionized calcium concentration was normalized to the average ionized calcium 
concentration for the appropriate bear for better comparison of seasonal fold changes. 
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Figure 2.5—Serum total OCN concentrations 
Serum OCN concentrations of 9 black bears in the 2004/05 and 2007/08 seasons. 
Letters O through M represent the month of serum collection. Vertical lines represent 
transitions between active and hibernating seasons. (A) OCN concentrations are 
represented by a line for each bear. (B) Single smoothed curve represents the average 
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed. 
(C) Each total OCN concentration was normalized to the average total OCN 
concentration for the appropriate bear for better comparison of seasonal fold changes.  
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Figure 2.6—Serum ucOCN concentrations 
Serum ucOCN concentrations of 4 black bears in the 2007/08 season. Letters O through 
M represent the month of serum collection. Vertical lines represent transitions between 
active and hibernating seasons. (A) ucOCN concentrations are represented by a line for 
each bear. (B) Single smoothed curve represents the average of all 4 bears. Arrows 
indicate the dates at which “peak-valley” means were analyzed. (C) Each ucOCN 
concentration was normalized to the average ucOCN concentration for the appropriate 
bear for better comparison of seasonal fold changes. 
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Figure 2.7—Serum adiponectin concentrations 
Serum adiponectin concentrations of 9 black bears in the 2007/08 and 2008/09 seasons. 
Letters O through M represent the month of serum collection. Vertical lines represent 
transitions between active and hibernating seasons. (A) Adiponectin concentrations are 
represented by a line for each bear. (B) Single smoothed curve represents the average 
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed. 
(C) Each adiponectin concentration was normalized to the average adiponectin 
concentration for the appropriate bear for better comparison of seasonal fold changes. 
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Figure 2.8—Serum glucose concentrations 
Serum glucose concentrations of 9 black bears in the 2007/08 and 2008/09 seasons. 
Letters O through M represent the month of serum collection. Vertical lines represent 
transitions between active and hibernating seasons. (A) Glucose concentrations are 
represented by a line for each bear. (B) Single smoothed curve represents the average 
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed. 
(C) Each glucose concentration was normalized to the average glucose concentration for 
the appropriate bear for better comparison of seasonal fold changes. 
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Figure 2.9—Serum insulin concentrations 
Serum insulin concentrations of 9 black bears in the 2007/08 and 2008/09 seasons. 
Letters O through M represent the month of serum collection. Vertical lines represent 
transitions between active and hibernating seasons. (A) Insulin concentrations are 
represented by a line for each bear. (B) Single smoothed curve represents the average 
of all 9 bears. Arrows indicate the dates at which “peak-valley” means were analyzed. 
(C) Each insulin concentration was normalized to the average insulin concentration for 
the appropriate bear for better comparison of seasonal fold changes. 
       O      N     D     J     F     M     A     M 
C 
                                                                      48 
 
Chapter Three — Serum neuropeptide Y and IGF-1 favor 
reduced bone turnover in hibernating black bears 
 
3.1 Introduction 
 
The long-term goal of this dissertation is to explore the biological mechanism 
through which hibernating bears protect their bones during prolonged periods of physical 
inactivity. One possible mechanism is endocrine modulation of bone metabolism. Since 
bears maintain balanced, though reduced, bone turnover during extended disuse 
(hibernation) [18, 20], this study quantified the seasonal serum levels of hormones which 
regulate disuse-induced bone loss and the rate of bone turnover. Leptin is a peptide 
hormone secreted by white adipose tissue. It signals the hypothalamus to suppress food 
intake, body mass, and adiposity, while increasing heat production [213, 214]. Serum 
leptin decreases during hind-limb suspension in rats [215, 216], and replacement of 
leptin can inhibit disuse-induced bone loss by suppressing bone resorption and 
preserving bone formation [216, 217]. Studies with knockout mice suggest that leptin’s 
antagonistic hormone neuropeptide Y (NPY) can suppress bone turnover. Mice lacking 
Y1 (which is the NPY receptor present in bone) have a high bone mass phenotype due 
to increased bone formation, though they also experience an increase in osteoclast 
activity [218]. Circulating serotonin may increase bone turnover. In vitro stimulation with 
serotonin promotes proliferation of osteoblasts and differentiation of monocytes into 
osteoclasts [219]. Studies utilizing beta-blockers, norepinephrine (NE) receptor 
antagonists, suggest a decrease in NE signaling may alleviate disuse-induced bone 
loss. Bone loss due to hind-limb unloading in rats and mice is suppressed by beta-
blockers through the stimulation of osteoblast activity and the repression of osteoclast 
activity [217, 220]. In vitro evidence suggests that insulin-like growth factor 1 (IGF-1) 
stimulates both osteoblast [221] and osteoclast recruitment and activation [222-224], and 
could thus act to increase overall bone turnover. Changes in the circulating levels of 
these hormones during hibernation could explain the balanced and reduced bone 
turnover observed in denning bears [18, 20]. 
 
The goal of this study was to quantify the serum concentrations of leptin, NPY, 
serotonin, NE, and IGF-1 in American black bears during the months immediately 
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surrounding and encompassing hibernation. The hypothesis was that serum 
concentrations of these hormones change in such a way that overcomes the negative 
influences of disuse on bone mass, while reducing overall bone turnover during 
hibernation to conserve metabolic energy. Based on the previous studies described 
above, we expected to see an increase in leptin and NPY, and a decrease in NE, 
serotonin and IGF-1.  
 
3.2 Methods and materials 
 
A total of 19 female black bears were captured and held in pens in the Virginia 
Tech Center for Bear Research from fall through spring, between the years 2002 and 
2009. Samples were collected as described in section 2.2.1. All statistical analyses were 
performed using JMP 7 software as described in section 2.2.3.  
 
Table 3.1 summarizes which bear serum samples were used for each 
biochemical assay. Due to limitations of serum sample sizes, not all bears were used for 
all assays. The choice of bear used for each assay depended upon sample availability at 
the time the assays were run. The serum collected from 8 bears was assayed for leptin 
by RIA (Millipore, St Louis, MO); the intra-assay coefficient of variation was 3.4%. The 
expected range is 7.4 + 3.7 ng/mL in a human female. The serum from 9 bears was 
assayed for NPY. NPY was quantified using a competitive RIA method with reagents 
manufactured by EURIA and distributed by ALPCO in the United States. The sensitivity 
of the NPY RIA method is 3 pmol/L and intra-assay precision averaged 4.8% while inter-
assay precision averaged 8.4%.  Normal levels in human serum range from                   
36-120 pmol/L. The serum collected from 6 bears was assayed for NE and serotonin by 
enzyme-linked immunosorbent assays (ELISA) (ALPCO). The sensitivity of the NE 
assay is 44 pg/mL, with an intra-assay precision of 16.1% and an inter-assay precision 
of 15%. Expected serum NE levels in humans are less than 600 pg/mL. The sensitivity 
of the serotonin assay is 5 ng/mL, with an intra-assay precision of 5.4% and an inter-
assay precision of 6.0%. Expected serotonin levels in female human serum are           
80-450 ng/mL. IGF-1 was measured in the serum of 5 bears by acid ethanol extraction 
RIA (Nichols Institute Diagnostics, San Juan Capistrano, CA); the intra-assay coefficient 
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of variation was 4.3%. Activities of TRACP and BSALP were quantified as in section 
2.2.2.  
 
3.3 Results 
 
Serum leptin had an increasing trend during the prehibernation fattening season, 
and began a downward trend during hibernation (Figure 3.1). By “seasonal means” and 
“peak-valley” analyses, there were no significant differences between prehibernation 
values and hibernation values; though serum leptin was lower during post-hibernation 
(Tables 3.2 and 3.3). By “seasonal means” analysis, leptin fell from 4.07+0.178 ng/mL in 
hibernation to 3.23+0.219 ng/mL in post-hibernation (p=0.0058) (Table 3.3). Serum NPY 
displayed a similar trend to leptin, though it was more pronounced and shifted towards 
the following decad (Figure 3.2). NPY increased over November and December, 
peaking a decad after the transition into hibernation, and then steadily fell through 
hibernation and post-hibernation. By both analysis models, NPY concentrations were 
significantly higher during hibernation than fall active and spring active periods (Tables 
3.2 and 3.3). By “seasonal means” analysis, NPY increased from 194+4 pmol/L in fall to 
219+4 pmol/L during hibernation and then dropped back to 178+6 in spring (p<0.0001) 
(Table 3.3). NPY levels were negatively correlated to TRACP (r = -0.528) and BSALP     
(r = -0.713) (Table 3.4), both of which decreased significantly during hibernation (Tables 
2.2 and 2.3). In one bear, all NPY levels were over the highest standard (300 pmol/L). 
This bear was omitted from the data presented. The omitted bear was 21 years old, 
which is at the end of the lifespan of bears. Even without this bear, there is an age effect 
with NPY, such that NPY increases with increasing age (Table 3.5).  
   
Serum NE had no distinguishing trends except in the months of December and 
May, which displayed distinct peaks (Figure 3.3 B). However, these peaks were not 
statistically significant by either analysis method (Tables 3.2 and 3.3), and the peaks 
were mainly due to the NE profile of one bear. There were no significant trends in NE, 
even when the aberrant bear was removed from analysis. Serum serotonin decreased 
during hibernation in all bears, though this trend was much more pronounced in some 
bears than in others (Figure 3.4). Statistical analysis reveals no difference by 
longitudinal “peak-valley” analysis (Table 3.2). By “seasonal means” analysis, serotonin 
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decreased from 788+30 ng/mL in prehibernation to 593+26 ng/mL in hibernation; there 
were no differences between post-hibernation mean and the means of prehibernation 
and hibernation serotonin levels (p<0.0001) (Table 3.3). Serum IGF-1 decreased during 
hibernation, and then ascended rapidly during post-hibernation (Figure 3.5). By 
longitudinal “peak-valley” analysis, hibernation IGF-1 levels are significantly lower than 
post-hibernation levels (Table 3.2). By “seasonal means” analysis, IGF-1 levels dropped 
from 387+31 ng/mL in prehibernation to 203+25 ng/mL during hibernation and then rose 
to 597+28 ng/mL in post-hibernation (p<0.0001) (Table 3.3). Serum IGF-1 levels were 
negatively correlated to serum levels of leptin (Table 3.4).  
 
3.4 Discussion 
 
 Bears hibernate for up to half a year annually. Although movement during 
denning is minimal [13], they do not experience the structural and mechanical changes 
that generally accompany disuse in other animals [16-21, 173, 174]. Histological data 
suggest that bone turnover rates are lower during hibernation, but they remain balanced 
such that any bone lost is replaced by newly formed bone [18, 20]. Chapter 2 quantified 
serum activities of the bone formation marker BSALP and the marker of osteoclast 
number TRACP. The decrease in BSALP and TRACP observed in that chapter confirm 
the histological data previously reported [18, 20]. The current study explored the 
seasonal profiles of several circulating hormones to determine whether these hormones 
change during hibernation in such a way that could prevent disuse-induced bone loss, 
while decreasing bone turnover (thus preserving metabolic energy during this extended 
anorectic period).    
 
3.4.1 Maintenance of serum leptin concentrations several weeks into hibernation 
may prevent bone loss and help bears maintain near-normal body 
temperatures 
 
Leptin is an energy homeostasis hormone which signals the hypothalamus to 
reduce adipose tissue mass [214]. As adipose tissue accumulates it releases leptin, 
which suppresses appetite, induces lipid catabolism, and produces heat [213, 214, 225, 
226]. Serum leptin levels generally follow adiposity trends, such as in humans [227-229], 
                                                                      52 
 
mice [227], and domestic sheep [230]. In contrast, in small overwintering animals that 
gain weight in the fall and fast during the winter, serum leptin becomes seasonally 
dissociated from body weight and basal metabolic rate [231-233]. For instance, in 
Raccoon Dogs (Nyctereutes procyonoides) [232, 234], blue foxes (Alopex lagopus) 
[232], and yellow-bellied marmots (Marmota flaiventris) [233], serum leptin increases in 
fall as body mass rises, but declines dramatically after the animals begin the winter fast, 
preceding the gradual drop in body mass. 
  
Although the bears in the current study experienced an average weight gain of 
28% from October to January (when hibernation began), serum leptin did not 
significantly increase over this period. In contrast, in small hibernators such as the 
woodchuck (Marmota monax) [235], raccoon dog [232, 234], or yellow-bellied marmot 
[233] serum leptin significantly increases during the months leading up to hibernation. It 
is possible that the black bears in the current study began increasing serum leptin in the 
months prior to the first data collection date in October, though other studies in bears do 
not support this idea of earlier rises in leptin. In a study of one European brown bear 
(Ursus arctos arctos), serum leptin began to rise in early October, for a total increase of 
41% during prehibernation [236]. A study in Japanese black bears (Ursus thibetanus 
japonicus) reported a 170% increase in serum leptin which began in October and 
peaked in November (when hibernation began) [237]. The sharper increase in serum 
leptin in Japanese bears was likely due to the sharper increase in weight during these 
months (70%). Between the beginning of January and the end of April, the current study 
observed a 37% decrease in serum leptin in black bears (Figure 3.1). Unlike in small 
hibernators such as the raccoon dog [232] and the yellow-bellied marmot [233], the 
decrease in serum leptin of black bears was gradual. It took place over the entire fasting 
period and continued through the first month of arousal. In contrast, in a study with 
yellow-bellied marmots that hibernated from October through April, serum leptin 
decreased 59% between November and February, thus preceding changes in weight 
(which began between January and February) [233].  
 
There are many notable differences between a bear’s hibernation state and that 
of a small hibernator. Most small hibernators can drop to ambient temperatures during 
periods of torpor, and some periodically arouse to eat and excrete wastes [115, 117, 
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120-122]. Most small hibernators are also believed to lose bone during hibernation [104-
109], though recent evidence suggests that golden-mantled ground squirrels do not 
[110]. In contrast, bears only drop 1-8oC below active body temperature, do not excrete 
wastes or eat, and do not lose bone during hibernation [13, 18-21, 34, 133, 161, 174]. In 
small hibernators like the raccoon dog and the marmot, serum leptin decreases steeply 
upon winter fast, preceding changes in weight [233, 234, 237], though in the raccoon 
dog leptin levels rise again before the end of winter [234]. The decrease in serum leptin 
of American black bears took place gradually through hibernation and continued into 
post-hibernation (Figure 3.1). It may be an evolutionary advantage for bears to retain 
raised leptin concentrations longer into hibernation, as the leptin would help them 
maintain higher body temperatures and suppress appetite-induced arousal. 
Furthermore, serum leptin decreases by 67% in hind-limb unloaded rats, and replacing 
serum leptin during unloading inhibits disuse-induced bone loss [215-217]. Therefore, 
maintaining high leptin levels longer into hibernation could help bears suppress bone 
loss during this extended period of disuse.  
 
3.4.2 Reduced IGF-1 and increased NPY in the serum of hibernating bears favor 
suppression of bone turnover 
 
The current study found that serum IGF-1 decreased during hibernation in black 
bears. IGF-1 also decreases in the serum of hibernating golden-mantled ground 
squirrels [238], which do not lose bone during this extended period of disuse [110]. It is 
possible that depressed serum levels of IGF-1 could promote the lower rate of bone 
turnover observed in hibernating bears [18, 20] by slowing the rates of osteoblast [221] 
and osteoclast [222-224] recruitment and activation. Such a decrease in bone turnover 
may, in the unique conditions of hibernation, help preserve bone despite disuse.  
 
Bears switch to fat metabolism during hibernation, due to anorectic conditions 
[111]; therefore they may be compared to animals on high fat diets: rats fed a high 
fat/low carbohydrate diet experience raised concentrations of leptin and lowered IGF-1 in 
the serum [239]. These rats display depressed rates of bone formation and unchanged 
bone resorption, resulting in reduced bone length and BMD of the tibia [239]. However, 
these 4-week-old rats were at an age of rapid growth [239, 240] through the duration of 
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the study. In contrast, studies reporting bone maintenance in hibernating bears used 
adult bears, which would not have been rapidly growing [16-18, 20, 21, 174].  Due to 
extended fasting periods, hibernating bears could also be compared to animals on a low 
protein diet: six-month-old rats fed a low protein diet for 14 weeks exhibit reduced bone 
formation and resorption [241], accompanied by reduced BMD and serum levels of    
IGF-1 [242, 243]. However, these protein-restricted rats had access to carbohydrates, 
unlike the hibernating bear. Both the protein-restricted and the high-fat diet animals in 
these studies were able to lose calcium due to urinary excretion, whereas bears do not 
excrete urine and remain eucalcemic during hibernation [35]. For bears to remain 
eucalcemic while not urinating, calcium mobilized by bone resorption would be returned 
to the bone by new formation. In the hibernating bear [18, 20], like diet-restricted rats 
[239, 241], bone resorption and formation decrease, with an accompanying reduction in 
serum IGF-1. It is possible that in the low-energy, non-growing, non-urinating state of 
hibernation, IGF-1 could reduce turnover without creating an imbalance between bone 
resorption and formation. This reduction in bone turnover could help conserve energy 
during the extended anorectic period of hibernation.  
 
As bears have no net production of urine during hibernation [113, 114], they can 
be compared to humans with reduced renal function. In keeping with the suggestion that 
reduced serum IGF-1 could  slow bone turnover in the hibernating bear, serum IGF-1 is 
lower in pediatric hemodialysis patients with adynamic bone disease (i.e. reduced bone 
turnover) than in renal patients with normal bone formation [244]. Unfortunately, it was 
not possible to verify whether there were relationships between the IGF-1 levels and 
bone formation and resorption markers (BSALP and TRACP, respectively) since these 
measurements were not made in the same bear serum samples. Further studies may 
help clarify whether IGF-1 suppresses bone formation in hibernating bears, and whether 
this reduction in formation could suppress disuse-induced bone loss in this model. 
 
Another possible mechanism of reducing bone turnover during hibernation is by 
increasing serum NPY, which suppresses osteoclast [245] and osteoblast [246] 
differentiation. The current study observed inverse correlations between NPY and bone 
turnover serum markers (i.e. BSALP, TRACP), suggesting that increased serum NPY 
levels during hibernation could contribute to the reduced turnover in bones of hibernating 
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bears. Similarly, serum NPY increases in humans as renal function decreases [247] and 
is inversely correlated to BSALP (r = -0.28) and total ALP (r = -0.51) in hemodialysis 
patients [248]. These data suggest a relationship between high NPY levels and low bone 
turnover in human patients.  
 
 Serum serotonin decreased during hibernation in black bears. This is the first 
known report of serum serotonin in a hibernator; however, serotonin levels increase in 
the cerebral spinal fluid of hibernating yellow-bellied marmots [249]. Although there may 
be species variations between different hibernators, it is possible that serotonin 
increases in the cerebral spinal fluid and decreases in the serum during hibernation, as 
serotonin cannot pass through the blood-brain barrier [250]. Serotonin promotes 
proliferation of osteoblasts and differentiation of osteoclasts in vitro [219]; thus, reduced 
serotonin during hibernation could favor suppressed bone turnover. However, there is 
controversy about the effects of serotonin on bone in vivo (for review see: [251]), and 
serotonin levels are not correlated to bone turnover markers BSALP and TRACP in 
black bears. Therefore, it is difficult to draw conclusions from this data. Although there 
was no seasonal variation in serum NE of black bears, it is possible that tissue sensitivity 
to NE changes during hibernation. For instance, reduced temperatures can inhibit the 
NE-induced lipolysis of white adipose tissue from golden-mantled ground squirrels [252]. 
Such an insensitivity to NE during hibernation, if exhibited in bone, could feasibly 
suppress disuse-induced bone resorption since inhibiting NE with beta-blockers can 
inhibit bone loss in hind-limb unloaded animals [217].  
 
Despite these interesting findings, there were some limitations to this study. For 
example, body mass was not recorded at many data collection points, so leptin could not 
be directly compared to changes in body mass in these bears. Another limitation is that 
serum was only collected in the months immediately surrounding and encompassing 
hibernation. Thus, the bears were either preparing for hibernation, hibernating, or 
recovering from hibernation throughout sample collection. It is possible that endocrine 
changes between summer and hibernation would be more pronounced. Another pitfall is 
that serum was collected under anesthesia, which could have an impact on endocrine 
concentrations during the blood collection; however, the same dose of anesthesia was 
given at each blood draw. There are possible effects of age and the birth of cubs on the 
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measured serum values. However, all statistical analyses were blocked by bear to 
control for inter-bear variability.  
 
3.4.3 Summary 
 
Bone is a complex organ which responds to many stimuli. It is likely that multiple 
factors work together to maintain bone integrity during hibernation in bears. These 
factors could include direct neural stimulation, as well as endocrine control. The anabolic 
role of circulating PTH was previously hypothesized to help maintain hibernating bear 
bone, due to its positive correlation to osteocalcin, a marker for bone formation [34]. The 
current study brings to light more potential endocrine effectors of bone preservation 
during hibernation. Maintaining serum leptin concentrations longer into hibernation could 
help inhibit disuse-induced bone loss. Reduced IGF-1 and increased NPY in the serum 
of hibernating bears could suppress bone resorption and formation rates while 
sustaining balanced turnover, thus conserving energy during this extended anorectic 
period. The endocrine changes observed in this study may help explain the reduced, 
balanced bone turnover that occurs during the unique physiological setting in which 
bears fast, reduce energy expenditure to a minimum, and remain eucalcemic despite no 
urine excretion for half a year.  
 
3.5 Tables and figures 
 
 
Season  Bears  Age (years)  Assays  Data Location 
2002‐2003  3 (UK)  UK  Leptin 
Figure 3.1  
Tables 3.2‐3.4 
2003‐2004  5 (5)  3‐12  Leptin, IGF‐1 
Figures 3.1, 3.5 
Tables 3.2‐3.4 
2006‐2007  2 (1)  UK  Serotonin, NE 
Figures 3.3, 3.4 
Tables 3.2‐3.5 
2007‐2008  4 (3)  5‐14  NPY, NE, Serotonin 
Figures 3.2‐3.4 
Tables 3.2‐3.5 
2008‐2009  5 (3)  2‐21  NPY  Tables 3.2‐3.5 
 
Table 3.1—Summary of assays 
The number of bears and assays that were performed in each hibernation season. The 
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as 
“UK.”  
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Serum 
Factor  
Fall
Active 
Winter
Hibernation 
Spring
Active Nbears p Power 
Leptin 
(ng/mL) 
LSM+SE 4.08+0.39AB 4.75+0.636A 2.98+0.249B 8 0.0099 0.8334 Date 11/10 1/09 4/28 
NPY 
(pmol/L) 
LSM+SE 193+20.2B 246+17.8A 175+15.1B 8 0.0009 0.8907 Date 11/20 1/19 4/19 
NE 
(ng/mL) 
LSM+SE 16.3+10.7 2.90+0.787 1.60+0.377 
6 0.1922 0.3081 
Date 12/30 2/8 4/18 
Sero. 
(ng/mL) 
LSM+SE 859+99.9 508+53.3 809+72.4 5 0.0667 0.5281 
Date 11/20 3/19 4/28 
IGF-1 
(ng/mL) 
LSM+SE 417+50.2AB 191+17.7B 633+85.8A 
5 0.0022 0.9803 Date 11/30 2/28 4/28 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serum 
Factor  
Fall
(Active) 
Winter
(Hibernation) 
Spring
(Active) p Power 
Leptin 
(ng/mL) 
LSM+SE 4.09+0.193A 4.07+0.178A 3.23+0.219B 0.0058 0.8342 Nsamples 45 48 31 
NPY 
(pmol/L) 
LSM+SE 194+4.42B 219+4.19A 178+6.34B <0.0001 0.9996 
Nsamples 56 64 28 
NE 
(ng/mL) 
LSM+SE 6.04+1.51 3.21+1.33 3.16+2.03 0.3208 0.2473 
Nsamples 33 45 19 
Serotonin 
(ng/mL) 
LSM+SE 788+29.9A 593+25.5B 689+40.2AB <0.0001 0.9949 
Nsamples 33 47 19 
IGF-1 
(ng/mL) 
LSM+SE 387+30.7B 203+25.4C 597+27.5A <0.0001 1 
Nsamples 15 22 19 
 
 
 
 
 
 
 
Table 3.2—Serum factor longitudinal “peak-valley” analyses 
Data are represented as LSM+SE. The date of “peak-valley” analysis is indicted below the 
mean serum concentrations. Letters (A, B, C) represent values that are significantly different 
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor. 
“Sero.” represents serotonin.  
Table 3.3—Serum factor “seasonal means” analyses 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. The p-value reported is for the partial F-test 
for the serum factor. 
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Dependent  
Variable 
Independent 
Variable 
Nbears β r p Power 
TRACP NPY 8 -0.00328 -0.528 <0.0001 0.9986 
BSALP NPY 8 -0.128 -0.713 <0.0001 0.9990 
Leptin IGF-1 5 -0.00144 -0.568 0.0023 0.8840 
 
 
 
 
 
 
 
 
 
 
 
Serum 
Factor 
Effect Model Direction p 
Leptin Age Seasonal Means - 0.0009 
NPY Age Seasonal Means + <0.0001 
Serotonin Age Seasonal Means + 0.0064 
IGF-1 Age Peak-Valley + 0.0113 
TRACP Cubs Seasonal Means + <0.0001 
TRACP Cubs Peak-Valley + 0.0431 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.4—Serum factor linear regression models 
Table 3.5—Serum factor effects analyses 
Table reports all effects between age or cubs and serum factors, indicating the model in 
which the effect was significant. For an age effect, a “+” direction indicates that the serum 
factor increases with age. For a cub effect, a “+” direction indicates that the serum factor 
increases if cubs were born. 
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Figure 3.1—Serum leptin concentrations 
Serum leptin concentrations of 8 black bears in the 2002/03 and 2003/04 seasons. 
Vertical lines represent transitions between active and hibernating seasons. (A) Leptin 
concentrations are represented by a line for each bear. (B) Single smoothed curve 
represents the average of all 8 bears. Arrows indicate the dates at which “peak-valley” 
means were analyzed. (C) Each leptin concentration was normalized to the average 
leptin concentration for the appropriate bear for better comparison of seasonal fold 
changes. 
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Figure 3.2—Serum NPY concentrations 
Serum NPY concentrations of 8 black bears in the 2007/08 and 2008/09 seasons. 
Vertical lines represent transitions between active and hibernating seasons. (A) NPY 
concentrations are represented by a line for each bear. (B) Single smoothed curve 
represents the average of all 8 bears. Arrows indicate the dates at which “peak-valley” 
means were analyzed. (C) Each NPY concentration was normalized to the average NPY 
concentration for the appropriate bear for better comparison of seasonal fold changes. 
A  B
C 
   O     N     D     J     F     M     A     M 
                                                                      61 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
N
or
ep
in
ep
hr
in
e 
(n
g/
m
L)
0
10
20
30
40
50
60
70
80
0
10
20
30
40
50
60
70
80
N
or
m
al
iz
ed
 N
or
ep
in
ep
hr
in
e
   O      N    D    J     F     M    A     M     O      N    D    J     F     M    A     M 
Figure 3.3—Serum NE concentrations 
Serum NE concentrations of 6 black bears in the 2006/07 and 2007/08 seasons. Vertical 
lines represent transitions between active and hibernating seasons. (A) NE 
concentrations are represented by a line for each bear. (B) Single smoothed curve 
represents the average of all 6 bears. Arrows indicate the dates at which “peak-valley” 
means were analyzed. (C) Each NE concentration was normalized to the average NE 
concentration for the appropriate bear for better comparison of seasonal fold changes. 
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Figure 3.4—Serum serotonin concentrations 
Serum serotonin concentrations of 6 black bears in the 2006/07 and 2007/08 seasons. 
Vertical lines represent transitions between active and hibernating seasons. (A) 
Serotonin concentrations are represented by a line for each bear. (B) Single smoothed 
curve represents the average of all 6 bears. Arrows indicate the dates at which “peak-
valley” means were analyzed. (C) Each serotonin concentration was normalized to the 
average serotonin concentration for the appropriate bear for better comparison of 
seasonal fold changes. 
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Figure 3.5—Serum IGF-1 concentrations 
Serum IGF-1 concentrations of 5 black bears in the 2003/04 season. Vertical lines 
represent transitions between active and hibernating seasons. (A) IGF-1 concentrations 
are represented by a line for each bear. (B) Single smoothed curve represents the 
average of all 5 bears. Arrows indicate the dates at which “peak-valley” means were 
analyzed. (C) Each IGF-1 concentration was normalized to the average IGF-1 
concentration for the appropriate bear for better comparison of seasonal fold changes. 
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Chapter Four — Attempts to find an anti-apoptotic 
environment in hibernating bear serum remain inconclusive 
 
4.1 Introduction 
 
Osteocyte apoptosis precedes bone loss in unloaded mice, and attenuating 
osteocyte and osteoblast apoptosis with injections of PTH suppresses this bone loss 
[48-51, 56]. It is possible that osteocyte and osteoblast apoptosis are required for 
disuse-induced bone loss, though no known studies have directly proven this idea. 
However, a study with a pan-caspase inhibitor in ovariectomized mice demonstrates that 
caspase activation is required for bone loss in that model of osteoporosis [162]. 
Apoptosis-inducing threats (e.g. ischemia, metabolic acidosis, anorexia) are prevalent in 
hibernating animals, yet qualitative observations suggest that these animals resist large-
scale apoptosis during hibernation (for review see: [163]). There are few in-depth studies 
on the apoptotic response during hibernation, though one study demonstrates reduced 
caspase-3 activation and no change in DNA laddering in the gut of hibernating ground 
squirrels compared to non-hibernating squirrels [45]. Bears may attenuate bone loss 
during hibernation by reducing susceptibility of osteoblasts and osteocytes to apoptosis, 
possibly through the circulation of anti-apoptotic hormones. The purpose of this chapter 
and the next is to determine whether serum levels of anti-apoptotic hormones increase 
during hibernation, thus providing an anti-apoptotic environment for osteoblasts and 
osteocytes. In this study, serum levels of the osteoblast apoptosis regulators PTH, 
melatonin, and testosterone were quantified in the serum of hibernating and active 
American black bears. The hypothesis was that levels of the anti-apoptotic hormones 
PTH and melatonin would increase, and the levels of the pro-apoptotic hormone 
testosterone would decrease in serum of hibernating bears.  
 
4.2 Methods and materials 
 
A total of 6 female black bears were captured and held in pens in the Virginia 
Tech Center for Bear Research from fall through spring, between the years 2006 and 
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2008. Samples were collected as described in section 2.2.1. Information about the bears 
used for each serum assay is shown in Table 4.1. Due to limitations of serum sample 
sizes, not all bears were used for all assays. The choice of bear used for each assay 
depended upon sample availability at the time the assays were run. The full-length and 
c-terminal PTH assays were sandwich ELISAs from Immutopics International (San 
Clemente, CA). Relative optical densities were reported. Serum melatonin and 
testosterone were quantified by RIA by Laurence Demmers at Pennsylvania State 
University. All statistical analyses were performed using JMP 7 software. Data in tables 
are presented as the LSM + SE. Graphs are represented with a point for each serum 
sample, and a smoothed average curve generated with JMP software by a cubic spline. 
All available samples from all bears were grouped by season (i.e. prehibernation, 
hibernation, and post-hibernation) and analyzed with a single-factor ANOVA, blocking by 
bear, with a Tukey’s post-hoc.  
 
4.3 Results 
 
 Serum concentrations of hormones are reported in Table 4.2. Serum levels of 
total PTH were not affected by season (Figure 4.1). However, levels of the c-terminal 
fragment of PTH were significantly lower during post-hibernation compared to 
prehibernation and hibernation seasons (p=0.0164), though the profiles of the two bears 
were different (Figure 4.2). Testosterone decreased from 54.7 ng/dL in prehibernation to 
17.4 ng/dL in post-hibernation (p=0.0361) (Figure 4.3). Melatonin was below 
quantifiable levels in all serum samples. 
 
4.4 Discussion 
 
 The goal of this study was to determine whether hormone concentrations in the 
serum of hibernating bears favored anti-apoptotic conditions for osteoblasts; therefore, 
concentrations of three hormones which regulate osteoblast apoptosis were quantified in 
the serum of hibernating and active American black bears. Melatonin has anti-apoptotic 
effects on osteoblasts [58], and administration of melatonin to ovariectomized rats 
decreases apoptosis and abates bone loss [253]. However, this study found that 
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concentrations of melatonin were below quantifiable levels in all samples. This finding 
was independently confirmed in the serum of grizzly bears, with the anatomical 
observation that the pineal gland in grizzly bears is extremely small (personal 
correspondence, Heiko Jansen).  
 
Testosterone has a decreasing trend with time in the serum of female American 
black bears, such that the levels during post-hibernation are significantly lower than the 
levels during prehibernation (Table 4.2). In contrast, previous findings demonstrate 
increased testosterone in late hibernation in black bears [254-256]; however, these 
previous studies used male bears, which probably have different circannual cycles of 
androgens than females. Testosterone’s effects on bone are not fully understood. Over-
activation of the androgen receptor in osteoblasts of mice increases bone turnover and 
reduces bone matrix quality and whole bone strength [257]. In culture, testosterone has 
pro-apoptotic effects on osteoblasts [258]. These two studies suggest that testosterone’s 
direct effects on bone are catabolic. However, testosterone has anabolic effects on 
tissues which positively influence bone metabolism (e.g. muscle) [259] and is a substrate 
for the synthesis of estrogen, a steroid hormone with anabolic effects on bone. 
Therefore, testosterone may have indirect anabolic effects on bone. Indeed, 
testosterone has a positive correlation with femoral BMD and with serum levels of OCN 
and BSALP in post-menopausal women [260, 261], suggesting that testosterone may 
promote bone formation in vivo. The serum levels of testosterone are not significantly 
different during hibernation from either active season; therefore there is no evidence that 
testosterone levels promote an anti-apoptotic environment during hibernation.     
 
PTH has anti-apoptotic effects on osteoblasts [49, 55], and intermittent injections 
of PTH can inhibit bone loss [56]. The Donahue lab has previously reported an increase 
in PTH from prehibernation through post-hibernation in bears [34]; however, this 
previous study was incomplete and limited in size. The current study has a complete 
sample set from November through April, but includes only two bears. In another study 
which quantified PTH in the serum of 14 active and 27 hibernating American black 
bears, no seasonal change in PTH was observed in non-lactating bears, though PTH 
was lower in lactating than non-lactating bears [262]. In that study, there was only one 
sampling point in each season, in contrast to the Donahue studies which had multiple 
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sampling points. It is possible to miss overall seasonal trends when only viewing one 
sampling point per season. A larger and more complete study must be performed before 
conclusions about seasonal PTH trends can be made. Therefore, it is unclear whether 
PTH increases during hibernation, thus preventing disuse-induced osteoblast and 
osteocyte apoptosis. The concentrations of the c-terminal fragment of PTH were also 
quantified in the serum of hibernating and active bears. C-terminal PTH promotes 
osteocyte apoptosis, and inhibits bone turnover (for review see: [263]). Levels of c-
terminal PTH decrease significantly during the post-hibernation season (Table 4.2). 
Together, the data in this study do not suggest that the serum from hibernating bears 
provides an anti-apoptotic environment for osteoblasts; however, the hormones studied 
here are only a few of many which can have effects on osteoblast apoptosis. Therefore, 
it would be informative to determine whether the serum from hibernating bears protects 
osteoblasts from apoptosis. Such a study is reported in the following chapter.  
 
4.5 Tables and figures 
 
 
Season  Bears  Age (years)  Assays  Data Location 
2006‐2007  2 (1)  UK 
PTH, c‐terminal PTH, 
testosterone 
Figures 4.1‐4.3 
Table 4.2 
2007‐2008  4 (3)  5‐14  melatonin 
 
 
 
 
 
 
 
 
Serum 
Factor  
Fall
(Active) 
Winter
(Hibernation) 
Spring
(Active) p Power 
PTH 
(relative) 
LSM+SE 12.8+3.0 15.3+2.7 14.8+4.6 0.8226 0.0776 Nsamples 12 15 5 
C-terminal 
PTH 
(relative) 
LSM+SE 30.7+1.9A 31.8+1.7A 21.3+3.0B 
0.0164 0.7493 
Nsamples 12 15 5 
Test. 
(ng/dL) 
LSM+SE 54.7+7.4A 41.2+6.6AB 17.4+11.5B 0.0361 0.6370 Nsamples 45 48 31 
Table 4.1—Summary of assays 
The number of bears and assays that were performed in each hibernation season. The 
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as 
“UK.”  
Table 4.2—Serum factor concentrations 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. The p-value reported is for the partial F-test 
for the serum factor. “Test” represents testosterone. 
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Figure 4.1—Serum PTH concentrations 
Serum PTH concentrations of 2 black bears in the 2006/07 season. Vertical lines 
represent transitions between active and hibernating seasons. (A) PTH concentrations 
are represented by a line for each bear. (B) Single smoothed curve represents the 
average of both bears. (C) Each PTH concentration was normalized to the average PTH 
concentration for the appropriate bear for better comparison of seasonal fold changes. 
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Figure 4.2—Serum C-terminal PTH concentrations 
Serum C-terminal PTH concentrations of 2 black bears in the 2006/07 season. Vertical 
lines represent transitions between active and hibernating seasons. (A) C-terminal PTH 
concentrations are represented by a line for each bear. (B) Single smoothed curve 
represents the average of both bears. (C) Each C-terminal PTH concentration was 
normalized to the average C-terminal PTH concentration for the appropriate bear for 
better comparison of seasonal fold changes. 
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Figure 4.3—Serum testosterone concentrations 
Serum testosterone concentrations of 2 black bears in the 2006/07 season. Vertical lines 
represent transitions between active and hibernating seasons. (A) Testosterone 
concentrations are represented by a line for each bear. (B) Single smoothed curve 
represents the average of both bears. (C) Each testosterone concentration was 
normalized to the average testosterone concentration for the appropriate bear for better 
comparison of seasonal fold changes. 
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Chapter Five — Serum from hibernating bears protects cells 
from caspase-3 and -7 activation 
 
5.1 Introduction 
 
In the previous chapter, serum from hibernating and active bears was screened 
for specific hormones which may suppress osteoblast and osteocyte apoptosis during 
hibernation. Such a suppression of apoptosis during hibernation could prevent disuse-
induced bone loss since osteocyte apoptosis precedes disuse-induced bone loss [48], 
and preventing apoptosis with injections of an anti-apoptotic hormone (PTH) prevents 
bone loss [49, 56]. Although none of the hormones quantified (i.e. PTH, melatonin, and 
testosterone) appears to promote an anti-apoptotic environment during hibernation, 
many apoptosis regulators remain unquantified. In the second stage of this aim,   
MC3T3-E1 osteoblasts were cultured in serum from active and hibernating black bears. 
Cell responses to apoptotic threat (i.e. serum starvation) were quantified. The hypothesis 
was that osteoblasts cultured in the serum of hibernating bears would have reduced 
caspase-3 activation compared to cells cultured in active bear serum. Such a reduction 
in response to apoptotic threat would suggest that circulating factors in the serum of 
hibernating bears provide an anti-apoptotic environment for osteoblasts, thereby 
protecting the bear from bone loss.  
 
It was reasonable to suspect that cells cultured in serum from different 
physiological conditions (i.e. from hibernating and active bears) would respond 
differently. Previous studies have observed changes in protein expression in cells 
incubated in serum from active and hibernating animals [264, 265]. Additionally, 
expression of osteoblast differentiation markers such as osteopontin, ALP activity, and 
OCN have been observed in mesenchymal stem cells cultured in serum from normal or 
osteoporotic patients [266] and in smooth muscle cells cultured in serum from normal or 
uremic patients [267]. Thus, by culturing osteoblasts in serum from hibernating and 
active bears, we could gain insight into the cellular mechanisms behind the maintenance 
of bone mass during hibernation. 
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5.2 Methods 
 
5.2.1 Black bear handling and serum sample collection 
 
 A total of 11 female black bears were captured and held in pens in the Virginia 
Tech Center for Bear Research from fall through spring, between the years 2006 and 
2009. Samples were collected as described in section 2.2.1. 
 
5.2.2 Cell culture 
 
All experiments were conducted using the osteoblastic cell line MC3T3-E1, 
subclone 4 (ATCC, Manassas, VA).  This cell line displays markers of the osteoblast 
phenotype including high ALP, type I collagen, and OCN expression when cultured in 
differentiation media (α-modified Eagle’s medium (α-MEM) with 10% fetal bovine serum 
(FBS), 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate) [268]. The cells were 
cultured in growth media (α-MEM with 10% FBS, and 1% penicillin/streptomycin) on    
100 mm culture dishes in a 5% CO2 air atmosphere at 37°C.  Media was replaced every 
48 hours, and cells were passaged when they reach 80% confluency.  Cells were not 
used beyond the tenth passage.  
 
5.2.3 MC3T3-E1 apoptotic response to seasonal bear serum 
 
 Seasonal MC3T3-E1 response to apoptotic threat was determined by a caspase-
3 and -7 activity assay. Cells were seeded at 20,000 cells/well in tissue culture-treated 
white-walled 96-well plates and allowed to attach overnight. Prior to starvation, cells 
were primed for 24 hours in 2% FBS or bear serum. Since bear serum was collected 
every 10 days, several prehibernation, hibernation, and post-hibernation serum samples 
were available for each bear. Each well received a serum sample from a single bear 
from one collection day. Cells were starved in serum-free α-MEM for 6 hours, unless 
otherwise noted. Media was aspirated and replaced with 50 μL PBS and 50 μL 
chemiluminescent DEVD substrate (Promega, Madison, WI), which releases photons 
upon degradation by caspases 3 and 7. After 1 hour, luminescence was quantified by a 
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Synergy HT Multi-Detection Microplate Reader (Bio-Tek, Winooski, VT). Caspase 
activity was reported as relative luminescence. In studies involving inhibitors, cells were 
pre-treated for one hour in 2% FBS supplemented with 1 μM SB206553, 20 μM H-89, 
100 ng/mL pertussis toxin, or DMSO vehicle. Cells were then stimulated for 24 hours in 
2% bear serum with inhibitors before starvation. All inhibitors were purchased from 
Tocris Bioscience (Ellisville, MO). In studies involving filtered samples, molecules larger 
than 10 kD were removed from α-MEM containing 2% bear serum with 10K centrifugal 
filters (VWR, West Chester, PA). “Unfiltered” controls were filtered serum-free α-MEM 
supplemented with 2% bear serum after filtration. Cells were cultured in filtered or 
“unfiltered” samples for 24 hours prior to 6 hour starvation in serum-free media. In initial 
determination of caspase-3/7 response to bear serum pre-treatment, all available 
samples from October through May were used. In the studies involving inhibitors and 
filtration, 3 early prehibernation (October) and 3 mid-hibernation (February) samples 
were analyzed for each bear. 
 
Seasonal cell response to apoptotic threat was also determined by Cell Death 
Detection ELISA (Roche), which quantifies the amount of histone-complexed DNA 
fragments in a cell lysate. Cells were seeded at 35,000 cells/cm2 in 6-well plates and 
allowed to attach overnight. Cells were then stimulated with 2% bear serum for 24 hours. 
After starvation for 24 hours, cells were trypsinized and 104 cells from each sample were 
lysed and analyzed as described in the manufacturer’s protocol. Seasonal cell response 
was also determined by with trypan blue, which stains dead cells. Cells were seeded at 
35,000 cells/cm2 in 6-well plates and allowed to attach overnight. They were then 
stimulated with 2% bear serum for 24 hours. After starvation for 6, 24, or 48 hours, cells 
were trypsinized and counted with a hemocytometer. The ratio of live to dead cells was 
determined. 
 
5.2.4 Caspase-3/7 activity of bear bone lysates 
 
Seven grizzly bears were housed at the Washington State University Bear 
Research, Education, and Conservation Facility (Pullman, WA, USA) for this study. All 
handling and treatment procedures were approved by the Washington State University 
Institutional Animal Care and Use Committee. Four bears were sacrificed after 16-18 
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weeks of hibernation, and 3 bears were sacrificed after at least 14 weeks of physical 
activity following hibernation. Bears were euthanized by an injection of pentobarbital (10 
ml per 100 lbs body weight). Transiliac crest biopsies were collected with a diamond-
edged 3/8” coring bit. The cortical sections were separated from the trabecular bone with 
a saw. Marrow was removed from the trabecular bone with a water pick. Cortical and 
trabecular sections were crushed separately into a fine powder in liquid nitrogen, and 
lysed in buffer L (10mM Tris-HCl pH 8.0, 1% IGEPAL, 2mM MgCl2, 150mM NaCl). After 
centrifugation to remove insoluble matter, protein concentration was quantified with the 
DC Protein Assay (BioRad Laboratories, Hercules, CA). Aliquots were stored at -80oC. 
15 μg of lysate was brought up to 50 μL in buffer L, and 50 μL of chemiluminescent 
DEVD substrate was added. After 1 hour incubation, caspase-3/7 activity was quantified. 
Caspase activity was normalized to a standard curve of purified caspase-3 (Enzo Life 
Sciences, Plymouth Meeting, PA). Caspase-3/7 activity was reported in international 
units (U) of activity. One U breaks down DEVD substrate at 1 pmol per minute. 
 
5.2.5 MC3T3-E1 gene expression response to bear serum 
 
Cells were seeded into 6-well plates at 20,000 cells/cm2 and grown overnight. 
Osteoblast differentiation was cultured for 6 days in differentiation media (α-MEM with 
2% bear serum, 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate), with a media 
change on the third day. RNA was purified with the SV Total RNA Isolation System 
(Promega, Madison, WI). Immediately after bear serum stimulation, media was 
aspirated, and cells were directly lysed in 140 μL RNA lysis buffer. Quality of RNA was 
assessed by gel electrophoresis and with a Nanodrop (Nanodrop Technologies, 
Willmington, DE).  cDNA equivalent of 300 ng RNA was generated in a 25 μL reaction 
using 250U SSII reverse transcriptase, 0.5 μg oligo-dT 12-18 primer, and 25 U RNase 
Out (Life Technologies, Carlsbad, CA) at 42°C for 20 minutes, 50°C for 10 minutes and 
42°C for 1 hour in a gradient thermocycler (Eppendorf, Westbury, NY). Primers for all 
genes of interest and the housekeeping gene were designed using PrimerQuest 
software (Integrated DNA Technologies, Coralville, IA) and the NCBI gene bank 
sequences, and the PCR conditions for each primer set were optimized using RNA from 
MC3T3-E1 cells. SYBR Green 2X master mix (ABGene, Rochester, NY) was used to set 
up PCR. cDNA equivalent of 2.5ng RNA was used in 25 μL PCR samples with 0.1 μM 
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gene specific primers and 12.5 μL SYBR mix.  Forty cycles of real-time PCR was 
performed using OneStep Plus (Life Technologies, Carlsbad, CA). Sample expression 
was normalized to a background calibrator (samples incubated in 2% FBS), and again to 
the housekeeping gene cyclophilin using a variation of the relative standard curve 
method [269]. Briefly, the average threshold cycle (CT) for the 2% FBS background was 
subtracted from the threshold cycle of each reaction to make ΔCT. Then the following 
calculation was performed, where GOI is “gene of interest,” RG is the reference gene, 
and E is the average efficiency of the primer: 
Eqn 5.1: ܰ݋ݎ݈݉ܽ݅ݖ݁݀ ܧݔ݌ݎ݁ݏݏ݅݋݊ ൌ  
ாಸೀ಺
     ష∆಴೅ሺಸೀ಺ሻ
ாೃಸ
     ష∆಴೅ሺೃಸሻ  
Gene expression of OCN and runt-related transcription factor 2 (Runx2) were quantified. 
Data was reported as relative normalized units.   
 
5.2.6 Biochemical Assays 
 
Serum was assayed for serotonin, adiponectin, and BSALP as described in 
section 2.2.2 and for NPY as described in section 3.2.  
 
5.2.7 Data representation and statistics 
 
All statistical analyses were performed using JMP 7 software. Data in Tables 5.2 
and 5.4 are presented as the LSM + SE. Samples were grouped by season (i.e. 
prehibernation, hibernation, and post-hibernation) and analyzed with a single-factor 
ANOVA, blocking by bear, with a Tukey’s post-hoc (for three seasons) or a student’s t-
test (for two seasons). Correlations between serum factors and cell responses were 
determined by least-squares linear regression, blocking by bear.  
 
5.3 Results 
 
In order to determine an appropriate time-point for quantifying caspase-3/7 
activity in MC3T3-E1 cells, a time-course was performed, comparing the caspase-3/7 
response to 3, 6, 9, and 18 hours of serum starvation (Figure 5.1). Caspase-3/7 activity 
was highest at 6 and 9 hours of starvation, and 6 hours was chosen as the time-point for 
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further assays. To determine whether bear serum had a seasonal effect in response to 
apoptotic threat, MC3T3-E1 pre-osteoblasts were primed for 24 hours in seasonal bear 
serum, then serum starved for 6 hours. The caspase-3/7 response to 6 hours’ serum 
starvation was graphed longitudinally with a smoothed average curve (Figure 5.2). The 
caspase-3/7 response began to decrease in serum collected approximately 10 days 
before hibernation, and remained at a lower level throughout hibernation. In serum 
collected just after hibernation, caspase-3/7 response immediately rose to levels higher 
than those stimulated by prehibernation serum, suggesting a state of increased 
osteoblast metabolism in post-hibernation. When samples were grouped by season and 
compared by ANOVA, caspase-3/7 activity dropped from 5.66+0.23 relative units in fall 
to 3.82+0.20 in winter; values then rose to 7.89+0.41 in the spring (p<0.0001) (Table 
5.2). Despite this drop in caspase-3/7 activity in MC3T3-E1 osteoblasts cultured in 
hibernating bear serum, no seasonal change in percent death was observed by Trypan 
blue staining after 6, 24, and 48 hours of serum starvation (data not shown). Similarly, 
no seasonal differences in apoptotic enrichment factor were observed with the Cell 
Death Detection ELISA after 24 hours of serum starvation (data not shown). To 
determine whether bone of hibernating bears confirmed the finding that caspase-3 and   
-7 activity was suppressed by hibernation, bone tissue lysates were assayed.                  
Caspase-3/7 activity of cortical bone tissue lysates had a decreasing trend of 65% from 
prehibernation to hibernation (p=0.2436) (Figure 5.3). The trabecular bone lysates had 
very low levels of caspase-3/7 activity in both active and hibernating seasons (data not 
shown).  
 
 Serum serotonin concentrations during the prehibernation and hibernation 
seasons were correlated to the caspase-3/7 response of pre-osteoblasts cultured in 
seasonal serum (r=0.807, p<0.0001), suggesting that reduced serotonin levels in the 
hibernation serum might desensitize the cells to apoptotic threat. Therefore, the         
5HT-2B / -2C inhibitor SB206553 was used to block the possible effects of serotonin on 
the cultured osteoblasts. There was a 47% decrease in caspase-3/7 response of cells 
primed in prehibernation serum compared to hibernation in the vehicle samples 
(p=0.0001) and a 43% seasonal decrease in the SB206553 samples (p=0.0007) (Figure 
5.4), suggesting that the 5HT-2B / -2C inhibitor did not suppress the seasonal effect of 
bear serum on caspase-3/7 activity. To help narrow down the internal signaling pathway 
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involved in the reduced caspase-3/7 response of cells primed in hibernation serum, 
experiments were repeated with H-89 and pertussis toxin. When the protein kinase A 
(PKA) pathway was inhibited with H-89, the percent decrease between cells in 
prehibernation versus hibernation serum was 39% in the vehicle sample (p<0.0001) and 
31% in the H-89 sample (p=0.0066) (Figure 5.5); however, H-89 reduced the      
caspase-3/7 response to serum starvation by approximately 12% (p<0.0001). In a similar 
experiment, the g-protein subunit Gi was blocked with pertussis toxin. In this experiment, 
the toxin-treated samples had a 38% decrease in caspase-3/7 activity between cells 
incubated in prehibernation or hibernation serum (p=0.0234), whereas there was a 48% 
decrease between prehibernation and hibernation samples in the vehicle treatment 
(p=0.0423) (Figure 5.6). Thus, neither the H-89 nor pertussis toxin had a strong impact 
on the seasonal effect of bear serum on the caspase-3 and -7 response of cultured 
MC3T3-E1 pre-osteoblasts.  
 
The final attempt at characterizing the serum factor responsible for the reduced 
response of pre-osteoblasts to apoptotic threat in hibernation serum was to filter out all 
molecules of size greater than 10 kD. Samples were treated with filtered and unfiltered 
serum for 24 hours, followed by a 6 hour serum starvation, as before. Controls using 
filtered and unfiltered 2% FBS were simultaneously collected. In the unfiltered FBS 
control, the starved sample had 260% higher caspase-3/7 activity than the unstarved 
sample (p<0.0001); however, there was no significant difference between the starved 
and unstarved samples after priming for 24 hours in filtered 2% FBS (p=0.6784) (Figure 
5.7 A). These data suggest that priming for 24 hours in filtered serum prior to six hours’ 
serum starvation does not activate caspases 3 and 7 at this time-point. There was also 
no seasonal difference between caspase activities of cells primed for 24 hours in filtered 
prehibernation serum versus filtered hibernation serum (p=0.1014) (Figure 5.7 B). 
Because the caspase-3/7 response to serum starvation is time-dependent and drops 
back to basal levels after 24 hours of starvation (Figure 5.1), we thought that the 
samples grown in filtered 2% serum may have experienced a starvation-like state during 
the 24 hour priming step. Therefore, we tried a second experiment in which the cells 
were cultured in filtered serum-free or 2% FBS media for 6 hours, followed by caspase 
activity analysis. Under these conditions, the samples stimulated for 6 hours in filtered 
serum-free media had a 27% increase in caspase-3/7 activity compared to samples 
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stimulated in filtered 2% FBS (p=0.0071) (Figure 5.8 A). The cells grown for 6 hours in 
filtered 2% bear serum were not significantly different between prehibernation and 
hibernation seasons (p=0.4490) (Figure 5.8 B).  
 
Serum levels of BSALP and adiponectin were positively correlated, and NPY was 
inversely correlated, with the caspase-3/7 response of cultured osteoblasts to apoptotic 
threat (Table 5.4). The gene expression of osteoblast differentiation markers OCN and 
Runx2 increased in differentiating osteoblasts cultured in serum from post-hibernation 
bears, compared to those in serum from prehibernation and hibernation bears (Table 
5.2).  
 
5.4 Discussion 
 
 Hibernating bears have a unique ability to maintain bone mechanical strength 
and structural properties despite extended periods of disuse [16-21, 173, 174]. The 
purpose of this study was to explore the hypothesis that a serum-borne factor in 
hibernating bears suppresses osteoblast apoptosis. Such a suppression of apoptosis 
may prevent disuse-induced bone loss during hibernation. MC3T3-E1 osteoblast-like 
cells were cultured in serum from active and hibernating bears for 24 hours, followed by 
an apoptotic threat. Figure 5.2 demonstrates a reduction in caspase-3 and -7 activation 
in cells cultured in hibernating bear serum, supporting the hypothesis. These data also 
demonstrate an increased caspase-3/7 response in post-hibernation serum compared to 
prehibernation serum (Table 5.2), indicating the metabolic rate of bone may be 
increased in the weeks immediately following hibernation. This higher metabolism in 
bone was also indicated in the gene expression data (Table 5.2). Expression of OCN 
and Runx2, markers of osteoblast differentiation, were significantly higher in osteoblasts 
cultured in post-hibernation serum. Such an increased metabolic state in the bones of 
post-hibernation bears has been indicated in previous publications [35].  
 
 The next step was to demonstrate that apoptosis decreases in the bone tissue of 
hibernating bears, compared to active bears. This step has proven more difficult. 
Hibernating animals are exposed to many conditions that would cause extensive tissue 
damage due to apoptosis in other animals; however, they fully recover from annual 
                                                                      79 
 
hibernation cycles without problem [163]. Despite this ability to recover from annual 
cycles of hibernation, studies have consistently shown an increase in TUNEL positive 
cells in tissues from hibernating animals [45, 168, 169], which would normally indicate an 
increase in apoptosis. However, one of these studies demonstrated that caspase-3 
activation in the gut of hibernating ground squirrels decreases, despite increased TUNEL 
positive cells [45]. Thus, TUNEL stains in hibernating tissues may be inaccurately 
interpreted as an increase in apoptosis. It is possible that the increase in TUNEL positive 
cells during hibernation may be due to an accumulation of damaged DNA during this 
season [45]. In support of this claim, other studies have shown that TUNEL stains can 
incorrectly label cells with DNA damage that are destined for repair [46]. Thus, a TUNEL 
stain was not attempted on bone biopsies from bears. The caspase-3 stain for apoptotic 
cells could likewise not be used on bear bone tissue, because an antibody could not be 
found which would bind bear caspase-3. Therefore, this study determined the caspase 
activity of bone lysate using a DEVD substrate, which is broken down by caspases 3 and 
7. Only three active and four hibernating bone biopsies were available for analysis, so 
this study had low power and did not attain significance. However, there was a trend for 
decreased caspase-3/7 activity in the lysate of hibernating bear cortical bone compared 
to lysate from active samples (Figure 5.3). These data further support the hypothesis 
that apoptosis is decreased in the bones of hibernating bears, but a study with more 
samples is necessary for conclusive confirmation. 
 
 The next goal of the current study was to characterize the serum factor 
responsible for reduced apoptotic response of osteoblasts cultured in serum from 
hibernating bears. If the post-hibernation samples were removed from analysis, serum 
levels of serotonin had a strong positive correlation to the osteoblast caspase-3/7 
response to apoptotic threat. Although there is no known literature of a pro-apoptotic 
effect of serotonin on osteoblasts, many studies suggest that circulating serotonin has a 
catabolic effect on bone (for review see: [251]). The direct effect of serotonin on MC3T3-
E1 proliferation is suppressed by the 5HT-2B / -2C receptor inhibitor SB206553 [219], so 
this inhibitor was chosen for the current study. SB206553 did not inhibit the seasonal 
effect of bear serum on MC3T3-E1 response to apoptotic threat (Figure 5.4), indicating 
that if serotonin is responsible for the seasonal effect of bear serum on osteoblast 
apoptotic response, then it is not through the 5HT-2B or -2C receptors; however, there 
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are also 5HT-1A, -2A, and -1D receptors and 5HTT transporters on osteoblasts [270], 
none of which would have been blocked by SB206553; therefore, serotonin has not 
been definitely ruled out as a potential apoptosis effector in this system.    
 
 H-89 inhibits the PKA pathway, an internal signaling cascade which, in 
osteoblasts, responds to a variety of hormones including parathyroid hormone, calcitonin 
gene-related peptide, and norepinephrine [271-274]. H-89 can suppress anti-apoptotic 
signaling in osteoblasts [272, 275, 276]; however, H-89 does not significantly suppress 
the seasonal difference in apoptotic response of pre-osteoblasts primed in bear serum 
(Figure 5.5), suggesting that the PKA pathway is not vital to this seasonal difference in 
caspase-3/7 response. Pertussis toxin inhibits the g-protein subunit Gi. A variety of 
hormones and factors can function through the Gi subunit of g-protein coupled receptors, 
including parathyroid hormone, aluminum, lysophosphatidic acid, epinephrine, and 
melatonin [277-280]. Pertussis toxin can suppress anti-apoptotic signaling in osteoblasts 
[281, 282]. Pertussis toxin did not greatly alter the seasonal difference observed 
between pre-osteoblasts primed in prehibernation and hibernation serum samples 
(Figure 5.6), suggesting that the Gi subunit is not necessary for this seasonal difference 
in caspase-3/7 response.     
 
In an attempt to determine the size of the serum factor responsible for the 
seasonal difference in apoptotic response, molecules larger than 10 kD were filtered out 
of the media before stimulation. Samples were treated with filtered and unfiltered serum 
for 24 hours, followed by a 6 hour serum starvation, as in previous experiments. There 
was not a seasonal difference between cells primed in filtered prehibernation and 
hibernation serum samples (Figure 5.7 B); however, there was also no difference 
between starved and unstarved cells which were primed in filtered 2% FBS (Figure 5.7 
A), suggesting that the 24 hour priming in filtered media suppresses caspase-3/7 
response at this time-point. The caspase-3/7 response to starvation is time-dependent 
(Figure 5.1), and we thought that the filtered media might induce a starvation-like state 
in the cells. Therefore, we ran a second experiment in which cells were cultured in 
filtered 2% FBS or serum free media for 6 hours, followed by caspase-3/7 activity 
analysis. In this second experiment, there was a significant difference between the 2% 
FBS and the serum-free media (Figure 5.8 A). We then cultured cells for 6 hours in 
                                                                      81 
 
filtered seasonal bear serum and found no significant difference between the caspase-
3/7 response of prehibernation and hibernation samples (Figure 5.8 B). This 
suppression of the seasonal difference between cells cultured in prehibernation and 
hibernation serum samples may suggest that a molecule larger than 10kD is necessary 
for the seasonal difference in caspase-3/7 activity; however, the data remains 
inconclusive since the experimental conditions are different than our original experiment 
in which we saw the seasonal difference, and no proper control for this experiment 
exists. 
 
Least squares linear regression analysis was used to determine relationships 
between the caspase-3/7 response to apoptotic threat and bone turnover markers in the 
serum. Interestingly, the caspase-3/7 response was positively correlated to the serum 
marker of osteoblast activity BSALP (Table 5.4), suggesting that the reduced osteoblast 
response to apoptotic threat in serum from hibernating bears may be coupled to reduced 
osteoblast differentiation. Previous studies have described a dependence on caspase-3 
for osteoblast differentiation. For instance, MC3T3-E1 cells activate caspases 8, 2, and 3 
upon stimulation of differentiation by BMP-4, and inhibitors of these caspases will 
suppress the effects of BMP-4 [283]. Another study demonstrates that osteoprogenitor 
cells from caspase-3-/- and caspase-3+/- mice have significantly decreased expression of 
Runx2 compared to cells from wild-type mice [284]. It is possible that the higher   
caspase-3/7 activity observed in osteoblasts cultured in active bear serum may be partly 
due to a higher differentiation potential in these cells. If true, this would explain why we 
observed a seasonal caspase-3/7 response to bear serum, but could not find any 
indication that the cells were undergoing apoptosis through trypan blue exclusion and 
Cell Death Detection assays.  
 
To support the idea that the seasonal differences in caspase-3/7 response may 
be due to reduced differentiation potential of cells in hibernating bear serum, regression 
analysis was used to determine relationships between gene expression of osteoblast 
differentiation markers and caspase-3/7 response. The seasonal caspase-3/7 response 
to serum starvation after 24 hours’ pre-treatment in bear serum was positively correlated 
to gene expression of OCN and Runx2 after 6 days of differentiation in seasonal bear 
serum (Table 5.4). A reduction of osteoblast differentiation during hibernation may be 
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favorable since differentiation would utilize metabolic energy, which bears must 
conserve during hibernation. In fact, although osteoblast activity remains balanced with 
osteoclast activity, activities of both cell types dramatically decrease during hibernation, 
as is seen in histomorphometric data [18, 20] and serum levels of BSALP (Table 5.3). 
 
Finally, regression analysis was used to determine what hormones may be 
responsible for reduced osteoblast differentiation and caspase-3/7 activation during 
hibernation. Serum levels of the neuropeptide NPY increase in the serum of hibernating 
bears, and are inversely correlated with caspase-3/7 response to apoptotic threat in 
osteoblasts (Table 5.4). Although there are no known studies demonstrating a 
relationship between NPY and osteoblast caspase-3 and -7 response, NPY is known to 
suppress osteoblast differentiation [246]. Furthermore, NPY is negatively correlated to 
serum BSALP, suggesting a possible relationship between NPY and bone turnover in 
the bear. Another potential effector of differentiation is adiponectin, which decreases in 
the serum of hibernating bears and is positively correlated to caspase-3/7 response to 
apoptotic threat in osteoblasts (Table 5.4). Again, although there are no known studies 
demonstrating a relationship between adiponectin and caspase-3 and -7 response, 
adiponectin has been shown to stimulate osteoblast proliferation, differentiation, and 
expression of BSALP in cultured osteoblasts [202]. Adiponectin levels are positively 
correlated to serum BSALP in the bears, suggesting that it, too, could be regulating 
turnover during hibernation.  
 
Bears have a unique ability to maintain bone despite prolonged mechanical 
unloading (i.e. hibernation). The aim of this study was to demonstrate that a factor in the 
serum of hibernating bears would protect cultured osteoblasts from apoptosis. Such a 
prevention of osteoblast and osteocyte apoptosis in the bones of hibernating bears may 
help maintain bone during this period of disuse. Compared to cells cultured in active 
bear serum, osteoblasts cultured in serum from hibernating bears had reduced caspase-
3 and -7 activity and a higher percentage of living cells after 6 hours of serum starvation. 
These findings suggest that the osteoblast response to apoptotic stimulus may be 
reduced during hibernation. This effect did not appear to be PKA dependent or strongly 
sensitive to pertussis toxin. Based upon regression analysis, two possible hormones are 
NPY and adiponectin. Both hormones have an impact on osteoblast differentiation, 
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which is dependent upon caspase-3 activation. It is likely that more than one serum 
factor is involved in the maintenance of bone mass during hibernation in bears; however, 
determining a few possible effector hormones could pinpoint new signaling pathways as 
potential drug targets. This study has taken a step towards that long-term goal.     
 
5.5 Tables and figures 
 
 
 
Season  Bears  
Age 
(years)
Assays  Data Location 
2006‐2007  2 (1)  UK  Caspase‐3, 6day qPCR (OCN, Runx2) 
Figure 5.2 
Tables 5.2, 5.3 
2007‐2008  4 (3)  5‐14  Caspase‐3 
Figure 5.2 
Tables 5.2, 5.3 
2008‐2009  5 (3)  2‐21 
SB206553 Caspase‐3, Caspase‐3, 
Pertussis Toxin Caspase‐3, H‐89 
Caspase‐3, 10kd and 30kd Filter 
Caspase‐3 
Figures 5.3‐5.7 
Table 5.2, 5.3 
 
 
 
 
 
 
Cell 
Response  
Fall
(Active) 
Winter
(Hibernation) 
Spring 
(Active) p 
Caspase-3/7 LSM+SE 5.66+0.23
B 3.82+0.20C 7.89+0.41A <0.0001 
Nsamples 40 53 14 
OCN LSM+SE 0.0564+0.005
B 0.0549+0.004B 0.0983+0.007A <0.0001 
Nsamples 11 16 5  
Runx2 
LSM+SE 0.654+0.083B 0.741+0.069B 1.13+0.12A 
0.0103 Nsamples 11 16 5 
 
 
 
 
 
Table 5.1—Summary of assays 
The number of bears and assays that were performed in each hibernation season. The 
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as 
“UK.”  
Table 5.2—Cell responses to bear serum 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the means. Letters (A, B, C) represent values that are significantly different 
from each other at α=0.05. The p-value reported is for the partial F-test for the serum factor. 
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Dependent  
Variable 
Independent 
Variable 
Nbears β r p Power 
Caspase-3/7 6 day OCN 2 0.00532 0.796 <0.0001 0.9971 
Caspase-3/7 6 day Runx2 2 0.0535 0.453 0.0069 0.8058 
Caspase-3/7 BSALP 4 0.130 0.728 0.0066 0.8214 
Caspase-3/7 NPY 4 -0.0107 -0.437 0.0496 0.5061 
Caspase-3/7 Adiponectin 4 0.000936 0.493 0.0131 0.7158 
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Table 5.3—Linear regression models 
Figure 5.1—Caspase-3/7 activity time-course 
MC3T3-E1 cells were starved in serum free α-MEM for 3-24 hours. Data are represented as 
LSM+SE. Units are of relative luminescence normalized to the average of the “time 0” no-
starve control.   
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Figure 5.2—Longitudinal analysis of caspase-3/7 response 
MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, and were then starved in 
serum free α-MEM for 6 hours. Caspase-3/7 response was normalized to a no-starve FBS 
control. Each point represents the caspase-3/7 response from pre-incubation in one serum 
sample. Vertical lines represent transitions between active and hibernating seasons. The 
smoothed average curve was generated with JMP software by a cubic spline. Samples are 
from 11 black bears in the 2006/07 – 08/09 seasons.  
Figure 5.3—Caspase-3/7 activity in cortical bone lysate from hibernating and active bears 
Caspase-3/7 activity was quantified in 15μg protein equivalent of crushed bone lysate. Data 
are represented as LSM+SEM. A t-test was used to determine the p-value, with an n=4 
hibernation and 3 active samples for each season. Due to small sample size, seasonal 
variation did not obtain significance (p=0.2436). 
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Figure 5.4—Seasonal caspase-3/7 response with 5HT-2B / 5HT-2C inhibitor 
MC3T3-E1 cells were pretreated in SB206553 for one hour, and were then cultured in 
seasonal bear serum supplemented with SB206553 for 24 hours. Afterwards, they were 
starved in serum free α-MEM for 6 hours. Caspase-3/7 activities were normalized to the no-
starve FBS control. Caspase-3/7 activities were compared between prehibernation and 
hibernation for each treatment with a student’s t-test. Both treatments had a significant 
seasonal difference, indicated with asterisks (p<0.0008). Samples are from 3 black bears of 
the 2008/09 season.  
Figure 5.5—Seasonal caspase-3/7 response with PKA inhibitor 
MC3T3-E1 cells were pretreated in H-89 for one hour, and were then cultured in seasonal 
bear serum supplemented with H-89 for 24 hours. Afterwards, they were starved in serum 
free α-MEM for 6 hours. Caspase-3/7 activities were normalized to the no-starve FBS control. 
Caspase-3/7 activities were compared between prehibernation and hibernation for each 
treatment with a student’s t-test. Both treatments had a significant seasonal difference, 
indicated with one (p<0.05) or three asterisks (p<0.0001). Samples are from 5 black bears of 
the 2008/09 season. 
** ** 
*** 
* 
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Figure 5.6—Seasonal caspase-3/7 response with pertussis toxin 
MC3T3-E1 cells were pretreated in pertussis toxin for one hour, and were then cultured in 
seasonal bear serum supplemented with pertussis toxin for 24 hours. Afterwards, they were 
starved in serum free α-MEM for 6 hours. Caspase-3/7 activities were normalized to the no-
starve FBS control. Caspase-3/7 activities were compared between prehibernation and 
hibernation for each treatment with a student’s t-test. Both treatments had a significant 
seasonal difference, indicated with an asterisk (p<0.05). Samples are from 3 black bears of 
the 2008/09 season.  
* 
* 
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Figure 5.7—Seasonal caspase-3/7 response with 24 hour prime with filtered serum 
Media supplemented with 2% FBS, no serum, or 2% bear serum was filtered to remove 
molecules >10kD. Cells were cultured in filtered or unfiltered media for 24 hours, followed by 
a 6 hour starvation. Caspase-3/7 activities were normalized to the average of the no-starve 
FBS control. (A) Comparisons between caspase activities of starved and unstarved cells after 
24 hours in 2% FBS, followed by 6 hours of serum starvation. (B) Comparisons between 
caspase activities of cells after 24 hours incubation in 2% prehibernation or hibernation 
serum, followed by 6 hours of starvation. Bear serum samples are from 5 black bears of the 
2008/09 season. Statistical significance between samples was determined with a student’s t-
test and is indicated with three asterisks (p<0.0001). 
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Figure 5.8—Seasonal caspase-3/7 response after 6 hour stimulation in filtered serum 
Media supplemented with 2% FBS, no serum, or 2% bear serum was filtered to remove 
molecules >10kD. Cells were cultured in filtered media for 6 hours. Caspase-3/7 activities 
were normalized to the average of a no-starve unfiltered FBS control. (A) Comparisons 
between caspase activities of cells in 2% FBS or serum free media. (B) Comparisons 
between caspase activities of cells in 2% prehibernation or hibernation serum. Bear serum 
samples are from 5 black bears of the 2008/09 season. Statistical significance between 
samples was determined with a student’s t-test and is indicated with an asterisk (p<0.05). 
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Chapter Six — MC3T3-E1 osteoblasts cultured in serum 
from post-hibernation bears have higher metabolism than 
osteoblasts cultured in serum from other seasons 
 
6.1 Introduction 
 
 Hibernation is a state of energy conservation during prolonged anorectic periods. 
Cell proliferation, bone formation, and bone resorption are all metabolically expensive 
activities; therefore the theme of this dissertation centers on mechanisms to reduce bone 
turnover during hibernation. In this study, the gene expression responses of MC3T3-E1 
osteoblasts to seasonal bear serum were explored. These genes can be grouped into 
four hypotheses, all suggestive of reduced proliferation and activities of bone cells during 
hibernation.   
 
The first hypothesis of this study was that cell cycle regulators favor reduced 
proliferation in osteoblasts cultured in serum from hibernating bears (compared to cells 
in serum from active bears). Suppressing proliferation would help preserve metabolic 
energy during hibernation. Cell cycle regulation is also closely tied to apoptosis since, 
upon DNA damage cells halt in the G1 or G2 phases (for review see: [285]). This halt 
allows the cell time to repair itself. If repair is unsuccessful, then the apoptotic cascade is 
activated. Therefore, a balance between reduced proliferation and reduced apoptosis 
must be achieved during hibernation, since an increase in apoptosis could promote 
irreparable tissue damage during the long months of hibernation. Qualitative 
observations suggest that such tissue damage is not present in hibernating animals (for 
review see: [163]). Increased TUNEL staining has been observed in various tissues of 
hibernating animals [45, 168, 169], but this increase in TUNEL staining may be due to 
accumulated DNA damage over the weeks of hibernation and may not lead to activation 
of the caspase cascade [45]. A halt in cell cycle during hibernation may be necessary 
because of accumulated DNA damage. At the same time, such a halt would prevent 
excessive use of metabolic energy. The tumor-suppressor gene protein 53 (p53) is 
activated upon DNA damage, resulting in a halt in the G1 phase of the cell cycle (for 
review see: [41]). Thus, p53 expression was expected to increase in osteoblasts cultured 
in hibernating bear serum. Cyclin D1 regulates the cell cycle by promoting progression 
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beyond the G1/S checkpoint, thus inducing proliferation of osteoblast progenitors (for 
review see: [286, 287]). Expression of Cyclin D1 was expected to decrease in 
osteoblasts cultured in the serum from hibernating bears. Clock genes (e.g. Per1, Per2, 
Bmal1) control cell cycle progression past the G1/S and G2/M checkpoints. A halt in the 
G1 phase could be indirectly caused by an increase in Bmal1 through modulation of          
c-myc and Cyclin D1 [285, 288, 289]. Alternatively, a halt in the G2 phase could be due 
to an increase in Per1 [290]. Since a halt in either cell phase could slow proliferation and 
prevent excessive use of metabolic energy, an increase in either Per1 or Bmal1 in 
osteoblasts cultured in hibernating bear serum was expected.  
 
In the second hypothesis, the caspase-3/7 response of osteoblasts cultured in 
seasonal bear serum (observed in Chapter 5) was expected to be correlated to gene 
expression of apoptosis regulators. In the Bcl-2 family, expression of anti-apoptotic Bcl-2 
and Bcl-XL were expected to increase in osteoblasts cultured in the serum of hibernating 
bears, with a concurrent decrease in expression of pro-apoptotic BAK, BAX, and BAD. 
Likewise, the pro-survival gene Akt was expected to increase in osteoblast cultured in 
serum from hibernating bears. Thus, osteoblasts cultured in serum from hibernating 
bears were expected to favor anti-apoptotic gene expression compared to cells cultured 
in serum from active bears. If such a decrease in apoptotic signaling occurred in 
osteoblasts of the hibernating bear, bone resorption could be suppressed during this 
period of disuse. 
 
The third hypothesis of this study was that expression of osteoblast differentiation 
markers would decrease in cells cultured in hibernating serum (compared to cells in 
active serum). The transcription factor Runx2 is upregulated during the differentiation of 
osteoblasts (for review see: [291]), and was expected to be lower in osteoblasts cultured 
in serum from hibernating bears. Ubiquitin is a small regulatory protein which is 
covalently bound to other proteins as a tag for proteolysis. It is often used as a reference 
gene because its expression is ubiquitous in all cell types. In osteoblasts, Smad ubiquitin 
regulatory factor 1 (Smurf1) ligates ubiquitin to Runx2 and other osteogenic regulators 
(for review see: [292]). The subsequent proteolysis of these tagged proteins suppresses 
osteoblast activity (i.e. matrix production, BSALP activity) [293, 294]. Smurf1 was 
expected to increase in osteoblasts cultured in hibernating bear serum thus reducing 
                                                                      92 
 
osteoblast activity. c-fos is a proto-oncogene in the AP-1 family of transcription factors. It 
is essential in the regulation of bone development (for review see: [295]) and for the 
anabolic actions of PTH on bone [296, 297]. Its expression was expected to decrease in 
osteoblasts cultured in hibernating bear serum. Osteopontin (OPN), collagen I (ColI), 
and OCN are essential cell matrix proteins produced by osteoblasts during the formation 
of bone (for review see: [298]). These genes were expected to decrease in osteoblasts 
cultured in hibernating bear serum, which would suggest that a serum-borne factor is 
responsible for the decreased bone formation observed in hibernating bears [18, 20].  
 
 The fourth hypothesis of this study was that expression of pro-resorptive genes 
would decrease in osteoblasts cultured in serum from hibernating bears. Under catabolic 
stimulation (e.g. reduced mechanical loading), osteoblasts increase expression of the 
pro-resorptive cytokine receptor activator for NFκ-B ligand (RANKL) and decrease 
expression of its decoy receptor OPG. An increased RANKL to OPG ratio promotes 
osteoclast activation followed by the resorption of bone (for review see: [299]). Bone 
resorption is decreased during hibernation in bears [18, 20]; therefore it was expected 
that the expression of RANKL would decrease and OPG would increase in osteoblasts 
cultured in serum from hibernating bears (compared to cells in active serum). 
Macrophage colony stimulating factor (M-CSF) is a pro-resorptive cytokine expressed by 
a variety of bone cells, including osteoblasts. It promotes the proliferation of osteoclast 
precursors (for review see: [300]). Osteoblast expression of M-CSF was expected to 
decrease in cells cultured in serum from hibernating bears.  
 
 Finally, the gene expressions of three cell-surface receptors were quantified in 
osteoblasts cultured in seasonal bear serum. The PTH receptor (PTH1R) was expected 
to increase in osteoblasts cultured in hibernating bear serum. This would suggest that a 
factor in hibernating bear serum increases PTH signaling in osteoblasts even though the 
circulating levels of PTH remain homeostatic in these serum samples (reported in 
Chapter 4). An increase in PTH signaling prevents bone loss during disuse in rats [56], 
and may help protect hibernating bears from bone loss. ADRβ2, the adrenergic receptor 
which binds NE, was expected to decrease in osteoblasts cultured in the serum of 
hibernating bears since beta-blockers inhibit bone loss due to disuse [217, 220]. As 
observed in Chapter 3, although there is no seasonal variation in serum NE of black 
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bears, it is possible that tissue sensitivity to NE changes during hibernation. Such an 
insensitivity to NE is observed in golden-mantled ground squirrels subjected to reduced 
temperature [252]. Osteoblast expression of Toll-like receptor 4 was expected to 
decrease in the serum of hibernating bears (compared to serum from active bears) 
because activation of TLR4 on osteoblasts induces expression of RANKL [301] and 
promotes osteoblast apoptosis [302], thus promoting bone resorption.  
 
 The expressions of these genes were screened under several different cell 
culture conditions in order to determine how seasonal bear serum affects osteoblast cell 
response.  
 
6.2 Methods and materials 
 
A total of 6 female black bears were captured and held in pens in the Virginia 
Tech Center for Bear Research from fall through spring, between the years 2006 and 
2008. Samples were collected as described in section 2.2.1. Information about the bears 
used for each serum assay is shown in Table 6.1. Due to limitations of serum sample 
sizes, not all bears were used for all assays. The choice of bear used for each assay 
depended upon sample availability at the time the assays were run. Cell culture was 
performed as described in section 5.2.2, except that MC3T3-E1 subclone 14 osteoblasts 
were used for the 3 hour differentiated condition. These cells were not used after 
passage 30, since higher passage numbers have been shown to alter the phenotype of 
MC3T3-E1 cells [303]. In all other cell culture studies in this report, MC3T3-E1 subclone 
4 cells were used below passage 10. Subclones 4 and 14 are both mineralizing lines of 
MC3T3-E1 osteoblasts and behave similarly in culture [304]. When subconfluent in 
normal culture media (α-MEM, 10% FBS, 1% penicillin/streptomycin), these subclones 
of MC3T3-E1 are considered pre-osteoblasts because they actively proliferate and do 
not produce mineralized matrix; however, ascorbic acid stimulates the production of 
extracellular matrix proteins and terminal osteoblast differentiation markers, and β-
glycerophosphate stimulates mineralization of the matrix. 
 
For gene expression assays, cells were seeded at 20,000 cells/cm2 in 6-well 
plates and grown overnight. Four cell culture conditions were used in this study. They 
                                                                      94 
 
varied the length of bear serum stimulation and the differentiation state of the MC3T3-E1 
cells. After stimulation in one of four conditions, RNA was isolated, and real-time PCR 
performed as described in section 5.2.5. In each condition, three potential reference 
genes (β-actin, ubiquitin, cyclophilin) and the geometric means [305] of the various 
combinations of reference genes were checked for seasonal trends by a single-factor 
ANOVA for season, blocking by bear. The reference gene (or geometric mean) with the 
lowest magnitude of seasonal variation and the highest least significant number was 
chosen for normalization. Ubiquitin was later removed from reference gene analysis in 
all samples since it had a significant seasonal trend in one of the conditions.  
 
In the first condition, undifferentiated pre-osteoblasts (seeded the previous day) 
were stimulated in 2% seasonal bear serum for 3 hours. Since bear serum was collected 
every 10 days, several prehibernation, hibernation, and post-hibernation serum samples 
were available for each bear. Each well received only one serum sample, and the bear 
and date of collection were recorded. After 3 hours of stimulation, RNA was isolated. 
Real-time PCR was performed on BAD, Bcl-2, Cyclin D1, Per1, PTH1R, Runx2, Smurf1, 
and ubiquitin. Cyclophilin was used as a reference gene. In the second condition, after 
cells were allowed to attach overnight, they were switched to differentiation media (α-
MEM with 10% FBS, 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate) and 
grown for 6 days, with a media change on the third day. Differentiating osteoblasts were 
then stimulated in differentiation media supplemented with 2% seasonal bear serum for 
3 hours. Real-time PCR was performed on Akt, BAD, BAK, BAX, Bcl-XL, c-fos, MCSF, 
OCN, OPG, p53, Per1, TLR4, and ubiquitin. Samples were normalized to the geometric 
mean of 2 reference genes (β-actin and cyclophilin). In the third condition, after cells 
were allowed to attach overnight, undifferentiated pre-osteoblasts were stimulated in 
normal growth media supplemented with 2% bear serum for 24 hours. Real-time PCR 
was performed on ADRβ2, Akt, BAD, BAK, BAX, Bcl-2, Bcl-XL, BmalI, ColI, Cyclin D1, 
M-CSF, OCN, OPG, OPN, p53, Per1, Per2, PTH1R, RANKL, Runx2, Smurf1, TLR4, and 
ubiquitin. Samples were normalized to the reference gene β-actin. In the fourth 
condition, after cells were allowed to attach overnight, media was replaced with 
differentiation media containing 2% bear serum (instead of FBS). Cells were allowed to 
differentiate in bear serum for 6 days, with a media change on day 3. Real-time PCR 
was performed on BAD, BAX, Bcl-2, c-fos, ColI, Cyclin D1, OCN, OPG, OPN, Per1, 
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PTH1R, RANKL, Runx2, Smurf1, TLR4, and ubiquitin. Cyclophilin was used as the 
reference gene.  
 
All statistical analyses were performed using JMP 7 software. Data were 
presented as the LSM + SE. The units were relative since all samples were normalized 
to reference genes and to a reference (FBS) sample. All available samples from all 
bears were grouped by season (i.e. prehibernation, hibernation, and post-hibernation) 
and analyzed with a single-factor ANOVA, blocking by bear, with a Tukey’s post-hoc. 
Graphs are represented with a point for each serum sample, and a smoothed average 
curve generated with JMP software by a cubic spline. 
 
6.3 Results 
 
In the first condition (undifferentiated pre-osteoblasts stimulated for 3 hours in 
seasonal bear serum), there were no seasonal trends (Table 6.2). In the second study 
(differentiated osteoblasts stimulated for 3 hours in seasonal bear serum), ubiquitin 
expression increased from 0.998+0.058 in osteoblasts cultured in prehibernation serum 
to 1.32+0.10 in osteoblasts cultured in post-hibernation serum (p=0.0341). Expression of 
ubiquitin in osteoblasts cultured in hibernation serum was not different from either active 
season (Table 6.3). In the third study (undifferentiated pre-osteoblasts stimulated for 24 
hours in seasonal bear serum) (Table 6.4), Akt expression increased from 0.796+0.102 
in cells cultured in hibernating bear serum to 1.55+0.182 in cells cultured in post-
hibernation serum; there was no significant difference in Akt gene expression in cells 
cultured in prehibernation bear serum compared to hibernation serum (p=0.0046).   
Cyclin D1 gene expression increased from 0.950+0.032 in cells cultured in hibernation 
serum to 1.12+0.05 in cells cultured in post-hibernation serum; Cyclin D1 expression 
was not different in cells cultured in prehibernation serum compared to those in 
hibernation nor post-hibernation serum (p=0.0177). In the fourth condition (differentiated 
in bear serum for 6 days) (Table 6.5), expression of the markers for osteoblast 
differentiation Runx2 and OCN were upregulated in post-hibernation compared to 
prehibernation and hibernation seasons. Runx2 increased from 0.741+0.069 in cells 
cultured in hibernation serum to 1.13+0.12 in cells cultured in post-hibernation serum; 
Runx2 gene expression did not change in cells cultured in prehibernation serum 
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compared to those in hibernation serum (p=0.0103). OCN gene expression increased 
from 0.055+0.004 in osteoblasts cultured in hibernation serum to 0.098+0.01 in 
osteoblasts cultured in post-hibernation serum; there was no difference in OCN 
expression between cells cultured in prehibernation serum and those in hibernation 
serum (p<0.0001).  
  
6.4 Discussion 
 
 The goal of this study was to determine whether serum from hibernating bears 
contained factors which suppress proliferation, apoptosis, and differentiation of cultured 
osteoblasts when compared to serum from active bears. There were no gene expression 
changes between osteoblasts cultured in hibernation serum compared to prehibernation 
serum; however, there were several genes which were upregulated in MC3T3-E1 cells 
cultured in post-hibernation serum. In differentiated osteoblasts cultured in seasonal 
bear serum for three hours, the expression of ubiquitin increased throughout the time-
frame of the study, with a significant increase between osteoblasts in post-hibernation 
serum compared to those in prehibernation serum. This increase in ubiquitin suggests 
that the metabolism of osteoblasts may be stimulated by post-hibernation serum. 
Ubiquitin is a small protein which is covalently linked to proteins as a tag for proteolysis. 
In osteoblasts, it is ligated to several vital regulators of differentiation including Runx2, 
Smad1, and MEKK2 [292-294]. Ubiquitin also tags cell cycle (e.g. Cyclin D1) and clock 
proteins (e.g. Per1, Per2, Bmal1) [306, 307] for proteolysis. The efficient recycling of 
these cell cycle and clock genes is necessary for metabolically active cells. Therefore, 
an increase in ubiquitin expression during post-hibernation is indicative of an increase in 
the cycle of protein production and breakdown which is necessary in any active cell. 
Fitting with this suggestion of high osteoblast metabolism in post-hibernation serum, 
Cyclin D1 and Akt are upregulated in undifferentiated osteoblasts cultured in post-
hibernation serum at the 24 hour time-point. Cyclin D1 signals cells to progress past the 
G1/S checkpoint (for review see: [286, 287]), and Akt promotes cell proliferation and 
metabolism (for review see: [308]). Thus, increases in these genes in post-hibernation 
serum suggest that serum-borne factors in post-hibernation circulation stimulate 
osteoblast proliferation and activity. Finally, expression of the osteoblast differentiation 
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factors Runx2 and OCN also increase in osteoblasts differentiated in post-hibernation 
serum, further supporting the idea of increased osteoblast activity in this season.  
  
 In summary, the gene expression studies suggest that factors circulating in bears 
in the weeks immediately following hibernation promote a hypermetabolic state in 
osteoblasts. Differentiated osteoblasts have higher expression of ubiquitin and 
differentiation markers, suggesting active protein metabolism and bone formation during 
post-hibernation. Undifferentiated osteoblasts have higher expression of Akt and Cyclin 
D1, suggesting active proliferation of osteoblasts during post-hibernation. These data fit 
an earlier report of high bone turnover rate in spring-time bears [35]. 
 
6.5 Tables and figures 
 
 
 
 
Season  Bears 
Age 
(years)
Assays  Data Location 
2006‐2007  2 (1)  UK  3hr UD, 3hr D, 24hr UD, 6 day D  Table 6.2‐6.5 
2007‐2008  4 (3)  5‐14  24hr UD  Table 6.4 
 
 
 
 
  
Table 6.1—Summary of assays 
The number of bears and assays that were performed in each hibernation season. The 
number of bears that gave birth to cubs is in parentheses. Unknown values are indicated as 
“UK.” Assays in undifferentiated cells are labeled “UD,” and assays in differentiated cells are 
labeled “D.” 
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Serum 
Factor  
Fall
(Active) 
Winter
(Hibernation) 
Spring
(Active) p Power 
BAD LSM+SE 0.972+0.064 1.02+0.06 0.850+0.110 0.4310 0.1704 Nsamples 6 7 2 
Bcl-2 LSM+SE 0.873+0.160 0.924+0.148 1.12+0.277 0.7452 0.0874 Nsamples 6 7 2 
Cyclin D1 LSM+SE 1.00+0.132 1.01+0.122 1.02+0.229 0.9975 0.0503 
Nsamples 6 7 2 
Per1 LSM+SE 1.17+0.270 1.49+0.250 1.20+0.47 0.6601 0.1043 
Nsamples 6 7 2 
PTH1R LSM+SE 0.892+0.107 0.950+0.099 1.28+0.185 0.2255 0.2867 
Nsamples 6 7 2 
Runx2 LSM+SE 0.509+0.119 0.677+0.110 0.911+0.206 0.2552 0.2633 
Nsamples 6 7 2 
Smurf1 
LSM+SE 1.15+0.146 0.840+0.135 1.25+0.253 
0.2293 0.2836 Nsamples 6 7 2 
UBQ 
LSM+SE 0.911+0.093 0.939+0.086 0.981+0.161 
0.9283 0.0590 Nsamples 6 7 2 
 
 
  
Table 6.2—Gene expression 3 hour undifferentiated 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. The p-value reported is for the partial F-test for the 
serum factor. Ubiquitin is abbreviated “UBQ.” 
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Serum 
Factor  
Fall
(Active) 
Winter
(Hibernation) 
Spring
(Active) p Power 
Akt LSM+SE 0.933+0.073 0.850+0.073 0.616+0.126 0.1169 0.4289 Nsamples 12 12 4 
BAD LSM+SE 0.744+0.103 0.466+0.103 0.884+0.179 0.0771 0.5069 Nsamples 12 12 4 
BAK LSM+SE 0.860+0.108 0.971+0.108 0.690+0.188 0.4261 0.1842 Nsamples 12 12 4 
BAX LSM+SE 0.860+0.108 0.971+0.108 0.690+0.188 0.1842 0.4261 Nsamples 12 12 4 
Bcl-XL LSM+SE 1.16+0.16 1.26+0.16 0.779+0.273 0.3329 0.2289 
Nsamples 12 12 4 
c-fos LSM+SE 0.963+0.135 0.689+0.135 0.783+0.234 0.3700 0.2095 
Nsamples 12 12 4 
M-CSF LSM+SE 1.15+0.159 1.02+0.159 1.25+0.275 0.7252 0.0959 
Nsamples 12 12 4 
OCN 
LSM+SE 1.11+0.19 1.23+0.19 1.93+0.34 
0.1248 0.4163 Nsamples 12 12 4 
OPG 
LSM+SE 1.12+0.20 0.704+0.201 0.663+0.348 
0.2867 0.2567 Nsamples 12 12 4 
p53 
LSM+SE 1.27+0.24 1.04+0.24 1.00+0.42 
0.7679 0.0873 Nsamples 12 12 4 
Per1 
LSM+SE 3.02+0.59 4.88+0.59 2.81+1.01 
0.0658 0.5356 Nsamples 12 12 4 
TLR4 LSM+SE 1.28+0.35 1.65+0.35 1.68+0.61 0.7245 0.0961 Nsamples 12 12 4 
UBQ LSM+SE 0.998+0.058
B 1.08+0.06AB 1.32+0.10A 0.0341 0.6472 Nsamples 12 12 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.3—Gene expression 3 hour differentiated 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. Ubiquitin is abbreviated “UBQ.” 
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Serum 
Factor  
Fall
(Active) 
Winter
(Hibernation) 
Spring
(Active) p Power 
ADRβ2 LSM+SE 1.70+0.19 1.56+0.17 1.55+0.232 0.8378 0.0726 Nsamples 11 16 5 
Akt LSM+SE 0.976+0.123
B 0.796+0.102B 1.55+0.182A 0.0046 0.8767 Nsamples 11 16 5 
BAD LSM+SE 1.46+0.22 1.50+0.18 1.23+0.32 0.7639 0.0887 Nsamples 11 16 5 
BAK LSM+SE 1.53+0.13 1.30+0.10 1.15+0.19 0.1959 0.3317 Nsamples 11 16 5 
BAX LSM+SE 1.50+0.09 1.30+0.08 1.28+0.14 0.2152 0.3137 Nsamples 11 16 5 
Bcl-2 LSM+SE 1.38+0.14 1.13+0.12 0.948+0.206 0.1832 0.3447 Nsamples 11 16 5 
Bcl-XL LSM+SE 1.32+0.10 1.38+0.08 1.16+0.15 0.1690 0.4691 Nsamples 11 16 5 
BmalI LSM+SE 1.96+0.14 2.11+0.11 1.67+0.20 0.1830 0.3449 Nsamples 11 16 5 
ColI LSM+SE 2.80+0.28 2.73+0.23 1.92+0.41 0.1841 0.3437 Nsamples 11 16 5 
Cyclin D1 LSM+SE 1.01+0.04
AB 0.950+0.032B 1.12+0.05A 0.0177 0.7266 Nsamples 33 48 19 
M-CSF LSM+SE 0.733+0.061 0.643+0.050 0.676+0.090 0.5321 0.1472 Nsamples 11 16 5 
OCN LSM+SE 7.74+1.13 5.22+0.94 3.98+1.7 0.1285 0.4127 Nsamples 11 16 5 
OPG LSM+SE 0.568+0.051 0.489+0.043 0.606+0.076 0.3101 0.2443 Nsamples 11 16 5 
OPN LSM+SE 1.37+0.26 1.39+0.21 1.58+0.38 0.8944 0.0655 Nsamples 11 16 5 
p53 LSM+SE 1.01+0.07 1.05+0.05 0.919+0.096 0.4942 0.1599 Nsamples 11 16 5 
Per1 LSM+SE 1.65+0.11 1.73+0.089 1.47+0.16 0.3730 0.2096 Nsamples 10 16 5 
Per2 LSM+SE 3.03+0.55 3.05+0.45 2.37+0.82 0.7494 0.0916 Nsamples 10 16 5 
PTH1R LSM+SE 0.969+0.041 1.04+0.03 0.920+0.054 0.1110 0.4479 Nsamples 33 48 19 
RANKL LSM+SE 0.180+0.227 0.500+0.189 0.743+0.338 0.3480 0.2228 Nsamples 11 16 5 
Runx2 LSM+SE 0.770+0.030 0.727+0.025 0.750+0.040 0.5560 0.1456 Nsamples 33 48 19 
Smurf1 LSM+SE 0.927+0.045 0.875+0.038 0.826+0.0610 0.3919 0.2096 Nsamples 34 48 19 
TLR4 LSM+SE 1.10+0.07 1.14+0.06 1.28+0.10 0.3507 0.2214 Nsamples 11 16 5 
UBQ LSM+SE 1.02+0.06 1.03+0.044 1.18+0.08 0.2108 0.3172 Nsamples 34 48 19 
Table 6.4—Gene expression 24 hour undifferentiated 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. Ubiquitin is abbreviated “UBQ.” 
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Serum 
Factor  
Fall
(Active) 
Winter
(Hibernation) 
Spring
(Active) p Power 
BAD LSM+SE 1.08+0.06 1.01+0.05 1.09+0.084 0.5550 0.1400 Nsamples 11 16 5 
BAX LSM+SE 1.39+0.15 1.42+0.123 1.84+0.22 0.2149 0.3139 Nsamples 11 16 5 
Bcl-2 LSM+SE 0.628+0.076 0.605+0.063 0.812+0.113 0.2821 0.2620 
Nsamples 11 16 5 
c-fos LSM+SE 1.07+0.09 1.06+0.073 1.34+0.13 0.1771 0.3512 
Nsamples 11 16 5 
ColI LSM+SE 1.26+0.120 1.05+0.10 1.39+0.18 0.1824 0.3455 
Nsamples 11 16 5 
Cyclin D1 LSM+SE 1.30+0.083 1.09+0.069 1.29+0.123 0.1161 0.4319 
Nsamples 11 16 5 
OCN 
LSM+SE 0.056+0.005B 0.055+0.004B 0.098+0.01A <0.0001 0.9994 Nsamples 11 16 5 
OPG 
LSM+SE 1.55+0.13 1.45+0.11 1.69+0.19 
0.5412 0.1443 Nsamples 11 16 5 
OPN 
LSM+SE 1.09+0.099 1.11+0.082 1.41+0.15 
0.1702 0.3588 Nsamples 11 16 5 
Per1 LSM+SE 1.74+0.16 2.20+0.13 2.21+0.23 0.0737 0.5161 Nsamples 11 16 5 
PTH1R LSM+SE 1.16+0.06 1.15+0.05 1.09+0.09 0.8342 0.0755 Nsamples 11 16 5 
RANKL LSM+SE 3.86+1.61 2.19+1.30 0.928+2.166 0.5305 0.1462 Nsamples 11 16 5 
Runx2 LSM+SE 0.654+0.083
B 0.741+0.069B 1.13+0.12A 0.0103 0.8026 Nsamples 11 16 5 
Smurf1 LSM+SE 1.09+0.09 1.03+0.08 1.40+0.14 0.0838 0.4927 Nsamples 11 16 5 
TLR4 LSM+SE 1.15+0.07 1.21+0.06 1.29+0.10 0.5217 0.1505 Nsamples 11 16 5 
UBQ LSM+SE 0.918+0.042 0.794+0.035 0.905+0.062 0.0657 0.5365 Nsamples 11 16 5 
 
 
 
 
 
 
Table 6.5—Gene expression 6 day differentiated 
Data are represented as LSM+SE. The total number of samples included in the ANOVA is 
indicated below the mean concentrations. Letters (A, B, C) represent values that are 
significantly different from each other at α=0.05. Ubiquitin is abbreviated “UBQ.” 
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Figure 6.1—Longitudinal analysis of BAD gene expression in undifferentiated cells stimulated 
for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.  
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Figure 6.2—Longitudinal analysis of Bcl-2 gene expression in undifferentiated cells stimulated 
for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.3—Longitudinal analysis of Cyclin D1 gene expression in undifferentiated cells 
stimulated for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.  
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Figure 6.4—Longitudinal analysis of Per1 gene expression in undifferentiated cells stimulated 
for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.5—Longitudinal analysis of PTH1R gene expression in undifferentiated cells 
stimulated for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.  
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Figure 6.6—Longitudinal analysis of Runx2 gene expression in undifferentiated cells 
stimulated for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.7—Longitudinal analysis of Smurf1 gene expression in undifferentiated cells 
stimulated for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 1 black bear in the 2006/07 season.  
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Figure 6.8—Longitudinal analysis of ubiquitin gene expression in undifferentiated cells 
stimulated for 3 hours in seasonal bear serum 
MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by real-time PCR 
quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.9—Longitudinal analysis of Akt gene expression in differentiated cells stimulated for 
3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.10—Longitudinal analysis of BAD gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.11—Longitudinal analysis of BAK gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.12—Longitudinal analysis of BAX gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.13—Longitudinal analysis of Bcl-XL gene expression in differentiated cells 
stimulated for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.14—Longitudinal analysis of c-fos gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.15—Longitudinal analysis of M-CSF gene expression in differentiated cells 
stimulated for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.16—Longitudinal analysis of OCN gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.17—Longitudinal analysis of OPG gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.18—Longitudinal analysis of p53 gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.19—Longitudinal analysis of Per1 gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.20—Longitudinal analysis of TLR4 gene expression in differentiated cells stimulated 
for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.21—Longitudinal analysis of ubiquitin gene expression in differentiated cells 
stimulated for 3 hours in seasonal bear serum 
Differentiated MC3T3-E1 cells were cultured in seasonal bear serum for 3 hours, followed by 
real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.22—Longitudinal analysis of ADRβ2 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.23—Longitudinal analysis of Akt gene expression in undifferentiated cells stimulated 
for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.24—Longitudinal analysis of BAD gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.25—Longitudinal analysis of BAK gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.26—Longitudinal analysis of BAX gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.27—Longitudinal analysis of Bcl-2 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.28—Longitudinal analysis of Bcl-XL gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.29—Longitudinal analysis of BmalI gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.30—Longitudinal analysis of ColI gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.31—Longitudinal analysis of Cyclin D1 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.  
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Figure 6.32—Longitudinal analysis of M-CSF gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.33—Longitudinal analysis of OCN gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.34—Longitudinal analysis of OPG gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.35—Longitudinal analysis of OPN gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.36—Longitudinal analysis of p53 gene expression in undifferentiated cells stimulated 
for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.37—Longitudinal analysis of Per1 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.  
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Figure 6.38—Longitudinal analysis of Per2 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.39—Longitudinal analysis of PTH1R gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.  
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Figure 6.40—Longitudinal analysis of RANKL gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.41—Longitudinal analysis of Runx2 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.  
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Figure 6.42—Longitudinal analysis of Smurf1 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.  
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Figure 6.43—Longitudinal analysis of TLR4 gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.44—Longitudinal analysis of ubiquitin gene expression in undifferentiated cells 
stimulated for 24 hours in seasonal bear serum 
Undifferentiated MC3T3-E1 cells were cultured in seasonal bear serum for 24 hours, followed 
by real-time PCR quantification of relative gene expression. Each point represents the gene 
expression response from one serum sample. Vertical lines represent transitions between 
active and hibernating seasons. Samples are from 5 black bears in the 2007/08 season.  
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Figure 6.45—Longitudinal analysis of BAD gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.46—Longitudinal analysis of BAX gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.47—Longitudinal analysis of Bcl-2 gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.48—Longitudinal analysis of c-fos gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.49—Longitudinal analysis of ColI gene expression in cells differentiated for 6 days in 
seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.50—Longitudinal analysis of Cyclin D1 gene expression in cells differentiated for 6 
days in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.51—Longitudinal analysis of OCN gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.52—Longitudinal analysis of OPG gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.53—Longitudinal analysis of OPN gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.54—Longitudinal analysis of Per1 gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.55—Longitudinal analysis of PTH1R gene expression in cells differentiated for 6 
days in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.56—Longitudinal analysis of RANKL gene expression in cells differentiated for 6 
days in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.57—Longitudinal analysis of Runx2 gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.58—Longitudinal analysis of Smurf1 gene expression in cells differentiated for 6 
days in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
                                                                      131 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
TL
R4
 G
en
e 
Ex
pr
es
si
on
U
bi
qu
it
in
 G
en
e 
Ex
pr
es
si
on
    O      N      D      J      F      M      A      M
Month of Serum Collection 
Figure 6.59—Longitudinal analysis of TLR4 gene expression in cells differentiated for 6 days 
in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Figure 6.60—Longitudinal analysis of ubiquitin gene expression in cells differentiated for 6 
days in seasonal bear serum 
MC3T3-E1 cells were differentiated in seasonal bear serum for 6 days, followed by real-time 
PCR quantification of relative gene expression. Each point represents the gene expression 
response from one serum sample. Vertical lines represent transitions between active and 
hibernating seasons. Samples are from 2 black bears in the 2006/07 season.  
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Chapter Seven — Conclusion 
 
 The long-term goal of this study is to identify the biological mechanism through 
which bears maintain bone despite the prolonged mechanical unloading of hibernation. 
This mechanism could bring insight into new signaling pathway targets for drug 
development in osteoporosis prevention. This study was broken down into three short-
term Aims. The first Aim was to determine whether serum markers of bone turnover 
confirmed previously published histomorphometric data [18, 20] to suggest that 
osteoclast and osteoblast activities decrease dramatically during hibernation. The bone 
formation marker OCN and the resorption marker ICTP both increase during hibernation 
[34], in apparent conflict with findings in histological studies. However, these turnover 
markers accumulate in patients with reduced renal function, and hibernating bears can 
be compared to renal patients because they do not urinate during hibernation. 
Therefore, serum levels of BSALP, an indicator of osteoblast activity, and TRACP, an 
indicator of osteoclast number, were quantified in active and hibernating American black 
bears. Neither of these serum markers is affected by renal function. The hypothesis was 
that levels of BSALP and TRACP in serum from hibernating bears would be lower 
compared to levels in active bear serum.  
 
In support of the first hypothesis, this study found that serum BSALP and TRACP 
levels were significantly decreased during hibernation. These data are mentioned in 
Chapters 2 and 3. In Chapter 2, positive correlations between the energy homeostasis 
hormone adiponectin and serum turnover markers were discussed. Such correlations 
suggest that reduced levels of adiponectin during hibernation may be partially 
responsible for suppressing bone metabolism at this time of low energy expenditure. 
This finding supports previous studies which demonstrate a positive relationship 
between adiponectin and the activities of osteoblasts and osteoclasts [202, 203, 206]. 
Chapter 3 discusses an inverse correlation between serum levels of the energy 
homeostasis hormone NPY and bone turnover markers. These relationships suggest 
that raised levels of NPY may be partially responsible for suppressing bone metabolism 
during hibernation in bears. These data support a previous study which demonstrates a 
possible relationship between high serum NPY and adynamic bone disease [248], a 
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condition in renal patients in which bone turnover is dramatically decreased. Other 
possible effectors of low bone turnover during hibernation were discussed in Chapter 3. 
These include decreased levels of IGF-1 and serotonin in the serum of bears during 
hibernation. It is likely that a combination of serum factors down-regulates bone 
metabolism in hibernating bears, and any of these serum factors would be interesting 
subjects of further study. 
 
The second Aim of this study was to evaluate the inter-relationship of OCN and 
energy homeostasis hormones. Not only is OCN a vital component of bone’s 
extracellular matrix, it can also act as an energy hormone—increasing adiponectin and 
insulin secretion and promoting glucose uptake in humans and other animals. In mice, 
this stimulatory effect on adiponectin and glucose is due to ucOCN [152]. The 
hypothesis was that total and ucOCN would increase in the serum of hibernating bears, 
with correlated increases in adiponectin and insulin and a correlated decrease in serum 
glucose. In Chapter 2, increased serum levels of OCN were reported, but levels of 
adiponectin and glucose were inversely correlated to total and ucOCN. Insulin levels 
likewise decreased during hibernation, but with no correlation to OCN. These data 
suggest that if OCN acts as an energy homeostasis hormone in bears in the months 
immediately surrounding and encompassing hibernation, then it does so in a previously 
unreported manner. It is possible that the unique physiological state of bears in this 
season is regulated by a unique interaction of OCN with energy homeostasis. Another 
surprising finding reported in Chapter 2 is that total and ucOCN were negatively 
correlated to serum serotonin, and glucose and adiponectin were positively correlated to 
serotonin. A correlation of serotonin to OCN has not been reported previously, and 
earlier studies on the relationship between serotonin and adiponectin would suggest an 
inverse relationship [189, 190]. Therefore, these relationships, too, may be due to the 
unique physiological state of the weeks surrounding and encompassing hibernation. 
 
The third Aim of this study was to evaluate serum concentrations of anti-
apoptotic hormones (e.g. PTH, melatonin) and to determine whether the serum from 
hibernating bears had a protective effect on cultured osteoblasts submitted to an 
apoptotic threat. The hypothesis was that serum levels of these anti-apoptotic hormones 
would increase during hibernation in bears, and that osteoblasts cultured in serum from 
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hibernating bears would have a suppressed response to apoptotic threat compared to 
cells cultured in serum from active bears. Chapter 4 reported that despite previous 
findings [34], serum PTH had no significant trend by season. The anti-resorptive c-
terminal fragment of PTH decreased during post-hibernation, which could increase bone 
metabolism as previously described in post-hibernation bears [35]. Melatonin was below 
quantifiable levels in all serum samples. Thus, the hormones quantified in this study did 
not support the hypothesis that hibernating bear serum provides an anti-apoptotic 
environment for osteoblasts, though many apoptosis regulators remain unquantified.  
 
Despite the failure of the experiments in Chapter 4 to find anti-apoptotic 
conditions in the serum of hibernating bears, Chapter 5 reports that osteoblasts cultured 
in serum from hibernating bears were less responsive to apoptotic threat than cells 
cultured in serum from active bears. This finding was most pronounced in the 
suppressed caspase -3 and -7 response of osteoblasts grown in hibernating bear serum. 
A series of experiments were performed to characterize the hormone responsible for this 
reduced response. A filtration experiment suggested that the hormone of interest may be 
greater than 10 kD in size, with reduced concentrations in hibernation serum. Serum 
adiponectin (which is greater than 10 kD and has reduced levels during hibernation) was 
positively correlated to the caspase-3/7 response. Furthermore, caspase-3/7 response 
was positively correlated to gene expression of osteoblast differentiation markers OCN 
and Runx2, as well as to serum levels of BSALP. These correlations suggest that the 
reduction in caspase-3/7 may be partly due to the reduced differentiation potential of 
osteoblasts during hibernation. Caspase-3 activation is necessary for differentiation of 
osteoblasts [283, 284]. Hormonal fluctuations which could suppress osteoblast 
metabolism during hibernation, such as the reduction in adiponectin levels, may do so by 
suppressing caspase-3 activation. Thus, the reduced caspase-3/7 response to apoptotic 
threat in osteoblasts cultured in hibernating bear serum may be an indication of reduced 
osteoblast differentiation potential.    
 
The overlying theme of this report is that bone metabolism is decreased during 
hibernation, and this decrease could be modulated by an array of hormones. Such a 
decrease in bone metabolism during hibernation would be beneficial, because bears 
need to conserve as much energy as possible during the prolonged anorectic period of 
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hibernation. This report brings to light several potential hormonal effectors of reduced 
bone turnover, but raises new questions. Is it possible to attenuate disuse-induced bone 
loss by inducing hypometabolic states in osteoblasts and osteoclasts? If so, such a 
mechanism could be applied to protect people who are at risk of disuse induced bone 
loss (e.g. paralyzed patients, astronauts, patients confined to long-term bed-rest, or 
submariners). Most current studies on the effects of reduced bone turnover on bone 
mechanical strength and structure suggest that this condition reduces bone strength and 
BMD; however, these studies tend to take place in young (i.e. rapidly growing) rodents, 
and there are no known studies on the effects of suppressing bone turnover in 
conditions of disuse. The hormones brought to light in this study may work together to 
desensitize bone to mechanical stimulus by inducing hypometabolic states in the 
osteoblasts and osteoclasts. Studying the effects of these hormones on mechanically 
unloaded bones could yield intriguing results. Therefore, this report has achieved one 
small step in the long-term goal to determine the mechanism through which bears 
maintain bone during hibernation and to develop a treatment for people at risk of disuse 
osteoporosis.  
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 Appendix A—Complete tables of correlations 
 
Table A.1—Complete list of TRACP correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
BSALP TRACP 9 22.7 0.723 <0.0001 1 
Total ALP TRACP 9 25.4 0.726 <0.0001 1 
TRACP Adiponectin 9 0.000117 0.430 0.0222 0.6313 
TRACP NPY 8 -0.00328 -0.528 <0.0001 0.9986 
PTH1R Gene 
Expression 
24hr UD 
TRACP 4 -0.216 -0.602 0.0267 0.6088 
 
 
 
 
 
 
 
 
Table A.2—Complete list of BSAP correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
BSALP TRACP 9 22.7 0.723 <0.0001 1 
Total ALP BSALP 9 1.076 0.981 <0.0001 1 
BSALP Total Calcium 4 -5.79 -0.687 0.0307 0.6000 
BSALP Adiponectin 9 0.00676 0.627 0.0012 0.9077 
BSALP Glucose 9 0.0524 0.602 0.0290 0.5917 
BSALP NPY 8 -0.128 -0.713 <0.0001 0.9990 
BSALP Albumin 4 -7.82 -0.753 0.0034 0.8838 
BSALP Total Protein 4 -6.10 -0.794 0.0006 0.9699 
Globulin BSALP 4 -0.0283 -0.748 0.0209 0.6652 
BSALP AST/ALT 4 5.91 0.712 0.0089 0.7855 
BSALP Sodium 4 1.08 0.695 0.0244 0.6396 
BSALP Chloride 4 0.994 0.703 0.0192 0.6788 
Caspase-3/7 BSALP 4 0.130 0.728 0.0066 0.8214 
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Table A.3—Complete list of total ALP correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Total ALP TRACP 9 25.4 0.726 <0.0001 1 
Total ALP BSALP 9 1.076 0.981 <0.0001 1 
Total ALP Adiponectin 9 0.00840 0.638 0.0003 0.9611 
Insulin Total ALP 9 0.0344 0.686 0.0112 0.7235 
Total ALP NPY 8 -0.146 -0.718 <0.0001 0.9995 
Total ALP Albumin 4 -9.23 -0.744 0.0018 0.9288 
Total ALP Total Protein 4 -6.54 -0.753 0.0013 0.9446 
Total ALP AST/ALT 4 6.10 0.418 0.0182 0.6856 
Total ALP BUN 4 0.356 0.687 0.0109 0.7611 
Total ALP Crn 4 -5.79 -0.743 0.0018 0.9268 
Total ALP BUN/Crn 4 0.501 0.683 0.0065 0.8214 
Total ALP Sodium 4 1.13 0.642 0.0361 0.5709 
Total ALP Potassium 4 7.07 0.649 0.0302 0.6025 
Total ALP Chloride 4 1.04 0.648 0.0311 0.5976 
Caspase-3/7 Total ALP 9 0.0609 0.731 <0.0001 0.9993 
 
 
 
 
 
 
Table A.4—Complete list of total calcium correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
BSALP Total Calcium 4 -5.79 -0.687 0.0307 0.6000 
Ionized Calcium Total Calcium 4 0.175 0.542 0.0041 0.8399 
Total Calcium Total OCN 4 -0.00522 -0.417 0.0119 0.7269 
Glucose Total Calcium 4 57.8 0.536 0.0042 0.8386 
Total Calcium NPY 4 0.00348 0.421 0.0154 0.6933 
Albumin Total Calcium 4 0.683 0.682 <0.0001 0.9999 
Total Calcium Total Protein 4 0.348 0.623 <0.0001 0.9985 
Globulin Total Calcium 4 0.312 0.635 0.0298 0.5929 
ALT Total Calcium 4 10.5 0.525 0.0023 0.8848 
AST/ALT Total Calcium 4 -0.752 -0.635 <0.0001 0.9887 
Chloride Total Calcium 4 -2.26 -0.562 0.0156 0.6915 
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Table A.5—Complete list of ionized calcium correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Ionized Calcium Total Calcium 4 0.175 0.542 0.0041 0.8399 
Ionized Calcium Adiponectin 4 9.05e-5 0.487 0.0277 0.6047 
Ionized Calcium Glucose 4 0.00106 0.508 0.0150 0.6961 
Ionized Calcium Total Protein 4 -0.115 -0.574 0.0012 0.9241 
Globulin Ionized Calcium 4 -1.32 -0.744 <0.0001 0.9960 
Ionized Calcium BUN 4 0.00704 0.507 0.0152 0.6942 
Ionized Calcium Crn 4 -0.102 -0.520 0.0095 0.7552 
Ionized Calcium BUN:Crn 4 0.0104 0.517 0.0107 0.7403 
Chloride Ionized Calcium 4 4.95 0.553 0.0229 0.6352 
Ionized Calcium Runx2 Gene  
Expression 24hr UD 
6 0.198 0.989 0.0189 0.6584 
Ionized Calcium UBQ Gene  
Expression 6day D 
2 -0.237 -0.540 0.0013 0.9335 
ColI Gene 
Expression  
6day D 
Ionized Calcium 2 -2.56 -0.345 0.0362 0.5655 
BAD Gene 
Expression  
6day D 
Ionized Calcium 2 -1.29 -0.467 0.0186 0.6748 
Smurf1 Gene 
Expression  
6day D 
Ionized Calcium 2 -2.08 -0.576 0.0348 0.5723 
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Table A.6—Complete list of osteocalcin correlations 
Dependent  
Variable 
Independent 
Variable 
Nbears β r p Power 
Total Calcium Total OCN 4 -0.00522 -0.417 0.0119 0.7269 
ucOCN Total OCN 4 0.272 0.874 <0.0001 1 
Adiponectin Total OCN 4 -10.43 -0.521 <0.0001 0.9863 
Glucose Total OCN 4 -1.11 -0.627 <0.0001 0.9883 
Total OCN IGF-1 5 -0.0502 -0.485 0.0265 0.6109 
Serotonin Total OCN 4 -3.87 -0.513 <0.0001 0.9890 
AST Total OCN 4 -0.288 -0.483 0.0074 0.7837 
ALT Total OCN 4 -0.231 -0.699 <0.0001 0.9999 
AST/ALT Total OCN 4 0.0124 0.475 <0.0001 0.9993 
BUN Total OCN 4 -0.167 -0.539 <0.0001 0.9893 
Crn Total OCN 4 0.0111 0.477 0.0004 0.9618 
BUN/Crn Total OCN 4 -0.102 -0.458 0.0012 0.9218 
Total OCN Sodium 4 2.982 0.242 0.0371 0.5566 
Potassium Total OCN 4 -0.00392 -0.322 0.0487 0.5091 
Total OCN Caspase-3/7 4 -6.20 -0.426 0.0135 0.7113 
Adiponectin ucOCN 4 -26.4 -0.443 0.0020 0.8873 
Glucose ucOCN 4 -2.628 -0.533 0.0048 0.8259 
Serotonin ucOCN 4 -11.2 -0.473 0.0003 0.9622 
ALT ucOCN 4 -0.486 -0.525 0.0023 0.8846 
AST/ALT ucOCN 4 0.0295 0.581 0.0011 0.9625 
ucOCN BUN 4 -0.439 -0.446 0.0021 0.8899 
ucOCN Crn 4 7.18 0.527 0.0002 0.9799 
ucOCN BUN/Crn 4 -0.523 -0.396 0.0072 0.7861 
ucOCN Caspase-3/7 4 -2.10 -0.527 0.0037 0.8502 
Adiponectin %ucOCN 4 -23.4 -0.484 0.0004 0.9573 
Glucose %ucOCN 4 -2.23 -0.554 0.0021 0.8907 
Insulin %ucOCN 4 -0.0517 -0.499 0.0283 0.6008 
Serotonin %ucOCN 4 -8.41 -0.460 0.0006 0.9462 
AST %ucOCN 4 -0.535 -0.175 0.0500 0.5044 
ALT %ucOCN 4 -0.439 -0.575 0.0003 0.9667 
AST/ALT %ucOCN 4 0.0223 0.571 0.0016 0.9056 
BUN %ucOCN 4 -0.362 -0.468 0.0008 0.9420 
Crn %ucOCN 4 0.0301 0.523 <0.0001 0.9871 
BUN/Crn %ucOCN 4 -0.222 -0.403 0.0053 0.8168 
%ucOCN Caspase-3/7 4 -2.67 -0.491 0.0035 0.8549 
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Table A.7—Complete list of adiponectin correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
TRACP Adiponectin 9 0.000117 0.430 0.0222 0.6313 
BSALP Adiponectin 9 0.00676 0.627 0.0012 0.9077 
Total ALP Adiponectin 9 0.00840 0.638 0.0003 0.9611 
Ionized Calcium Adiponectin 4 9.05e-5 0.487 0.0277 0.6047 
Adiponectin Total OCN 4 -10.43 -0.521 <0.0001 0.9863 
Adiponectin ucOCN 4 -26.4 -0.443 0.0020 0.8873 
Adiponectin %ucOCN 4 -23.4 -0.484 0.0004 0.9573 
Glucose Adiponectin 4 0.0291 0.427 0.0014 0.9004 
Insulin Adiponectin 9 0.00143 0.709 <0.0001 0.9837 
Adiponectin Serotonin 4 0.899 0.411 0.0065 0.7918 
AST Adiponectin 4 0.0161 0.527 0.0016 0.9056 
ALT Adiponectin 4 0.00677 0.500 0.0054 0.8153 
Adiponectin BUN 4 36.3 0.551 <0.0001 0.9899 
Adiponectin Crn 4 -454 -0.506 0.0003 0.9661 
BUN:Crn Adiponectin 4 0.00475 0.448 0.0016 0.9063 
Potassium Adiponectin 4 0.000232 0.379 0.0148 0.6980 
Caspase-3/7 Adiponectin 4 0.000936 0.493 0.0131 0.7158 
 
 
Table A.8—Complete list of glucose correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
BSALP Glucose 9 0.0524 0.602 0.0290 0.5917 
Glucose Total Calcium 4 57.8 0.536 0.0042 0.8386 
Ionized 
Calcium 
Glucose 4 0.00106 0.508 0.0150 0.6961 
Glucose Total OCN 4 -1.11 -0.627 <0.0001 0.9883 
Glucose ucOCN 4 -2.628 -0.533 0.0048 0.8259 
Glucose %ucOCN 4 -2.23 -0.554 0.0021 0.8907 
Glucose Adiponectin 9 0.0291 0.427 0.0014 0.9004 
Glucose Serotonin 4 0.103 0.570 0.0011 0.9258 
Glucose ALT 4 2.70 0.576 0.0009 0.9368 
AST/ALT Glucose 4 -0.00580 -0.674 <0.0001 0.9982 
Glucose Crn 4 -40.1 -0.558 0.0018 0.9006 
Glucose Sodium 4 -8.51 -0.544 0.0032 0.8616 
Caspase-3/7 Glucose 9 0.0147 0.569 0.0010 0.9290 
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Table A.9—Complete list of insulin correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Insulin Total ALP 9 0.0344 0.686 0.0112 0.7235 
Insulin %ucOCN 4 -0.0517 -0.499 0.0283 0.6008 
Insulin Adiponectin 9 0.00143 0.709 <0.0001 0.9837 
Insulin ALT 4 0.0643 0.506 0.0429 0.5324 
Insulin BUN 4 0.106 0.575 0.0042 0.8419 
Insulin Crn 4 -1.20 -0.539 0.0146 0.7027 
Insulin BUN:Crn 4 0.118 0.535 0.0170 0.6810 
Insulin Caspase-3/7 9 0.256 0.759 0.0422 0.5329 
Smurf1 Gene 
Expression 
24hr UD 
Insulin 4 0.0362 0.606 0.0229 0.6337 
 
 
 
Table A.10—Complete list of leptin and IGF-1 correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Total OCN IGF-1 5 -0.0502 -0.485 0.0265 0.6109 
Leptin IGF-1 5 -0.00144 -0.568 0.0023 0.884 
 
 
Table A.11—Complete list of NPY correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
TRACP NPY 8 -0.00328 -0.528 <0.0001 0.9986 
BSAP NPY 8 -0.128 -0.713 <0.0001 0.9990 
Total ALP NPY 8 -0.146 -0.718 <0.0001 0.9995 
Total Calcium NPY 4 0.00348 0.421 0.0154 0.6933 
NPY Albumin 4 51.7 0.649 <0.0001 0.9881 
NPY Total Protein 4 25.6 0.582 0.0021 0.8914 
NPY ALT 4 1.24 0.508 0.0372 0.5563 
NPY AST/ALT 4 -25.1 -0.532 0.0153 0.6934 
NPY Sodium 4 -6.48 -0.593 0.0013 0.9190 
NPY Chloride 4 -5.41 -0.533 0.0147 0.6995 
Caspase-3/7 NPY 4 -0.0107 -0.437 0.0496 0.5061 
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Table A.12—Complete list of norepinephrine correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Norepinephrine Total Protein 4 5.78 
 
0.378 0.0390 0.5481 
Norepinephrine Sodium 4 -1.86 -0.452 0.0057 0.8098 
PTH1R gene 
expression 
6 day diff 
Norepinephrine 2 0.0696 0.535 0.0366 0.5649 
p53 gene 
expression 
24hr non-diff  
Norepinephrine 2 -0.0910 -0.429 0.0090 0.7775 
 
 
 
 
 
 
 
Table A.13—Complete list of serotonin correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Serotonin Total OCN 4 -3.87 -0.513 <0.0001 0.9890 
Serotonin ucOCN 4 -11.2 -0.473 0.0003 0.9622 
Serotonin ucOCN :Total OCN 4 -8.41 -0.460 0.0006 0.9462 
Adiponectin Serotonin 4 0.899 0.411 0.0065 0.7918 
Glucose Serotonin 4 0.103 0.570 0.0011 0.9258 
Serotonin Total Bilirubin 4 -1673 -0.437 0.0161 0.6870 
ALT Serotonin 4 0.0165 0.521 0.0027 0.8746 
AST/ALT Serotonin 4 -0.00127 -0.657 <0.0001 0.9957 
Serotonin BUN 4 9.39 0.364 0.0270 0.6089 
Serotonin Creatinine 4 -176 -0.467 0.0019 0.8975 
BAD gene 
expression  
6 day diff. 
Serotonin 2 0.000414 0.515 0.0169 0.6898 
Cyclin D1 gene 
expression 
24hr non-diff 
Serotonin 2 0.000954 0.438 0.0073 0.8004 
OCN gene 
expression 
3hr diff 
Serotonin 2 -0.00151 0.358 0.0326 0.5860 
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Table A.14—Complete list of caspase-3/7 correlations 
Dep.  
Variable 
Indep. 
Variable 
Nbears β r p Power 
Caspase-3/7 Glucose 9 0.0147 0.569 0.0010 0.9290 
Caspase-3/7 Total protein 4 -1.02 -0.412 0.0128 0.7268 
Caspase-3/7 Albumin 4 -1.76 -0.415 0.0120 0.7349 
Caspase-3/7 Globulin 4 -1.51 -0.348 0.0334 0.5783 
Caspase-3/7 BUN 4 0.0907 0.430 0.0094 0.7661 
Caspase-3/7 Creatinine 4 -1.55 -0.583 0.0568 0.976 
Caspase-3/7 Potassium 4 1.41 0.328 0.0431 0.534 
Caspase-3/7 NPY 8 -0.0133 -0.609 0.0057 0.804 
Caspase-3/7 Insulin 9 0.270 0.610 0.0422 0.533 
Caspase-3/7 ucOCN 4 -0.0853 -0.483 0.0037 0.851 
Caspase-3/7 Adiponectin 9 0.00149 0.660 <0.0001 0.990 
Caspase-3/7 C-terminal PTH 2 -0.176 -0.439 0.0104 0.758 
 
 
